{"items": "266", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Here's Why Arcutis Stock More Than Doubled in Market Value in One Year", "url": "https://www.zacks.com/stock/news/2391837/heres-why-arcutis-stock-more-than-doubled-in-market-value-in-one-year", "time_published": "20250103T182800", "authors": ["Zacks Equity Research"], "summary": "The rally in ARQT's stock could be attributed to the encouraging regulatory updates seeking label expansion for its sole marketed drug.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.190348, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ARQT", "relevance_score": "0.282234", "ticker_sentiment_score": "0.321737", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.282234", "ticker_sentiment_score": "0.046443", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.282234", "ticker_sentiment_score": "0.048602", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.348592", "ticker_sentiment_score": "0.156908", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "MESO Stock Surges 80% in a Month After FDA Approval of GVHD Drug", "url": "https://www.zacks.com/stock/news/2391722/meso-stock-surges-80-in-a-month-after-fda-approval-of-gvhd-drug", "time_published": "20250103T155600", "authors": ["Zacks Equity Research"], "summary": "Mesoblast stock climbs 80% in a month following the FDA's approval of Ryoncil as the only approved therapy for SR-aGVHD in children aged two months and older.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.96136"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.082399, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MESO", "relevance_score": "0.539641", "ticker_sentiment_score": "0.197191", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.262805", "ticker_sentiment_score": "0.009964", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.211652", "ticker_sentiment_score": "0.040312", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.262805", "ticker_sentiment_score": "0.095648", "ticker_sentiment_label": "Neutral"}]}, {"title": "CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA", "url": "https://www.zacks.com/stock/news/2391709/capr-stock-up-on-completion-of-rolling-submission-of-dmd-drug-bla", "time_published": "20250103T152300", "authors": ["Zacks Equity Research"], "summary": "Capricor stock gains 8% upon completing the rolling submission of the BLA for its lead asset, deramiocel, to treat DMD cardiomyopathy in the United States.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e0/1871.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.136486, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.220008", "ticker_sentiment_score": "0.008626", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.176825", "ticker_sentiment_score": "0.033684", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAPR", "relevance_score": "0.220008", "ticker_sentiment_score": "0.163514", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CSTL", "relevance_score": "0.220008", "ticker_sentiment_score": "0.077722", "ticker_sentiment_label": "Neutral"}, {"ticker": "NPNKF", "relevance_score": "0.044551", "ticker_sentiment_score": "0.100949", "ticker_sentiment_label": "Neutral"}]}, {"title": "Neumora Stock Hits Record Low on Depression Drug Study Failure", "url": "https://www.zacks.com/stock/news/2391560/neumora-stock-hits-record-low-on-depression-drug-study-failure", "time_published": "20250103T141400", "authors": ["Zacks Equity Research"], "summary": "NMRA stock falls after its experimental depression treatment failed to meet the primary and secondary endpoints in the first of three late-stage studies.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.002452, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NMRA", "relevance_score": "0.318897", "ticker_sentiment_score": "-0.245149", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CTMX", "relevance_score": "0.215894", "ticker_sentiment_score": "0.037466", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.215894", "ticker_sentiment_score": "0.039213", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.268", "ticker_sentiment_score": "0.127871", "ticker_sentiment_label": "Neutral"}]}, {"title": "PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?", "url": "https://www.zacks.com/stock/news/2391214/pgen-stock-surges-more-than-40-in-a-week-whats-driving-the-rally", "time_published": "20250102T182800", "authors": ["Zacks Equity Research"], "summary": "The upside in Precigen's stock comes after it completes the rolling submission of an FDA filing for its first potentially marketed product.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.104012, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PGEN", "relevance_score": "0.361626", "ticker_sentiment_score": "0.353288", "ticker_sentiment_label": "Bullish"}, {"ticker": "CSTL", "relevance_score": "0.245959", "ticker_sentiment_score": "0.140409", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.185781", "ticker_sentiment_score": "0.041291", "ticker_sentiment_label": "Neutral"}]}, {"title": "VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag", "url": "https://www.zacks.com/stock/news/2390869/vstm-up-as-nda-for-ovarian-cancer-combo-gets-fdas-priority-review-tag", "time_published": "20250102T145600", "authors": ["Zacks Equity Research"], "summary": "The FDA accepts Verastem's NDA for the accelerated approval of avutometinib to treat recurrent KRAS mutant ovarian cancer under priority review. The stock rises 41%.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/86/1981.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.069222, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.242406", "ticker_sentiment_score": "0.009323", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.195025", "ticker_sentiment_score": "0.036213", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSTM", "relevance_score": "0.50287", "ticker_sentiment_score": "0.102415", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.242406", "ticker_sentiment_score": "0.083961", "ticker_sentiment_label": "Neutral"}]}, {"title": "JNJ Inks Licensing Deal With Kaken for Eczema Candidate KP-723", "url": "https://www.zacks.com/stock/news/2388625/jnj-inks-licensing-deal-with-kaken-for-eczema-candidate-kp-723", "time_published": "20241227T121700", "authors": ["Zacks Equity Research"], "summary": "Johnson & Johnson announces a global licensing deal with Kaken for the latter's eczema candidate, KP-723, to further strengthen its dermatology portfolio.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ff/1612.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.068527, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.244109", "ticker_sentiment_score": "0.007533", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.184363", "ticker_sentiment_score": "0.037926", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.244109", "ticker_sentiment_score": "0.096047", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.607406", "ticker_sentiment_score": "0.407117", "ticker_sentiment_label": "Bullish"}, {"ticker": "KKPCF", "relevance_score": "0.061949", "ticker_sentiment_score": "0.081167", "ticker_sentiment_label": "Neutral"}]}, {"title": "MindMed Stock Skyrockets 94% Year to Date: What's Driving It?", "url": "https://www.zacks.com/stock/news/2387577/mindmed-stock-skyrockets-94-year-to-date-whats-driving-it", "time_published": "20241224T152500", "authors": ["Zacks Equity Research"], "summary": "2024 was a transformational year for MNMD as it executed many important milestones.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.159571, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.237551", "ticker_sentiment_score": "0.031344", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNMD", "relevance_score": "0.294446", "ticker_sentiment_score": "0.095314", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.237551", "ticker_sentiment_score": "0.042315", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.237551", "ticker_sentiment_score": "0.148654", "ticker_sentiment_label": "Neutral"}]}, {"title": "Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek", "url": "https://www.zacks.com/stock/news/2387103/vertex-secures-fda-approval-for-new-cystic-fibrosis-drug-alyftrek", "time_published": "20241223T184400", "authors": ["Zacks Equity Research"], "summary": "The FDA's nod is based on late-stage data, which show that treatment with VRTX's Alyftrek enhances patient benefit compared to the blockbuster drug Trikafta.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/29/1920.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.055168, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.324495", "ticker_sentiment_score": "-0.007095", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.165788", "ticker_sentiment_score": "0.038087", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.165788", "ticker_sentiment_score": "-0.149455", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.219809", "ticker_sentiment_score": "0.130208", "ticker_sentiment_label": "Neutral"}]}, {"title": "AZN's Tagrisso Gets Approval in the EU for Expanded Use in NSCLC", "url": "https://www.zacks.com/stock/news/2386987/azns-tagrisso-gets-approval-in-the-eu-for-expanded-use-in-nsclc", "time_published": "20241223T155600", "authors": ["Zacks Equity Research"], "summary": "AstraZeneca wins approval in the EU for the label expansion of Tagrisso to treat adult patients with locally advanced, unresectable NSCLC.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/a3/2951.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.086859, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.229149", "ticker_sentiment_score": "0.00716", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.172919", "ticker_sentiment_score": "0.036212", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.389744", "ticker_sentiment_score": "0.057648", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.229149", "ticker_sentiment_score": "0.091328", "ticker_sentiment_label": "Neutral"}]}, {"title": "RARE Submits BLA to the FDA for Sanfilippo Syndrome Gene Therapy", "url": "https://www.zacks.com/stock/news/2386436/rare-submits-bla-to-the-fda-for-sanfilippo-syndrome-gene-therapy", "time_published": "20241220T162700", "authors": ["Zacks Equity Research"], "summary": "Ultragenyx submits a BLA to the FDA seeking the accelerated approval of UX111 for patients with Sanfilippo syndrome type A in the United States.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.081564, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.150827", "ticker_sentiment_score": "0.005273", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.03792", "ticker_sentiment_score": "0.132587", "ticker_sentiment_label": "Neutral"}, {"ticker": "RARE", "relevance_score": "0.296313", "ticker_sentiment_score": "0.052518", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.113418", "ticker_sentiment_score": "0.028478", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABEO", "relevance_score": "0.03792", "ticker_sentiment_score": "0.09157", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.150827", "ticker_sentiment_score": "0.067366", "ticker_sentiment_label": "Neutral"}]}, {"title": "VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo", "url": "https://www.zacks.com/stock/news/2386433/vrtx-down-as-non-opioid-drug-shows-similar-pain-reduction-as-placebo", "time_published": "20241220T161300", "authors": ["Zacks Equity Research"], "summary": "Vertex announces data from a phase II study evaluating its NaV1.8 pain signal inhibitor, suzetrigine, for treating painful lumbosacral radiculopathy. Shares down.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.089028, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.232996", "ticker_sentiment_score": "-0.149786", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.232996", "ticker_sentiment_score": "0.032809", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.232996", "ticker_sentiment_score": "0.045463", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.232996", "ticker_sentiment_score": "0.046557", "ticker_sentiment_label": "Neutral"}]}, {"title": "KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707", "url": "https://www.zacks.com/stock/news/2385855/krys-reports-upbeat-initial-data-from-lung-cancer-study-of-kb707", "time_published": "20241219T160800", "authors": ["Zacks Equity Research"], "summary": "Krystal Biotech reports initial data from a phase I/II study showing therapeutic benefit in NSCLC patients treated with its immunotherapy candidate, KB707.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c2/71314.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.102252, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KRYS", "relevance_score": "0.461468", "ticker_sentiment_score": "0.284584", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.215415", "ticker_sentiment_score": "0.006817", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.162437", "ticker_sentiment_score": "0.034684", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.215415", "ticker_sentiment_score": "0.086982", "ticker_sentiment_label": "Neutral"}]}, {"title": "SRPT Finishes Enrolment in Late-Stage Study for Rare Muscular Disorder", "url": "https://www.zacks.com/stock/news/2385698/srpt-finishes-enrolment-in-late-stage-study-for-rare-muscular-disorder", "time_published": "20241219T134500", "authors": ["Zacks Equity Research"], "summary": "The phase III EMERGENE study evaluates Sarepta's experimental gene therapy for an ultra-rare form of muscle disorder for which there is no treatment beyond symptom management.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.144401, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SRPT", "relevance_score": "0.342487", "ticker_sentiment_score": "-0.026563", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.232439", "ticker_sentiment_score": "0.134242", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.175433", "ticker_sentiment_score": "0.039606", "ticker_sentiment_label": "Neutral"}]}, {"title": "GILD's Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer", "url": "https://www.zacks.com/stock/news/2385341/gilds-trodelvy-gets-second-breakthrough-therapy-tag-for-lung-cancer", "time_published": "20241218T151400", "authors": ["Zacks Equity Research"], "summary": "Gilead announces that the FDA grants a second Breakthrough Therapy designation to Trodelvy for the extensive-stage small cell lung cancer indication.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c9/2325.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998311"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.051406, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.179454", "ticker_sentiment_score": "0.007413", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.179454", "ticker_sentiment_score": "0.023088", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.135094", "ticker_sentiment_score": "0.030967", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.179454", "ticker_sentiment_score": "0.07425", "ticker_sentiment_label": "Neutral"}]}, {"title": "EWTX Stock Rises on Upbeat Data From Rare Muscular Disorder Study", "url": "https://www.zacks.com/stock/news/2384502/ewtx-stock-rises-on-upbeat-data-from-rare-muscular-disorder-study", "time_published": "20241217T141800", "authors": ["Zacks Equity Research"], "summary": "Data from a mid-stage study show that treatment with Edgewise's experimental drug reduces levels of a biomarker related to skeletal muscle damage.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.125537, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.204503", "ticker_sentiment_score": "0.008189", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.154125", "ticker_sentiment_score": "0.03488", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.302553", "ticker_sentiment_score": "0.128586", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.204503", "ticker_sentiment_score": "0.114802", "ticker_sentiment_label": "Neutral"}]}, {"title": "Merck Ends Development of Two Experimental Cancer Drugs", "url": "https://www.zacks.com/stock/news/2384462/merck-ends-development-of-two-experimental-cancer-drugs", "time_published": "20241217T140300", "authors": ["Zacks Equity Research"], "summary": "MRK's decision to discontinue the development of two cancer drugs follows a series of setbacks in multiple late-stage studies.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ef/472.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976671"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.029045, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SPRO", "relevance_score": "0.155451", "ticker_sentiment_score": "0.035073", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.206245", "ticker_sentiment_score": "0.115554", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.206245", "ticker_sentiment_score": "0.008243", "ticker_sentiment_label": "Neutral"}]}, {"title": "CHMP Endorses Merck's Kidney Cancer Drug for Two Indications", "url": "https://www.zacks.com/stock/news/2384062/chmp-endorses-mercks-kidney-cancer-drug-for-two-indications", "time_published": "20241216T155700", "authors": ["Zacks Equity Research"], "summary": "The CHMP's opinion is based on positive results from two late-stage studies on MRK's Welireg in two indications associated with renal cell carcinoma.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ef/472.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.188581, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SPRO", "relevance_score": "0.165409", "ticker_sentiment_score": "0.037991", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.219312", "ticker_sentiment_score": "0.126447", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.219312", "ticker_sentiment_score": "0.008657", "ticker_sentiment_label": "Neutral"}]}, {"title": "EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce", "url": "https://www.zacks.com/stock/news/2384053/edit-stock-falls-on-decision-to-end-reni-cel-studies-cut-workforce", "time_published": "20241216T154300", "authors": ["Zacks Equity Research"], "summary": "Editas stock falls as it ends development of reni-cel for SCD and TDT following failed attempts to find a commercial partner. It plans to cut workforce by 65%.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ba/1149.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.066891, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EDIT", "relevance_score": "0.187827", "ticker_sentiment_score": "-0.065924", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.187827", "ticker_sentiment_score": "0.006135", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.141448", "ticker_sentiment_score": "0.031797", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.187827", "ticker_sentiment_score": "0.07833", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  May Find a Bottom Soon, Here's Why You Should Buy the Stock Now", "url": "https://www.zacks.com/stock/news/2383973/cytomx-therapeutics-ctmx-may-find-a-bottom-soon-heres-why-you-should-buy-the-stock-now", "time_published": "20241216T145507", "authors": ["Zacks Equity Research"], "summary": "CytomX Therapeutics (CTMX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default316.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.226056, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.405651", "ticker_sentiment_score": "0.425337", "ticker_sentiment_label": "Bullish"}]}, {"title": "ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline", "url": "https://www.zacks.com/stock/news/2383942/abbv-to-acquire-nimble-therapeutics-to-strengthen-immunology-pipeline", "time_published": "20241216T144200", "authors": ["Zacks Equity Research"], "summary": "AbbVie is set to acquire privately held biotech, Nimble Therapeutics, for $200 million to strengthen its immunology pipeline.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/31/1512.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.275853, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.677342", "ticker_sentiment_score": "0.544626", "ticker_sentiment_label": "Bullish"}, {"ticker": "CTMX", "relevance_score": "0.208017", "ticker_sentiment_score": "0.006632", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.1568", "ticker_sentiment_score": "0.033883", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.208017", "ticker_sentiment_score": "0.084645", "ticker_sentiment_label": "Neutral"}]}, {"title": "KRYS Stock Down on Initial Clinical Updates on KB407 & KB408", "url": "https://www.zacks.com/stock/news/2383462/krys-stock-down-on-initial-clinical-updates-on-kb407-kb408", "time_published": "20241213T160800", "authors": ["Zacks Equity Research"], "summary": "Krystal Biotech posts initial clinical updates on its two pipeline candidates, KB407 and KB408, which are being developed to treat rare respiratory diseases.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.077842, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KRYS", "relevance_score": "0.471856", "ticker_sentiment_score": "0.042208", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.220809", "ticker_sentiment_score": "0.031436", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.220809", "ticker_sentiment_score": "0.033226", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.220809", "ticker_sentiment_score": "0.106351", "ticker_sentiment_label": "Neutral"}]}, {"title": "SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS", "url": "https://www.zacks.com/stock/news/2383449/snys-tolebrutinib-gets-fda-breakthrough-therapy-tag-for-nrspms", "time_published": "20241213T155800", "authors": ["Zacks Equity Research"], "summary": "The FDA bestows a Breakthrough Therapy designation to Sanofi's tolebrutinib for treating non-relapsing secondary progressive multiple sclerosis.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/8d/2080.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.110354, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.253646", "ticker_sentiment_score": "0.035122", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.253646", "ticker_sentiment_score": "0.03712", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.253646", "ticker_sentiment_score": "0.118781", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.253646", "ticker_sentiment_score": "0.226168", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "NVO Gets Positive CHMP Opinion in EU for Ozempic Expanded Use in CKD", "url": "https://www.zacks.com/stock/news/2383219/nvo-gets-positive-chmp-opinion-in-eu-for-ozempic-expanded-use-in-ckd", "time_published": "20241213T134800", "authors": ["Zacks Equity Research"], "summary": "Novo Nordisk's diabetes drug, Ozempic, receives positive CHMP opinion in the EU for expanded use in T2D and CKD patients.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.181025, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.158259", "ticker_sentiment_score": "0.006801", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.119038", "ticker_sentiment_score": "0.030254", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.417053", "ticker_sentiment_score": "0.252006", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CSTL", "relevance_score": "0.158259", "ticker_sentiment_score": "0.069502", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why Q32 Bio Stock Hit a New Record Low on Wednesday", "url": "https://www.zacks.com/stock/news/2382902/heres-why-q32-bio-stock-hit-a-new-record-low-on-wednesday", "time_published": "20241212T160000", "authors": ["Zacks Equity Research"], "summary": "Shares of QTTB fall after its experimental autoimmune disease drug failed to meet the primary endpoint in a mid-stage study for eczema.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.048054, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SPRO", "relevance_score": "0.186259", "ticker_sentiment_score": "0.041347", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.246582", "ticker_sentiment_score": "0.138744", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.246582", "ticker_sentiment_score": "0.009508", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why Agios Stock Plummeted More Than 20% on Monday", "url": "https://www.zacks.com/stock/news/2381632/heres-why-agios-stock-plummeted-more-than-20-on-monday", "time_published": "20241210T154600", "authors": ["Zacks Equity Research"], "summary": "The fall in AGIO stock comes after reports of an unexpected side effect linked to its sole-marketed drug Pyrukynd in thalassemia patients.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/37/2337.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.09531, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AGIO", "relevance_score": "0.215415", "ticker_sentiment_score": "-0.094335", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPRX", "relevance_score": "0.162437", "ticker_sentiment_score": "0.133604", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.215415", "ticker_sentiment_score": "0.008564", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.215415", "ticker_sentiment_score": "0.133374", "ticker_sentiment_label": "Neutral"}]}, {"title": "AbbVie's Recently Acquired Parkinson's Drug Meets Third Study Goal", "url": "https://www.zacks.com/stock/news/2381629/abbvies-recently-acquired-parkinsons-drug-meets-third-study-goal", "time_published": "20241210T153900", "authors": ["Zacks Equity Research"], "summary": "Data from a late-stage study shows that treatment with flexible doses of ABBV's tavapadon reduced the burden of Parkinson's disease.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/31/1512.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.174388, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.273399", "ticker_sentiment_score": "0.138801", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.220308", "ticker_sentiment_score": "0.008688", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.166169", "ticker_sentiment_score": "0.03811", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.220308", "ticker_sentiment_score": "0.126897", "ticker_sentiment_label": "Neutral"}]}, {"title": "Grifols Stock Declines After Brookfield Drops Buyout Offer", "url": "https://www.zacks.com/stock/news/2376569/grifols-stock-declines-after-brookfield-drops-buyout-offer", "time_published": "20241128T150200", "authors": ["Zacks Equity Research"], "summary": "Brookfield decides to drop its buyout offer for GRFS following discrepancies over the company's valuation.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": -0.007292, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GRFS", "relevance_score": "0.817006", "ticker_sentiment_score": "-0.086081", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.304679", "ticker_sentiment_score": "0.0429", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.304679", "ticker_sentiment_score": "0.045212", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAM", "relevance_score": "0.062434", "ticker_sentiment_score": "-0.003014", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.245959", "ticker_sentiment_score": "0.088083", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/24/11/g42212288/cytomx-therapeutics-to-present-at-the-36th-annual-piper-sandler-healthcare-conference", "time_published": "20241127T130000", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Nov. 27, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.109565, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.087824", "ticker_sentiment_score": "0.041182", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.259267", "ticker_sentiment_score": "0.063415", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.087824", "ticker_sentiment_score": "0.041182", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.087824", "ticker_sentiment_score": "0.041182", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2024/11/27/2988176/37704/en/CytomX-Therapeutics-to-Present-at-the-36th-Annual-Piper-Sandler-Healthcare-Conference.html", "time_published": "20241127T130000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., Nov. 27, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a fireside chat ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.09784, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.10607", "ticker_sentiment_score": "0.047068", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.210274", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.10607", "ticker_sentiment_score": "0.047068", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.10607", "ticker_sentiment_score": "0.047068", "ticker_sentiment_label": "Neutral"}]}, {"title": "AstraZeneca's Combination Therapy Meets Goal in Prostate Cancer Study", "url": "https://www.zacks.com/stock/news/2375636/astrazenecas-combination-therapy-meets-goal-in-prostate-cancer-study", "time_published": "20241126T191800", "authors": ["Zacks Equity Research"], "summary": "Data from a late-stage study shows that treatment with a three-drug combo involving AZN's Truqap benefits patients with an aggressive form of prostate cancer.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e5/1416.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.024526, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.544246", "ticker_sentiment_score": "-0.29585", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CSTL", "relevance_score": "0.259727", "ticker_sentiment_score": "0.10006", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.321393", "ticker_sentiment_score": "0.049535", "ticker_sentiment_label": "Neutral"}]}, {"title": "JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer", "url": "https://www.zacks.com/stock/news/2373587/jazz-secures-fda-approval-for-ziihera-in-biliary-tract-cancer", "time_published": "20241121T170800", "authors": ["Zacks Equity Research"], "summary": "Following the FDA's approval, Jazz's Ziihera becomes the first dual HER2-targeted bispecific antibody and chemotherapy-free treatment approved for biliary tract cancer.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.059838, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BGNE", "relevance_score": "0.073321", "ticker_sentiment_score": "0.05335", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.354572", "ticker_sentiment_score": "0.048186", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.354572", "ticker_sentiment_score": "0.053332", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAZZ", "relevance_score": "0.354572", "ticker_sentiment_score": "0.114098", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.2872", "ticker_sentiment_score": "0.099748", "ticker_sentiment_label": "Neutral"}]}, {"title": "Grifols' Board Rejects Brookfield's Buyout Offer, Stock Down 8%", "url": "https://www.zacks.com/stock/news/2372720/grifols-board-rejects-brookfields-buyout-offer-stock-down-8", "time_published": "20241120T143000", "authors": ["Zacks Equity Research"], "summary": "Per GRFS, Brookfield's offer to buy its entire outstanding share capital for 6.45 billion euros significantly undervalues GRFS' prospects and long-term potential.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.029182, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GRFS", "relevance_score": "0.787342", "ticker_sentiment_score": "-0.12512", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.343755", "ticker_sentiment_score": "0.047079", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.343755", "ticker_sentiment_score": "0.052109", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.278222", "ticker_sentiment_score": "0.097252", "ticker_sentiment_label": "Neutral"}]}, {"title": "Down -25.59% in 4 Weeks, Here's Why CytomX Therapeutics  ( CTMX )  Looks Ripe for a Turnaround", "url": "https://www.zacks.com/stock/news/2372121/down--2559-in-4-weeks-heres-why-cytomx-therapeutics-ctmx-looks-ripe-for-a-turnaround", "time_published": "20241119T143507", "authors": ["Zacks Equity Research"], "summary": "CytomX Therapeutics (CTMX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default59.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.168999, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.493128", "ticker_sentiment_score": "0.212655", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC", "url": "https://www.zacks.com/stock/news/2371987/chmp-endorses-astrazenecas-tagrisso-for-expanded-use-in-nsclc", "time_published": "20241119T132300", "authors": ["Zacks Equity Research"], "summary": "The CHMP's opinion is based on late-stage data, which show that treatment with AZN's Tagrisso extends progression-free survival by more than three years in certain NSCLC patients.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e5/1416.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.105582, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.327366", "ticker_sentiment_score": "0.045361", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.327366", "ticker_sentiment_score": "0.05021", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.387875", "ticker_sentiment_score": "-0.038241", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.264658", "ticker_sentiment_score": "0.093431", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Q3 Earnings and Revenues Top Estimates", "url": "https://www.zacks.com/stock/news/2366870/cytomx-therapeutics-ctmx-q3-earnings-and-revenues-top-estimates", "time_published": "20241107T225509", "authors": ["Zacks Equity Research"], "summary": "CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of 143.75% and 76.70%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default341.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999953"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.123812, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRSN", "relevance_score": "0.204072", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.395012", "ticker_sentiment_score": "0.1156", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Report Third Quarter 2024 Financial Results on November 7, 2024 - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/24/10/g41650384/cytomx-therapeutics-to-report-third-quarter-2024-financial-results-on-november-7-2024", "time_published": "20241031T120000", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Oct. 31, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of masked, conditionally activated biologic therapeutics, today announced that it will report third quarter financial results on Thursday, November 7, 2024, after the close of ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.109476, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.089462", "ticker_sentiment_score": "0.048799", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.263942", "ticker_sentiment_score": "0.074256", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.089462", "ticker_sentiment_score": "0.048799", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.089462", "ticker_sentiment_score": "0.048799", "ticker_sentiment_label": "Neutral"}]}, {"title": "Day One Biopharmaceuticals, Inc.  ( DAWN )  Surpasses Q3 Earnings and Revenue Estimates", "url": "https://www.zacks.com/stock/news/2361062/day-one-biopharmaceuticals-inc-dawn-surpasses-q3-earnings-and-revenue-estimates", "time_published": "20241030T212013", "authors": ["Zacks Equity Research"], "summary": "Day One Biopharmaceuticals (DAWN) delivered earnings and revenue surprises of 290% and 144.68%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default30.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999687"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.152057, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.20997", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAWN", "relevance_score": "0.405651", "ticker_sentiment_score": "0.208029", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY\u00ae, in a Phase 1 Study in Patients with Solid Tumors", "url": "https://www.globenewswire.com/news-release/2024/09/09/2942754/37704/en/CytomX-Therapeutics-Announces-First-Patient-Dosed-with-CX-801-a-Dually-Masked-Interferon-Alpha-2b-PROBODY-in-a-Phase-1-Study-in-Patients-with-Solid-Tumors.html", "time_published": "20240909T120000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., Sept. 09, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of masked, conditionally activated biologic therapeutics, today announced that the first patient has been dosed with CX-801 monotherapy in a Phase 1 study ( ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.076989, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.039483", "ticker_sentiment_score": "0.047495", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.195498", "ticker_sentiment_score": "0.045242", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.039483", "ticker_sentiment_score": "0.047495", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.039483", "ticker_sentiment_score": "0.047495", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference", "url": "https://www.globenewswire.com/news-release/2024/06/18/2900339/37704/en/CytomX-Therapeutics-to-Present-at-the-H-C-Wainwright-2nd-Annual-Immune-Cell-Engager-Virtual-Conference.html", "time_published": "20240618T120000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., June 18, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.140431, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.109956", "ticker_sentiment_score": "0.055734", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.217834", "ticker_sentiment_score": "0.115574", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.109956", "ticker_sentiment_score": "0.055734", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.109956", "ticker_sentiment_score": "0.055734", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Lowered to \"Hold\" at StockNews.com", "url": "https://www.defenseworld.net/2024/06/18/cytomx-therapeutics-nasdaqctmx-lowered-to-hold-at-stocknews-com.html", "time_published": "20240618T065241", "authors": ["Defense World Staff"], "summary": "StockNews.com lowered shares of CytomX Therapeutics ( NASDAQ:CTMX - Free Report ) from a buy rating to a hold rating in a report issued on Monday morning.", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&Symbol=CTMX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.998356"}, {"topic": "Earnings", "relevance_score": "0.947132"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.246044, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JEF", "relevance_score": "0.060541", "ticker_sentiment_score": "0.06", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.871234", "ticker_sentiment_score": "0.414366", "ticker_sentiment_label": "Bullish"}]}, {"title": "CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/24/06/g39366109/cytomx-therapeutics-promotes-chris-ogden-to-chief-financial-officer", "time_published": "20240617T201500", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., June 17, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of masked, conditionally activated biologics, today announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.133546, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.034087", "ticker_sentiment_score": "0.04386", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.1692", "ticker_sentiment_score": "0.038735", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.034087", "ticker_sentiment_score": "0.04386", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.034087", "ticker_sentiment_score": "0.04386", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer", "url": "https://www.globenewswire.com/news-release/2024/06/17/2900015/37704/en/CytomX-Therapeutics-Promotes-Chris-Ogden-to-Chief-Financial-Officer.html", "time_published": "20240617T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., June 17, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of masked, conditionally activated biologics, today announced the promotion of Chris Ogden to Chief Financial Officer effective June 15, 2024.", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.128854, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.036091", "ticker_sentiment_score": "0.046131", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.143629", "ticker_sentiment_score": "0.076539", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.036091", "ticker_sentiment_score": "0.046131", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.036091", "ticker_sentiment_score": "0.046131", "ticker_sentiment_label": "Neutral"}]}, {"title": " ( CTMX )  - Analyzing CytomX Therapeutics's Short Interest - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/insights/short-sellers/24/06/39190059/ctmx-analyzing-cytomx-therapeuticss-short-interest", "time_published": "20240605T170025", "authors": ["Benzinga Insights"], "summary": "CytomX Therapeutics's CTMX short percent of float has risen 143.23% since its last report. The company recently reported that it has 8.75 million shares sold short, which is 11.31% of all regular shares that are available for trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.292162, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.209365", "ticker_sentiment_score": "0.148634", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2024/05/22/2886834/37704/en/CytomX-Therapeutics-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html", "time_published": "20240522T200500", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., May 22, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.114504, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.113597", "ticker_sentiment_score": "0.056493", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.224903", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.113597", "ticker_sentiment_score": "0.056493", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.113597", "ticker_sentiment_score": "0.056493", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Announces New Employment Inducement Grants", "url": "https://www.globenewswire.com/news-release/2024/05/16/2883880/37704/en/CytomX-Therapeutics-Announces-New-Employment-Inducement-Grants.html", "time_published": "20240516T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., May 16, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of masked, conditionally activated biologics, today announced that on May 15, 2024, the Company granted two new employees options to purchase a total of 130,000 ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.17973, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.098255", "ticker_sentiment_score": "0.051259", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.288893", "ticker_sentiment_score": "0.210473", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.098255", "ticker_sentiment_score": "0.051259", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.098255", "ticker_sentiment_score": "0.051259", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Upgraded to \"Buy\" by StockNews.com", "url": "https://www.defenseworld.net/2024/05/12/cytomx-therapeutics-nasdaqctmx-upgraded-to-buy-by-stocknews-com.html", "time_published": "20240512T072446", "authors": ["Defense World Staff"], "summary": "CytomX Therapeutics ( NASDAQ:CTMX - Get Free Report ) was upgraded by StockNews.com from a \"hold\" rating to a \"buy\" rating in a research note issued to investors on Friday. CTMX has been the subject of several other research reports.", "banner_image": "https://www.marketbeat.com/logos/cytomx-therapeutics-inc-logo-1200x675.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999941"}, {"topic": "Earnings", "relevance_score": "0.938793"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.301845, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BK", "relevance_score": "0.104911", "ticker_sentiment_score": "0.198957", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JEF", "relevance_score": "0.05257", "ticker_sentiment_score": "0.113597", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.83383", "ticker_sentiment_score": "0.490815", "ticker_sentiment_label": "Bullish"}]}, {"title": "What's Going On With CytomX Therapeutics Stock On Thursday? - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38741805/analysts-varied-perspectives-on-cytomxs-cx-904-cancer-study-safety-profile-but-caut", "time_published": "20240509T185921", "authors": ["Vandana Singh"], "summary": "Wednesday, CytomX Therapeutics Inc CTMX released initial data from the ongoing CX-904 Phase 1a dose escalation clinical study, demonstrating a favorable safety profile and confirmed anti-cancer activity.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/09/Cancer-Image-by-PDPics-from-Pixabay-.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.10808, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.410505", "ticker_sentiment_score": "0.419724", "ticker_sentiment_label": "Bullish"}]}, {"title": "Gold Moves Higher; Roblox Issues Weak Outlook - Roblox  ( NYSE:RBLX ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38741293/gold-moves-higher-roblox-issues-weak-outlook", "time_published": "20240509T183025", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping over 200 points on Thursday. The Dow traded up 0.63% to 39,300.69 while the NASDAQ rose 0.18% to 16,331.58. The S&P 500 also rose, gaining, 0.32% to 5,204.48 . Real estate shares rose by 2% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/09/gold-miner-shutter2.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.207514, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CPOP", "relevance_score": "0.130926", "ticker_sentiment_score": "0.236595", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SEZL", "relevance_score": "0.130926", "ticker_sentiment_score": "0.325264", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.130926", "ticker_sentiment_score": "0.121721", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIVC", "relevance_score": "0.130926", "ticker_sentiment_score": "0.142756", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCSI", "relevance_score": "0.130926", "ticker_sentiment_score": "0.525862", "ticker_sentiment_label": "Bullish"}, {"ticker": "RBLX", "relevance_score": "0.258351", "ticker_sentiment_score": "-0.079849", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.130926", "ticker_sentiment_score": "0.189084", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Dow Jumps Over 150 Points; US Foods Posts Upbeat Earnings - US Foods Hldg  ( NYSE:USFD ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38737341/dow-jumps-over-150-points-us-foods-posts-upbeat-earnings", "time_published": "20240509T160129", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Thursday. The Dow traded up 0.48% to 39,244.53 while the NASDAQ rose 0.32% to 16,354.20. The S&P 500 also rose, gaining, 0.37% to 5,206.94 . Real estate shares rose by 1.7% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/09/xrdDAFilhIzFHI2-j4449787454-t23051106.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.928769"}], "overall_sentiment_score": 0.234316, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CPOP", "relevance_score": "0.137671", "ticker_sentiment_score": "0.242612", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SEZL", "relevance_score": "0.137671", "ticker_sentiment_score": "0.333221", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.137671", "ticker_sentiment_score": "0.125006", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIVC", "relevance_score": "0.137671", "ticker_sentiment_score": "0.146465", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCSI", "relevance_score": "0.137671", "ticker_sentiment_score": "0.536689", "ticker_sentiment_label": "Bullish"}, {"ticker": "USFD", "relevance_score": "0.205225", "ticker_sentiment_score": "0.020509", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.137671", "ticker_sentiment_score": "0.193957", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket - AppLovin  ( NASDAQ:APP ) ", "url": "https://www.benzinga.com/news/24/05/38729362/why-applovin-shares-are-trading-higher-by-15-here-are-20-stocks-moving-premarket", "time_published": "20240509T121328", "authors": ["Avi Kapoor"], "summary": "Shares of AppLovin Corporation APP rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. The company posted revenue of $1.058 billion, versus estimates of $974.361 million.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/09/xrdDAFrIeSK2eI2-j4239412416966744852-t23.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.897321"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.998932"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.157542, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APP", "relevance_score": "0.188683", "ticker_sentiment_score": "0.292874", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IVP", "relevance_score": "0.188683", "ticker_sentiment_score": "0.015787", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEZL", "relevance_score": "0.12645", "ticker_sentiment_score": "0.207045", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.12645", "ticker_sentiment_score": "0.129989", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.046647", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIVC", "relevance_score": "0.188683", "ticker_sentiment_score": "-0.033848", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIXI", "relevance_score": "0.12645", "ticker_sentiment_score": "0.328302", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DUOL", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.046647", "ticker_sentiment_label": "Neutral"}, {"ticker": "TC", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.202366", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "COMP", "relevance_score": "0.12645", "ticker_sentiment_score": "0.168451", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CMPGF", "relevance_score": "0.063425", "ticker_sentiment_score": "0.145132", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPOP", "relevance_score": "0.12645", "ticker_sentiment_score": "0.08911", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNI", "relevance_score": "0.063425", "ticker_sentiment_score": "0.255513", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BYND", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.072319", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.046647", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGL", "relevance_score": "0.188683", "ticker_sentiment_score": "0.110933", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARGX", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.145078", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONVO", "relevance_score": "0.12645", "ticker_sentiment_score": "-0.028717", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVS", "relevance_score": "0.188683", "ticker_sentiment_score": "0.263024", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g38712713/cytomx-therapeutics-reports-first-quarter-2024-financial-results-and-provides-business-update", "time_published": "20240508T201000", "authors": ["Globe Newswire"], "summary": "- Company announces positive initial Phase 1a dose escalation data for monotherapy CX-904 ( EGFRxCD3 T-cell engager ) in solid tumors - - First dose cohort cleared in Phase 1 clinical study of CX-2051, an EpCAM Targeting PROBODY\u00ae ADC, in solid tumors. Initial data anticipated in the first ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.12341, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.015392", "ticker_sentiment_score": "0.04007", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.076847", "ticker_sentiment_score": "0.023608", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.061512", "ticker_sentiment_score": "0.078222", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.046154", "ticker_sentiment_score": "0.071763", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination with KEYTRUDA\u00ae  ( pembrolizumab ) ", "url": "https://www.globenewswire.com/news-release/2024/05/07/2877258/37704/en/CytomX-Therapeutics-Announces-Clinical-Collaboration-with-Merck-to-Evaluate-CX-801-in-Combination-with-KEYTRUDA-pembrolizumab.html", "time_published": "20240507T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "- CX-801 is a dually masked, conditionally activated IFN\u03b12b cytokine designed using the CytomX Probody\u00ae Therapeutic Platform ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.086459, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.032961", "ticker_sentiment_score": "0.046708", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.195814", "ticker_sentiment_score": "0.049293", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.032961", "ticker_sentiment_score": "0.046708", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.032961", "ticker_sentiment_score": "0.046708", "ticker_sentiment_label": "Neutral"}]}, {"title": "Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Etsy  ( NASDAQ:ETSY ) , Fastly  ( NYSE:FSLY ) , DoorDash  ( NASDAQ:DASH ) ", "url": "https://www.benzinga.com/news/24/05/38580803/etsy-reports-downbeat-earnings-joins-fastly-doordash-and-other-big-stocks-moving-lower-in-thursdays", "time_published": "20240502T121725", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were higher this morning, with the Dow futures gaining over 150 points on Thursday. Shares of Etsy, Inc. ETSY fell sharply in today's pre-market trading after the company reported worse-than-expected first-quarter financial results.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/02/Etsy-photo-by-Sergei-Elagin-on-Shutterst.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.779048"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.99915"}], "overall_sentiment_score": -0.032221, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.078018", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELY", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.055336", "ticker_sentiment_label": "Neutral"}, {"ticker": "DASH", "relevance_score": "0.167322", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRU", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.307082", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APPN", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.047609", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.058466", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.327366", "ticker_sentiment_score": "-0.052233", "ticker_sentiment_label": "Neutral"}, {"ticker": "HDSN", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.073042", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDGR", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.055336", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.28442", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "Z", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.058466", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLY", "relevance_score": "0.167322", "ticker_sentiment_score": "0.074629", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.167322", "ticker_sentiment_score": "0.109292", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYC", "relevance_score": "0.167322", "ticker_sentiment_score": "-0.133514", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Surges 214.7%: Is This an Indication of Further Gains?", "url": "https://www.zacks.com/stock/news/2266699/cytomx-therapeutics-ctmx-surges-2147-is-this-an-indication-of-further-gains", "time_published": "20240502T120800", "authors": ["Zacks Equity Research"], "summary": "CytomX Therapeutics (CTMX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default141.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.198106, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABSI", "relevance_score": "0.53784", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.53784", "ticker_sentiment_score": "0.164934", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket - Aptevo Therapeutics  ( NASDAQ:APVO ) , Aspen Aerogels  ( NYSE:ASPN ) ", "url": "https://www.benzinga.com/news/24/05/38575263/why-aspen-aerogels-shares-are-trading-higher-by-26-here-are-20-stocks-moving-premarket", "time_published": "20240502T094331", "authors": ["Avi Kapoor"], "summary": "Shares of Aspen Aerogels, Inc. ASPN rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results. Aspen Aerogels posted a GAAP loss of 2 cents per share, compared to market expectations for a loss of 11 cents per share.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/02/Image17.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.994953"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.180456, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.2035", "ticker_sentiment_score": "-0.029119", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMCC", "relevance_score": "0.136499", "ticker_sentiment_score": "0.12526", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELY", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.048629", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.136499", "ticker_sentiment_score": "0.328227", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ENVX", "relevance_score": "0.136499", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONDS", "relevance_score": "0.136499", "ticker_sentiment_score": "0.449611", "ticker_sentiment_label": "Bullish"}, {"ticker": "DASH", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.201579", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ASPN", "relevance_score": "0.269033", "ticker_sentiment_score": "0.207338", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BFLY", "relevance_score": "0.136499", "ticker_sentiment_score": "0.443822", "ticker_sentiment_label": "Bullish"}, {"ticker": "ETSY", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.048629", "ticker_sentiment_label": "Neutral"}, {"ticker": "APVO", "relevance_score": "0.136499", "ticker_sentiment_score": "0.189456", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBS", "relevance_score": "0.136499", "ticker_sentiment_score": "0.201579", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CVNA", "relevance_score": "0.136499", "ticker_sentiment_score": "0.190668", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "Z", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.201579", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FSLY", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.090132", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.117129", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRME", "relevance_score": "0.136499", "ticker_sentiment_score": "0.464605", "ticker_sentiment_label": "Bullish"}, {"ticker": "RENT", "relevance_score": "0.136499", "ticker_sentiment_score": "0.163992", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Dow Jumps 200 Points Following Fed Decision; Pfizer Earnings Top Estimates - Pfizer  ( NYSE:PFE ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38561882/dow-jumps-200-points-following-fed-decision-pfizer-earnings-top-estimates", "time_published": "20240501T183212", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Wednesday. The Federal Reserve opted to keep the federal funds rate unchanged at 5.25% to 5.5%, as widely expected. The Dow traded up 0.55% to 38,022.21 while the NASDAQ rose 0.19% to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Pfizer-shutterstock2_0.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.02903, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KMB", "relevance_score": "0.068502", "ticker_sentiment_score": "-0.143562", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.136499", "ticker_sentiment_score": "0.074447", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVRX", "relevance_score": "0.136499", "ticker_sentiment_score": "0.021569", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.068502", "ticker_sentiment_score": "-0.143562", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.136499", "ticker_sentiment_score": "0.125211", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKY", "relevance_score": "0.136499", "ticker_sentiment_score": "0.449611", "ticker_sentiment_label": "Bullish"}, {"ticker": "SPGI", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.024627", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMDX", "relevance_score": "0.136499", "ticker_sentiment_score": "0.379389", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.2035", "ticker_sentiment_score": "-0.066229", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEG", "relevance_score": "0.136499", "ticker_sentiment_score": "-0.085301", "ticker_sentiment_label": "Neutral"}]}, {"title": "Crude Oil Down 3%; ISM Manufacturing PMI Falls In April - CytomX Therapeutics  ( NASDAQ:CTMX ) , Cemtrex  ( NASDAQ:CETX ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38558157/crude-oil-down-3-ism-manufacturing-pmi-falls-in-april", "time_published": "20240501T161704", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Wednesday. The Dow traded up 0.33% to 37,941.76 while the NASDAQ fell 0.35% to 15,603.45. The S&P 500 also fell, dropping, 0.25% to 5,023.16. Communication services shares rose by 1.1% on Wednesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/Crude-oil-4-logo.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.451494"}], "overall_sentiment_score": -0.002441, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KMB", "relevance_score": "0.079921", "ticker_sentiment_score": "-0.145593", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.236588", "ticker_sentiment_score": "0.012879", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVRX", "relevance_score": "0.159043", "ticker_sentiment_score": "0.023704", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.079921", "ticker_sentiment_score": "-0.145593", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.159043", "ticker_sentiment_score": "0.136865", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKY", "relevance_score": "0.159043", "ticker_sentiment_score": "0.484568", "ticker_sentiment_label": "Bullish"}, {"ticker": "SPGI", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.027005", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMDX", "relevance_score": "0.159043", "ticker_sentiment_score": "0.41083", "ticker_sentiment_label": "Bullish"}, {"ticker": "LEG", "relevance_score": "0.159043", "ticker_sentiment_score": "-0.093277", "ticker_sentiment_label": "Neutral"}]}, {"title": "What's Going On With CytomX Stock? - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/news/24/05/38557651/whats-going-on-with-cytomx-stock", "time_published": "20240501T160518", "authors": ["Erica Kollmann"], "summary": "CytomX Therapeutics, Inc. CTMX shares are racing higher Wednesday. The company said it will report first-quarter results and provide an initial CX-904 Phase 1a dose escalation update on May 8 after the close of markets. CytomX and Amgen, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/pharmaceuticals-therapeutics-medicine.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.967645"}], "overall_sentiment_score": 0.366113, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "AMGN", "relevance_score": "0.262522", "ticker_sentiment_score": "0.066739", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.497391", "ticker_sentiment_score": "0.490262", "ticker_sentiment_label": "Bullish"}]}, {"title": "US Stocks Mixed; Amazon Posts Upbeat Earnings - Amazon.com  ( NASDAQ:AMZN ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38552235/us-stocks-mixed-amazon-posts-upbeat-earnings", "time_published": "20240501T135159", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed this morning, with the Dow Jones gaining around 0.1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.09% to 37,851.28 while the NASDAQ rose 0.04% to 15,663.99. The S&P 500 also fell, dropping, 0.16% to 5,027.53. Materials shares rose by 0.7% on ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/01/wall-street-chart-shutter3.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.067043, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KMB", "relevance_score": "0.075635", "ticker_sentiment_score": "-0.144665", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.22421", "ticker_sentiment_score": "0.012338", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVRX", "relevance_score": "0.150592", "ticker_sentiment_score": "0.022879", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOM", "relevance_score": "0.075635", "ticker_sentiment_score": "-0.144665", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.150592", "ticker_sentiment_score": "0.155249", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CETX", "relevance_score": "0.150592", "ticker_sentiment_score": "0.132325", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGI", "relevance_score": "0.075635", "ticker_sentiment_score": "0.0727", "ticker_sentiment_label": "Neutral"}, {"ticker": "PALI", "relevance_score": "0.22421", "ticker_sentiment_score": "0.233935", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMZN", "relevance_score": "0.150592", "ticker_sentiment_score": "-0.048119", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEG", "relevance_score": "0.150592", "ticker_sentiment_score": "-0.090165", "ticker_sentiment_label": "Neutral"}]}, {"title": "Vanda  ( VNDA )  to Report Q1 Earnings: What's in the Cards?", "url": "https://www.zacks.com/stock/news/2261585/vanda-vnda-to-report-q1-earnings-whats-in-the-cards", "time_published": "20240424T175800", "authors": ["Zacks Equity Research"], "summary": "On Vanda's (VNDA) first-quarter 2024 earnings call, investors' focus is likely to be on the sales performance of its marketed drugs and certain pipeline and regulatory updates.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/49/1007.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.109272, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.190793", "ticker_sentiment_score": "-0.003041", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.048133", "ticker_sentiment_score": "-0.071085", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.1437", "ticker_sentiment_score": "0.171113", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VNDA", "relevance_score": "0.327366", "ticker_sentiment_score": "0.028564", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.1437", "ticker_sentiment_score": "0.159788", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Lowers CytomX Therapeutics  ( NASDAQ:CTMX )  to Hold", "url": "https://www.defenseworld.net/2024/04/24/stocknews-com-lowers-cytomx-therapeutics-nasdaqctmx-to-hold.html", "time_published": "20240424T082242", "authors": ["Defense World Staff"], "summary": "StockNews.com cut shares of CytomX Therapeutics ( NASDAQ:CTMX - Free Report ) from a buy rating to a hold rating in a research note issued to investors on Tuesday. Separately, JPMorgan Chase & Co. raised CytomX Therapeutics from an underweight rating to a neutral rating in a research report on ...", "banner_image": "https://www.marketbeat.com/logos/cytomx-therapeutics-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.307296, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BK", "relevance_score": "0.150592", "ticker_sentiment_score": "0.242149", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.745397", "ticker_sentiment_score": "0.478671", "ticker_sentiment_label": "Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.075635", "ticker_sentiment_score": "0.137129", "ticker_sentiment_label": "Neutral"}]}, {"title": "GSK Gears Up for Q1 Earnings: Here's What to Expect", "url": "https://www.zacks.com/stock/news/2260559/gsk-gears-up-for-q1-earnings-heres-what-to-expect", "time_published": "20240423T171600", "authors": ["Zacks Equity Research"], "summary": "We expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Nucala, Trelegy Ellipta and Shingrix to drive first-quarter sales performance.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.066665, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.193078", "ticker_sentiment_score": "-0.003069", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARGX", "relevance_score": "0.240014", "ticker_sentiment_score": "-0.058134", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.145437", "ticker_sentiment_score": "0.164755", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GSK", "relevance_score": "0.417611", "ticker_sentiment_score": "0.178525", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Incyte  ( INCY )  to Report Q1 Earnings: What's in the Cards?", "url": "https://www.zacks.com/stock/news/2260352/incyte-incy-to-report-q1-earnings-whats-in-the-cards", "time_published": "20240423T134400", "authors": ["Zacks Equity Research"], "summary": "Incyte's (INCY) first-quarter 2024 revenues are likely to have been driven by the U.S. sales and royalties from Novartis on ex-U.S. sales of its lead drug, Jakafi.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/98/2216.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999813"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.229025, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "INCY", "relevance_score": "0.709375", "ticker_sentiment_score": "0.31327", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MOR", "relevance_score": "0.046816", "ticker_sentiment_score": "0.305824", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVS", "relevance_score": "0.139804", "ticker_sentiment_score": "0.134181", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.185662", "ticker_sentiment_score": "0.058551", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.139804", "ticker_sentiment_score": "0.085178", "ticker_sentiment_label": "Neutral"}]}, {"title": "AbbVie  ( ABBV )  to Report Q1 Earnings: What's in the Cards?", "url": "https://www.zacks.com/stock/news/2259539/abbvie-abbv-to-report-q1-earnings-whats-in-the-cards", "time_published": "20240422T165600", "authors": ["Zacks Equity Research"], "summary": "Investor focus is likely to be on the sales of AbbVie's (ABBV) blockbuster immunology drugs Rinvoq and Skyrizi when it reports first-quarter results.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999965"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.203046, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LABP", "relevance_score": "0.100099", "ticker_sentiment_score": "0.137083", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.470606", "ticker_sentiment_score": "0.262532", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.198628", "ticker_sentiment_score": "-0.003136", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.149656", "ticker_sentiment_score": "0.175155", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Viking  ( VKTX )  to Report Q1 Earnings: What's in the Cards?", "url": "https://www.zacks.com/stock/news/2258702/viking-vktx-to-report-q1-earnings-whats-in-the-cards", "time_published": "20240419T151600", "authors": ["Zacks Equity Research"], "summary": "Devoid of marketed drugs, investors will focus on Viking Therapeutics' (VKTX) pipeline updates when it reports first-quarter earnings results.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.084138, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VKTX", "relevance_score": "0.346365", "ticker_sentiment_score": "0.034176", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.202366", "ticker_sentiment_score": "-0.003181", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARGX", "relevance_score": "0.202366", "ticker_sentiment_score": "-0.058898", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.152499", "ticker_sentiment_score": "0.180994", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY\u00ae T-Cell Engaging Bispecific  ( TCB )  Collaboration with Astellas", "url": "https://www.globenewswire.com/news-release/2024/04/03/2856845/37704/en/CytomX-Therapeutics-Announces-Nomination-of-Second-Clinical-Candidate-in-Broad-PROBODY-T-Cell-Engaging-Bispecific-TCB-Collaboration-with-Astellas.html", "time_published": "20240403T120000", "authors": ["CytomX Therapeutics Inc."], "summary": "- Achievement of latest clinical candidate triggers additional $5 million milestone payment to CytomX and is the third milestone achieved in the collaboration to date ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.135839, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.039811", "ticker_sentiment_score": "0.04956", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.039811", "ticker_sentiment_score": "0.04956", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.119038", "ticker_sentiment_score": "0.072062", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Oracle  ( NYSE:ORCL ) ", "url": "https://www.benzinga.com/news/24/03/37613941/why-oracle-shares-are-trading-higher-by-around-13-here-are-20-stocks-moving-premarket", "time_published": "20240312T121102", "authors": ["Avi Kapoor"], "summary": "Shares of Oracle Corporation ORCL rose sharply in today's pre-market trading after the company reported upbeat earnings for its fiscal third quarter. Oracle's third-quarter revenue increased 7% year-over-year to $13.3 billion, which missed the consensus estimate of $13.306 billion, according to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/03/12/oracle_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.996675"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.18239, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "RERE", "relevance_score": "0.140896", "ticker_sentiment_score": "0.228379", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SGDVV", "relevance_score": "0.070725", "ticker_sentiment_score": "-0.263178", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CTMX", "relevance_score": "0.140896", "ticker_sentiment_score": "0.19021", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NXL", "relevance_score": "0.20997", "ticker_sentiment_score": "0.052999", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONM", "relevance_score": "0.20997", "ticker_sentiment_score": "0.456781", "ticker_sentiment_label": "Bullish"}, {"ticker": "SGLY", "relevance_score": "0.140896", "ticker_sentiment_score": "0.358883", "ticker_sentiment_label": "Bullish"}, {"ticker": "ORCL", "relevance_score": "0.20997", "ticker_sentiment_score": "0.253999", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "STI", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.230838", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FNCH", "relevance_score": "0.140896", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNLX", "relevance_score": "0.20997", "ticker_sentiment_score": "0.063385", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUL", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.049533", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.069769", "ticker_sentiment_label": "Neutral"}, {"ticker": "LITM", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.406757", "ticker_sentiment_label": "Bearish"}, {"ticker": "CLRO", "relevance_score": "0.20997", "ticker_sentiment_score": "0.325402", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MNSO", "relevance_score": "0.140896", "ticker_sentiment_score": "0.193023", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACAD", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.268894", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HRTG", "relevance_score": "0.140896", "ticker_sentiment_score": "0.535242", "ticker_sentiment_label": "Bullish"}, {"ticker": "VINO", "relevance_score": "0.140896", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Lags Q4 Earnings Estimates", "url": "https://www.zacks.com/stock/news/2238863/cytomx-therapeutics-ctmx-lags-q4-earnings-estimates", "time_published": "20240311T212003", "authors": ["Zacks Equity Research"], "summary": "CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -50% and 13.90%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default293.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999953"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.157842, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CUE", "relevance_score": "0.20698", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.400265", "ticker_sentiment_score": "0.187726", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/24/03/g37598795/cytomx-therapeutics-reports-2023-financial-results-and-provides-business-update", "time_published": "20240311T201000", "authors": ["Globe Newswire"], "summary": "- CX-904 ( EGFRxCD3 T-cell engager ) initial Phase 1a dose escalation data in solid tumors anticipated in the 2nd half of 2024 - - CX-2051 ( EpCAM ADC ) Phase 1 clinical study initiation in solid tumors, including colorectal cancer ( CRC ) anticipated in the 1st half of 2024 -", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.096985, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.095075", "ticker_sentiment_score": "0.053096", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.110826", "ticker_sentiment_score": "0.062567", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.079287", "ticker_sentiment_score": "0.024774", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update", "url": "https://www.globenewswire.com/news-release/2024/03/11/2844158/37704/en/CytomX-Therapeutics-Reports-2023-Financial-Results-and-Provides-Business-Update.html", "time_published": "20240311T201000", "authors": ["CytomX Therapeutics Inc."], "summary": "- CX-904 ( EGFRxCD3 T-cell engager ) initial Phase 1a dose escalation data in solid tumors anticipated in the 2nd half of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.097025, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.09539", "ticker_sentiment_score": "0.042567", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.111193", "ticker_sentiment_score": "0.045954", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.063678", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate  ( ADC )  Toolkit - Akari Therapeutics  ( NASDAQ:AKTX ) , Peak Bio  ( OTC:PKBO ) ", "url": "https://www.benzinga.com/pressreleases/24/03/g37479142/akari-therapeutics-and-peak-bio-announce-definitive-agreement-to-merge-as-equals-creating-an-expan", "time_published": "20240305T130000", "authors": ["Globe Newswire"], "summary": "BOSTON and PLEASANTON, Calif., March 05, 2024 ( GLOBE NEWSWIRE ) -- Akari Therapeutics, Plc AKTX, a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, and Peak Bio Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990893"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.128261, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AKTX", "relevance_score": "0.089941", "ticker_sentiment_score": "0.033828", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIO", "relevance_score": "0.012875", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURN", "relevance_score": "0.012875", "ticker_sentiment_score": "0.031625", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.012875", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GERN", "relevance_score": "0.012875", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.012875", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate  ( ADC )  Toolkit - Akari Therapeutics  ( NASDAQ:AKTX ) , Peak Bio  ( OTC:PKBO ) ", "url": "https://www.benzinga.com/pressreleases/24/03/g37479163/akari-therapeutics-and-peak-bio-announce-definitive-agreement-to-merge-as-equals-creating-an-expan", "time_published": "20240305T130000", "authors": ["Globe Newswire"], "summary": "BOSTON and PLEASANTON, Calif., March 05, 2024 ( GLOBE NEWSWIRE ) -- Akari Therapeutics, Plc AKTX, a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, and Peak Bio Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990893"}, {"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.130563, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AKTX", "relevance_score": "0.077094", "ticker_sentiment_score": "0.03385", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIO", "relevance_score": "0.012869", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURN", "relevance_score": "0.012869", "ticker_sentiment_score": "0.031623", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.012869", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GERN", "relevance_score": "0.012869", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.012869", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Longtime Gilead Commercial Executive Joins IntegriChain as Chairman of the Board", "url": "https://www.prnewswire.com/news-releases/longtime-gilead-commercial-executive-joins-integrichain-as-chairman-of-the-board-302073845.html", "time_published": "20240228T150000", "authors": ["IntegriChain"], "summary": "PHILADELPHIA, Feb. 28, 2024 /PRNewswire/ -- IntegriChain, delivering pharma's only comprehensive technology, data, consulting, and outsourcing platform for data-driven commercialization, today announced the appointment of Jim Meyers, a highly experienced pharmaceutical commercialization ...", "banner_image": "https://mma.prnewswire.com/media/1218115/IntegriChain_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.938793"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.256053, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SGMO", "relevance_score": "0.05749", "ticker_sentiment_score": "0.04899", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABUS", "relevance_score": "0.05749", "ticker_sentiment_score": "0.04899", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.05749", "ticker_sentiment_score": "0.04899", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.114682", "ticker_sentiment_score": "0.045632", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX  ( CTMX )  to Report Q4 Earnings: Here's What to Expect", "url": "https://www.zacks.com/stock/news/2232603/cytomx-ctmx-to-report-q4-earnings-heres-what-to-expect", "time_published": "20240227T165200", "authors": ["Zacks Equity Research"], "summary": "Investor focus is likely to be on CytomX Therapeutics' (CTMX) updates on key cancer immunotherapeutic candidates, CX-904 and BMS-986288, on the fourth-quarter 2023 earnings call.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999756"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.096247, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.355588", "ticker_sentiment_score": "-0.141497", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMGN", "relevance_score": "0.218161", "ticker_sentiment_score": "0.122327", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.355588", "ticker_sentiment_score": "0.070899", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.288044", "ticker_sentiment_score": "-0.013155", "ticker_sentiment_label": "Neutral"}]}, {"title": "AstraZeneca's  ( AZN )  sBLA for Enhertu Gets FDA's Priority Tag", "url": "https://www.zacks.com/stock/news/2217677/astrazenecas-azn-sbla-for-enhertu-gets-fdas-priority-tag", "time_published": "20240130T124400", "authors": ["Zacks Equity Research"], "summary": "AstraZeneca's (AZN) sBLA for Enhertu to treat metastatic HER2-positive solid tumors gets priority review status by the FDA. A final decision is expected in second-quarter 2024.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e5/1416.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.983783"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.175923, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SKXJF", "relevance_score": "0.053992", "ticker_sentiment_score": "-0.074092", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.213517", "ticker_sentiment_score": "0.018579", "ticker_sentiment_label": "Neutral"}, {"ticker": "DERM", "relevance_score": "0.213517", "ticker_sentiment_score": "0.05874", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSKYF", "relevance_score": "0.053992", "ticker_sentiment_score": "-0.074092", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.412017", "ticker_sentiment_score": "0.12185", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.213517", "ticker_sentiment_score": "0.157631", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Apellis  ( APLS )  Down on Negative CHMP Opinion for Pegcetacoplan", "url": "https://www.zacks.com/stock/news/2216945/apellis-apls-down-on-negative-chmp-opinion-for-pegcetacoplan", "time_published": "20240129T134800", "authors": ["Zacks Equity Research"], "summary": "Apellis (APLS) stock falls on the CHMP's negative recommendation to the EMA regarding the approval of intravitreal pegcetacoplan in the EU for the treatment of geographic atrophy secondary to age-related macular degeneration.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/604.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.983783"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.072031, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APLS", "relevance_score": "0.312158", "ticker_sentiment_score": "-0.085816", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.159218", "ticker_sentiment_score": "0.02037", "ticker_sentiment_label": "Neutral"}, {"ticker": "DERM", "relevance_score": "0.159218", "ticker_sentiment_score": "0.059324", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.159218", "ticker_sentiment_score": "0.129027", "ticker_sentiment_label": "Neutral"}]}, {"title": "SpringWorks  ( SWTX )  Surges More Than 80% in 3 Months: Here's Why", "url": "https://www.zacks.com/stock/news/2215721/springworks-swtx-surges-more-than-80-in-3-months-heres-why", "time_published": "20240125T141900", "authors": ["Zacks Equity Research"], "summary": "SpringWorks (SWTX) receives a big boost with the FDA's approval for Ogsiveo (nirogacestat) to treat adult patients with progressing desmoid tumors.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/96/702.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.122949, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.397098", "ticker_sentiment_score": "0.032991", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.271274", "ticker_sentiment_score": "0.223434", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.335367", "ticker_sentiment_score": "0.199549", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWTX", "relevance_score": "0.271274", "ticker_sentiment_score": "0.288054", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Heron  ( HRTX )  Gains 19% on FDA Nod for Zynrelef Label Expansion", "url": "https://www.zacks.com/stock/news/2215517/heron-hrtx-gains-19-on-fda-nod-for-zynrelef-label-expansion", "time_published": "20240125T114400", "authors": ["Zacks Equity Research"], "summary": "Heron (HRTX) rises 19% on label expansion of its postoperative pain management drug, Zynrelef, to include additional orthopedic and soft tissue procedures.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7d/49079.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.983783"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.157613, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.222327", "ticker_sentiment_score": "0.02092", "ticker_sentiment_label": "Neutral"}, {"ticker": "DERM", "relevance_score": "0.222327", "ticker_sentiment_score": "0.058902", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.275867", "ticker_sentiment_score": "0.31531", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.222327", "ticker_sentiment_score": "0.162653", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Jasper Therapeutics  ( JSPR )  Surges 110% in a Month: Here's Why", "url": "https://www.zacks.com/stock/news/2215186/jasper-therapeutics-jspr-surges-110-in-a-month-heres-why", "time_published": "20240124T171400", "authors": ["Zacks Equity Research"], "summary": "Jasper Therapeutics (JSPR) surges after it provides business updates that highlight the company's progress with its pipeline. Multiple data readouts are expected throughout this year.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Life Sciences", "relevance_score": "0.5"}], "overall_sentiment_score": 0.054607, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "JSPR", "relevance_score": "0.343619", "ticker_sentiment_score": "0.157513", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.249361", "ticker_sentiment_score": "-0.020937", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.101154", "ticker_sentiment_score": "0.043569", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.200688", "ticker_sentiment_score": "0.12085", "ticker_sentiment_label": "Neutral"}]}, {"title": "Travere  ( TVTX )  Stock Up More Than 30% in 3 Months: Here's Why", "url": "https://www.zacks.com/stock/news/2215121/travere-tvtx-stock-up-more-than-30-in-3-months-heres-why", "time_published": "20240124T162500", "authors": ["Zacks Equity Research"], "summary": "Travere (TVTX) is on track to file an sNDA to the FDA to convert the accelerated approval for lead drug, Filspari, to full approval for IgAN in first-quarter 2024.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/86/1981.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.190711, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TVTX", "relevance_score": "0.359014", "ticker_sentiment_score": "0.098513", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.359014", "ticker_sentiment_score": "0.033207", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.244109", "ticker_sentiment_score": "0.203802", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.302429", "ticker_sentiment_score": "0.184301", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why Investors May Bet on BioMarin  ( BMRN )  Stock Now", "url": "https://www.zacks.com/stock/news/2215118/heres-why-investors-may-bet-on-biomarin-bmrn-stock-now", "time_published": "20240124T162100", "authors": ["Zacks Equity Research"], "summary": "Here, we discuss some reasons why investing in BioMarin (BMRN) stock now may turn out to be a more prudent move than ever.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99237"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.218932, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BMRN", "relevance_score": "0.100099", "ticker_sentiment_score": "0.022346", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.294093", "ticker_sentiment_score": "-0.0283", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.198628", "ticker_sentiment_score": "0.138377", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.246832", "ticker_sentiment_score": "0.11459", "ticker_sentiment_label": "Neutral"}]}, {"title": "Unicycive  ( UNCY )  Up on Positive Hyperphosphatemia Study Update", "url": "https://www.zacks.com/stock/news/2214931/unicycive-uncy-up-on-positive-hyperphosphatemia-study-update", "time_published": "20240124T143900", "authors": ["Zacks Equity Research"], "summary": "Unicycive (UNCY) rises after the encouraging progress in the late-stage development of its lead candidate, OLC, for the hyperphosphatemia indication. The NDA submission is expected around mid-2024.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/49/1007.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.986564"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.145217, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "UNCY", "relevance_score": "0.370733", "ticker_sentiment_score": "0.315829", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADMA", "relevance_score": "0.320974", "ticker_sentiment_score": "0.132193", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.217346", "ticker_sentiment_score": "0.018818", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.217346", "ticker_sentiment_score": "0.159823", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Inhibrx  ( INBX )  Up 6% on Sale of Rare Disease Drug to Sanofi", "url": "https://www.zacks.com/stock/news/2214518/inhibrx-inbx-up-6-on-sale-of-rare-disease-drug-to-sanofi", "time_published": "20240123T193000", "authors": ["Zacks Equity Research"], "summary": "Sanofi (SNY) will acquire Inhibrx (INBX) for nearly $2.2 billion. Post-acquisition, it will retain the rare disease drug and spin out all other pipeline programs into a newly-traded public company.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.139567, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "INBX", "relevance_score": "0.716023", "ticker_sentiment_score": "0.337321", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.279015", "ticker_sentiment_score": "-0.022981", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.169676", "ticker_sentiment_score": "0.119393", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.567965", "ticker_sentiment_score": "0.248232", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Ionis'  ( IONS )  Donidalorsen Meets Late-Stage HAE Study Goal", "url": "https://www.zacks.com/stock/news/2214493/ionis-ions-donidalorsen-meets-late-stage-hae-study-goal", "time_published": "20240123T182300", "authors": ["Zacks Equity Research"], "summary": "Ionis (IONS) reports positive phase III study results, which show that treatment with donidalorsen achieved a statistically significant reduction in HAE attacks.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.040288, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BCRX", "relevance_score": "0.099683", "ticker_sentiment_score": "0.051924", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHVS", "relevance_score": "0.197816", "ticker_sentiment_score": "-0.066432", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONS", "relevance_score": "0.197816", "ticker_sentiment_score": "0.136416", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.245835", "ticker_sentiment_score": "0.01332", "ticker_sentiment_label": "Neutral"}]}, {"title": "Lisata  ( LSTA )  Stock Up More Than 35% in 3 Months: Here's Why", "url": "https://www.zacks.com/stock/news/2214420/lisata-lsta-stock-up-more-than-35-in-3-months-heres-why", "time_published": "20240123T171200", "authors": ["Zacks Equity Research"], "summary": "Lisata (LSTA) is progressing well with the development of its lead investigational product candidate, LSTA1, which targets several cancer indications.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e6/2070.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.065234, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.398148", "ticker_sentiment_score": "0.033052", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.272029", "ticker_sentiment_score": "0.223923", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LSTA", "relevance_score": "0.272029", "ticker_sentiment_score": "0.159766", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.33628", "ticker_sentiment_score": "0.199957", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Mirum  ( MIRM )  Banks on Livmarli Sales Despite Recent Setback", "url": "https://www.zacks.com/stock/news/2214378/mirum-mirm-banks-on-livmarli-sales-despite-recent-setback", "time_published": "20240123T164400", "authors": ["Zacks Equity Research"], "summary": "Mirum's (MIRM) lead drug, Livmarli, continues to generate steady sales. The company's efforts to expand the label of the drug are also encouraging. However, pipeline setback remains a concern.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/39/612.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976671"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.11584, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TVTX", "relevance_score": "0.052801", "ticker_sentiment_score": "0.097632", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.308891", "ticker_sentiment_score": "0.027332", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIRM", "relevance_score": "0.208914", "ticker_sentiment_score": "0.097664", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.208914", "ticker_sentiment_score": "0.182071", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.259451", "ticker_sentiment_score": "0.163277", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AstraZeneca's  ( AZN )  Imfinzi Combo Meets Liver Cancer Study Goal", "url": "https://www.zacks.com/stock/news/2213719/astrazenecas-azn-imfinzi-combo-meets-liver-cancer-study-goal", "time_published": "20240122T194200", "authors": ["Zacks Equity Research"], "summary": "Data from a late-stage shows that AstraZeneca's (AZN) cancer combination therapy reduces the risk of disease progression or death in certain liver cancer patients by 23%.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.043259, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.234458", "ticker_sentiment_score": "-0.018104", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.488217", "ticker_sentiment_score": "0.130886", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.09495", "ticker_sentiment_score": "0.040773", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.18856", "ticker_sentiment_score": "0.113845", "ticker_sentiment_label": "Neutral"}]}, {"title": "Edgewise  ( EWTX )  Rallies 35% on Issue of New Common Stock", "url": "https://www.zacks.com/stock/news/2213712/edgewise-ewtx-rallies-35-on-issue-of-new-common-stock", "time_published": "20240122T190600", "authors": ["Zacks Equity Research"], "summary": "Edgewise (EWTX) will issue secondary shares to raise $240 million in gross proceeds. The capital will be used to fund key initiatives, including the potential commercial launch of lead pipeline drugs.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.149, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.265089", "ticker_sentiment_score": "-0.021985", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.107736", "ticker_sentiment_score": "0.042241", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.315493", "ticker_sentiment_score": "0.201876", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVO", "relevance_score": "0.213517", "ticker_sentiment_score": "0.123528", "ticker_sentiment_label": "Neutral"}]}, {"title": "Alvotech  ( ALVO )  Up on BLA Update for Two Biosimilar Candidates", "url": "https://www.zacks.com/stock/news/2213525/alvotech-alvo-up-on-bla-update-for-two-biosimilar-candidates", "time_published": "20240122T150300", "authors": ["Zacks Equity Research"], "summary": "The FDA concludes the reinspection of Alvotech's (ALVO) facility in Iceland. The company believes that it may receive approval for biosimilar candidates, AVT02 and AVT04, in the United States. Stock rises.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c3/648.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.243298, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALVO", "relevance_score": "0.43852", "ticker_sentiment_score": "0.291445", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.43852", "ticker_sentiment_score": "0.038341", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.371523", "ticker_sentiment_score": "0.230099", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "TransCode  ( RNAZ )  Down 50% on Issue of New Common Stock", "url": "https://www.zacks.com/stock/news/2213010/transcode-rnaz-down-50-on-issue-of-new-common-stock", "time_published": "20240119T180900", "authors": ["Zacks Equity Research"], "summary": "TransCode Therapeutics (RNAZ) will issue secondary shares and warrants, diluting its current shareholder base. The company plans to raise $7.5 million in gross proceeds from this issue.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}], "overall_sentiment_score": 0.066624, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.291644", "ticker_sentiment_score": "-0.023738", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNAZ", "relevance_score": "0.34648", "ticker_sentiment_score": "0.176745", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SRPT", "relevance_score": "0.11894", "ticker_sentiment_score": "0.043817", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.235252", "ticker_sentiment_score": "0.133405", "ticker_sentiment_label": "Neutral"}]}, {"title": "ADC Therapeutics  ( ADCT )  Rises 43% in a Month: Here's Why", "url": "https://www.zacks.com/stock/news/2213007/adc-therapeutics-adct-rises-43-in-a-month-heres-why", "time_published": "20240119T180500", "authors": ["Zacks Equity Research"], "summary": "ADC Therapeutics (ADCT) surges after it provides business updates that highlight the company's progress with its pipeline. Multiple data readouts are expected throughout this year.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.115308, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ADCT", "relevance_score": "0.523044", "ticker_sentiment_score": "0.26941", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.253514", "ticker_sentiment_score": "-0.021218", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.102888", "ticker_sentiment_score": "0.043781", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.204072", "ticker_sentiment_score": "0.122408", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:DLT", "relevance_score": "0.051551", "ticker_sentiment_score": "0.026922", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mesoblast  ( MESO )  Up on Rare Pediatric Disease Tag for Heart Drug", "url": "https://www.zacks.com/stock/news/2212927/mesoblast-meso-up-on-rare-pediatric-disease-tag-for-heart-drug", "time_published": "20240119T163000", "authors": ["Zacks Equity Research"], "summary": "Mesoblast's (MESO) Revascor (rexlemestrocel-L) gets FDA's Rare Pediatric Disease designation for treating children with congenital heart disease. Shares rise in after-hours trading.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.141271, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MESO", "relevance_score": "0.427425", "ticker_sentiment_score": "0.158758", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.427425", "ticker_sentiment_score": "0.037598", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.293214", "ticker_sentiment_score": "0.235399", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.361802", "ticker_sentiment_score": "0.211065", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Syros  ( SYRS )  Stock Surges 200% in 3 Months: Here's Why", "url": "https://www.zacks.com/stock/news/2212898/syros-syrs-stock-surges-200-in-3-months-heres-why", "time_published": "20240119T154300", "authors": ["Zacks Equity Research"], "summary": "Syros (SYRS) is progressing well with the development of its pipeline candidate, tamibarotene, targeting two different cancer indications.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/ba/1149.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.150204, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SYRS", "relevance_score": "0.276648", "ticker_sentiment_score": "0.161938", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.404563", "ticker_sentiment_score": "0.036199", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.276648", "ticker_sentiment_score": "0.224951", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.341857", "ticker_sentiment_score": "0.202409", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is ADC Therapeutics  ( ADCT )  Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/2212816/is-adc-therapeutics-adct-outperforming-other-medical-stocks-this-year", "time_published": "20240119T144003", "authors": ["Zacks Equity Research"], "summary": "Here is how ADC Therapeutics SA (ADCT) and CytomX Therapeutics (CTMX) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default117.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.251093, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ADCT", "relevance_score": "0.757528", "ticker_sentiment_score": "0.35605", "ticker_sentiment_label": "Bullish"}, {"ticker": "CTMX", "relevance_score": "0.483888", "ticker_sentiment_score": "0.236759", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "MAIA Soars 20% on Interim Results From Lung Cancer Study", "url": "https://www.zacks.com/stock/news/2212386/maia-soars-20-on-interim-results-from-lung-cancer-study", "time_published": "20240118T180600", "authors": ["Zacks Equity Research"], "summary": "MAIA Biotechnology (MAIA) reports updated results from a mid-stage study. Patients treated with its lead drug achieved disease control rates that were well-sustained compared with previous scans.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.004825, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVO", "relevance_score": "0.18343", "ticker_sentiment_score": "0.131918", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.300946", "ticker_sentiment_score": "-0.024438", "ticker_sentiment_label": "Neutral"}]}, {"title": "Instil  ( TIL )  Stock Rises More Than 20% in a Week: Here's Why", "url": "https://www.zacks.com/stock/news/2212365/instil-til-stock-rises-more-than-20-in-a-week-heres-why", "time_published": "20240118T172800", "authors": ["Zacks Equity Research"], "summary": "Instil's (TIL) recent deal with a collaborator to carry out preclinical manufacturing feasibility studies on its ITIL-306 program is a positive.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.078865, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.472338", "ticker_sentiment_score": "0.037074", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.326283", "ticker_sentiment_score": "0.25761", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TIL", "relevance_score": "0.472338", "ticker_sentiment_score": "0.025118", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.401331", "ticker_sentiment_score": "0.22721", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is it a Good Idea to Invest in Intellia  ( NTLA )  Stock Now?", "url": "https://www.zacks.com/stock/news/2212290/is-it-a-good-idea-to-invest-in-intellia-ntla-stock-now", "time_published": "20240118T165000", "authors": ["Zacks Equity Research"], "summary": "Here, we discuss some reasons why investing in Intellia (NTLA) stock now may turn out to be a more prudent move than ever.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.103398, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.371523", "ticker_sentiment_score": "0.034133", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.19117", "ticker_sentiment_score": "0.311717", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NTLA", "relevance_score": "0.803061", "ticker_sentiment_score": "0.216001", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.313218", "ticker_sentiment_score": "0.200468", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Allakos  ( ALLK )  Plummets 60% on Ending Development of Lead Drug", "url": "https://www.zacks.com/stock/news/2211650/allakos-allk-plummets-60-on-ending-development-of-lead-drug", "time_published": "20240117T171000", "authors": ["Zacks Equity Research"], "summary": "Allakos (ALLK) decides to stop developing its lead drug after top-line data from two mid-stage studies did not achieve their primary endpoints.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.04806, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.295867", "ticker_sentiment_score": "-0.024026", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.596532", "ticker_sentiment_score": "0.046136", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.120733", "ticker_sentiment_score": "0.04636", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.238718", "ticker_sentiment_score": "0.138524", "ticker_sentiment_label": "Neutral"}]}, {"title": "Aclaris  ( ACRS )  Stock Rises on Appointment of New Interim CEO", "url": "https://www.zacks.com/stock/news/2211548/aclaris-acrs-stock-rises-on-appointment-of-new-interim-ceo", "time_published": "20240117T161400", "authors": ["Zacks Equity Research"], "summary": "Aclaris (ACRS) appoints Neal Walker as interim CEO after current CEO, Douglas Manion, steps down from his role. Shares rise.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/604.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.084847, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.392948", "ticker_sentiment_score": "0.032746", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.268294", "ticker_sentiment_score": "0.2215", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACRS", "relevance_score": "0.136113", "ticker_sentiment_score": "0.039469", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.331765", "ticker_sentiment_score": "0.197928", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Reasons to Add Blueprint  ( BPMC )  Stock to Your Portfolio Now", "url": "https://www.zacks.com/stock/news/2210923/reasons-to-add-blueprint-bpmc-stock-to-your-portfolio-now", "time_published": "20240116T165100", "authors": ["Zacks Equity Research"], "summary": "Here, we discuss some reasons why investing in Blueprint (BPMC) stock now may turn out to be a more prudent move than ever.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/86/1981.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.976671"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.160975, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ZLAB", "relevance_score": "0.053509", "ticker_sentiment_score": "0.179755", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BPMC", "relevance_score": "0.106778", "ticker_sentiment_score": "0.124776", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.31282", "ticker_sentiment_score": "0.029893", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.211652", "ticker_sentiment_score": "0.182292", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.262805", "ticker_sentiment_score": "0.164932", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Adaptimmune  ( ADAP )  Surges More Than 80% in a Month: Here's Why", "url": "https://www.zacks.com/stock/news/2210881/adaptimmune-adap-surges-more-than-80-in-a-month-heres-why", "time_published": "20240116T161700", "authors": ["Zacks Equity Research"], "summary": "Adaptimmune (ADAP) surges on the completion of the rolling submission, with the FDA seeking approval for its most advanced pipeline candidate as the first engineered cell therapy for solid tumors.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.137053, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.293038", "ticker_sentiment_score": "0.069295", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.236396", "ticker_sentiment_score": "0.030949", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.119532", "ticker_sentiment_score": "0.043907", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.059935", "ticker_sentiment_score": "0.1", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.236396", "ticker_sentiment_score": "0.133925", "ticker_sentiment_label": "Neutral"}]}, {"title": "Iovance  ( IOVA )  Surges More Than 150% in 3 Months: Here's Why", "url": "https://www.zacks.com/stock/news/2210369/iovance-iova-surges-more-than-150-in-3-months-heres-why", "time_published": "20240115T172700", "authors": ["Zacks Equity Research"], "summary": "Iovance's (IOVA) surges on the anticipated FDA approval for its lead pipeline drug as the first individualized, one-time cell therapy for certain patients with melanoma.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.093496, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.21193", "ticker_sentiment_score": "0.053496", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOVA", "relevance_score": "0.170275", "ticker_sentiment_score": "0.024084", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.085629", "ticker_sentiment_score": "0.042008", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.170275", "ticker_sentiment_score": "0.107254", "ticker_sentiment_label": "Neutral"}]}, {"title": "Solid Biosciences  ( SLDB )  Rises 271% in 3 Months: Here's Why", "url": "https://www.zacks.com/stock/news/2210246/solid-biosciences-sldb-rises-271-in-3-months-heres-why", "time_published": "20240115T151800", "authors": ["Zacks Equity Research"], "summary": "The FDA's recent clearance of Solid Biosciences' (SLDB) investigational new drug application on SGT-003 for treating Duchenne muscular dystrophy pushes the stock higher.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.180437, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SLDB", "relevance_score": "0.367141", "ticker_sentiment_score": "0.345661", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.433523", "ticker_sentiment_score": "0.038038", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.367141", "ticker_sentiment_score": "0.225693", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Beat the Market the Zacks Way: DaVita, Block, Home Depot in Focus", "url": "https://www.zacks.com/stock/news/2210009/beat-the-market-the-zacks-way-davita-block-home-depot-in-focus", "time_published": "20240115T130600", "authors": ["Abhinab Dasgupta"], "summary": "Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/be/1070.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}, {"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.199966, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.065866", "ticker_sentiment_score": "0.312393", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FI", "relevance_score": "0.065866", "ticker_sentiment_score": "0.106175", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDCC", "relevance_score": "0.065866", "ticker_sentiment_score": "0.230752", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HD", "relevance_score": "0.065866", "ticker_sentiment_score": "0.060198", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMM", "relevance_score": "0.065866", "ticker_sentiment_score": "0.060198", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.065866", "ticker_sentiment_score": "0.08913", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.065866", "ticker_sentiment_score": "0.146311", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROL", "relevance_score": "0.098659", "ticker_sentiment_score": "0.112287", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQ", "relevance_score": "0.065866", "ticker_sentiment_score": "0.08913", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.032961", "ticker_sentiment_score": "0.011385", "ticker_sentiment_label": "Neutral"}]}, {"title": "Emergent  ( EBS )  Gets $235.8M DoD Contract for Anthrax Vaccine", "url": "https://www.zacks.com/stock/news/2209718/emergent-ebs-gets-2358m-dod-contract-for-anthrax-vaccine", "time_published": "20240112T192000", "authors": ["Zacks Equity Research"], "summary": "Emergent (EBS) signs a deal with the U.S. Department of Defense to supply its anthrax vaccine initially for a five-year period, with an option to extend it for another five years.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.10424, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.279653", "ticker_sentiment_score": "-0.022969", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.113866", "ticker_sentiment_score": "0.045288", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.225425", "ticker_sentiment_score": "0.13402", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.225425", "ticker_sentiment_score": "0.147569", "ticker_sentiment_label": "Neutral"}]}, {"title": "Amicus  ( FOLD )  Stock Rises More Than 25% in 3 Months: Here's Why", "url": "https://www.zacks.com/stock/news/2209482/amicus-fold-stock-rises-more-than-25-in-3-months-heres-why", "time_published": "20240112T143100", "authors": ["Zacks Equity Research"], "summary": "Sales of Amicus' (FOLD) lead drug, Galafold, are rising consistently. Also, the recent approval of the Pompe disease drug combination, Pombiliti + Opfolda, is a positive.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/66/1019.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.988787"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.263882, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "FOLD", "relevance_score": "0.26042", "ticker_sentiment_score": "0.288284", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.381949", "ticker_sentiment_score": "0.032086", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRLN", "relevance_score": "0.381949", "ticker_sentiment_score": "0.097876", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.322233", "ticker_sentiment_score": "0.150114", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36609305/cytomx-therapeutics-to-present-at-the-b-riley-securities-virtual-annual-oncology-conference", "time_published": "20240112T130000", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in a fireside ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.038723, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.095138", "ticker_sentiment_score": "0.022799", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.188928", "ticker_sentiment_score": "0.033129", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.28008", "ticker_sentiment_score": "0.032022", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Conference", "url": "https://www.globenewswire.com/news-release/2024/01/12/2808578/37704/en/CytomX-Therapeutics-to-Present-at-the-B-Riley-Securities-Virtual-Annual-Oncology-Conference.html", "time_published": "20240112T130000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., Jan. 12, 2024 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will participate in ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.055859, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.105604", "ticker_sentiment_score": "0.024792", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.209365", "ticker_sentiment_score": "0.037617", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.209365", "ticker_sentiment_score": "-0.014718", "ticker_sentiment_label": "Neutral"}]}, {"title": "Aclaris  ( ACRS )  Down 21% on Mixed Results From Eczema Study", "url": "https://www.zacks.com/stock/news/2209029/aclaris-acrs-down-21-on-mixed-results-from-eczema-study", "time_published": "20240111T164600", "authors": ["Zacks Equity Research"], "summary": "Though data from a mid-stage study shows that treatment with Aclaris' (ACRS) JAK inhibitor met its primary endpoint, it also displays a greater-than-expected placebo effect.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.23907", "ticker_sentiment_score": "-0.020236", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRS", "relevance_score": "0.144853", "ticker_sentiment_score": "-0.044098", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.096866", "ticker_sentiment_score": "0.043075", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.19231", "ticker_sentiment_score": "0.117024", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Sarepta's  ( SRPT )  Stock Price Moved Up 17% on Tuesday", "url": "https://www.zacks.com/stock/news/2208461/why-sareptas-srpt-stock-price-moved-up-17-on-tuesday", "time_published": "20240110T174900", "authors": ["Zacks Equity Research"], "summary": "Sarepta (SRPT) surges after its CEO made positive comments on the label expansion filing for the company's DMD gene therapy. The company expects a potential approval in August.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.242717, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SLDB", "relevance_score": "0.228073", "ticker_sentiment_score": "0.090738", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.172097", "ticker_sentiment_score": "0.127509", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.282886", "ticker_sentiment_score": "-0.02757", "ticker_sentiment_label": "Neutral"}]}, {"title": "Moderna  ( MRNA )  Issues 2023 Preliminary Results, Stock Up 4%", "url": "https://www.zacks.com/stock/news/2207654/moderna-mrna-issues-2023-preliminary-results-stock-up-4", "time_published": "20240109T181500", "authors": ["Zacks Equity Research"], "summary": "Moderna (MRNA) reports unaudited product sales of around $6.7 billion for 2023, meeting its previously issued guidance. Share price rises following the announcement.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.061261, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.64962", "ticker_sentiment_score": "0.15185", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVO", "relevance_score": "0.184598", "ticker_sentiment_score": "0.119388", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.273807", "ticker_sentiment_score": "-0.022647", "ticker_sentiment_label": "Neutral"}]}, {"title": "Ligand  ( LGND )  Up 9% on FDA Nod for Molluscum Infection Gel", "url": "https://www.zacks.com/stock/news/2207168/ligand-lgnd-up-9-on-fda-nod-for-molluscum-infection-gel", "time_published": "20240108T174700", "authors": ["Zacks Equity Research"], "summary": "Following the FDA approval, Ligand's (LGND) Zelsuvmi is the first at-home treatment option available for molluscum contagiosum.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.117254, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NOVNQ", "relevance_score": "0.067347", "ticker_sentiment_score": "0.136401", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGND", "relevance_score": "0.264658", "ticker_sentiment_score": "0.181149", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VRCA", "relevance_score": "0.134214", "ticker_sentiment_score": "0.200904", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.387875", "ticker_sentiment_score": "-0.035141", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.327366", "ticker_sentiment_score": "0.019165", "ticker_sentiment_label": "Neutral"}]}, {"title": "Allogene  ( ALLO )  Down 20% on Strategic Changes in Pipeline", "url": "https://www.zacks.com/stock/news/2206512/allogene-allo-down-20-on-strategic-changes-in-pipeline", "time_published": "20240105T175200", "authors": ["Zacks Equity Research"], "summary": "Allogene (ALLO) decides to deprioritize two pivotal studies for the third-line treatment of certain lymphoma patients and start a new study to focus on the first-line treatment of the indication.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.083191, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALLO", "relevance_score": "0.354319", "ticker_sentiment_score": "0.076714", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.22616", "ticker_sentiment_score": "0.05996", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.091509", "ticker_sentiment_score": "0.047721", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.181819", "ticker_sentiment_score": "0.072537", "ticker_sentiment_label": "Neutral"}]}, {"title": "Esperion  ( ESPR )  Settles Milestone Dispute With Daiichi Sankyo", "url": "https://www.zacks.com/stock/news/2205756/esperion-espr-settles-milestone-dispute-with-daiichi-sankyo", "time_published": "20240104T160800", "authors": ["Zacks Equity Research"], "summary": "Daiichi Sankyo amends its existing collaboration with Esperion (ESPR), including the resolution of a commercial dispute over milestone payments. This amendment is valued at $125 million.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/34/973.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.107205, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ESPR", "relevance_score": "0.179788", "ticker_sentiment_score": "0.112841", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKXJF", "relevance_score": "0.060388", "ticker_sentiment_score": "0.088", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.295155", "ticker_sentiment_score": "0.074228", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSKYF", "relevance_score": "0.060388", "ticker_sentiment_score": "0.088", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRPT", "relevance_score": "0.120431", "ticker_sentiment_score": "0.053112", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.238133", "ticker_sentiment_score": "0.0912", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Outlines 2024 Company Priorities and Milestones - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36488030/cytomx-therapeutics-outlines-2024-company-priorities-and-milestones", "time_published": "20240104T130000", "authors": ["Globe Newswire"], "summary": "- CX-904 ( EGFRxCD3 T-cell engager ) initial Phase 1a dose escalation data anticipated in the 2nd half of 2024 - - IND application filed for conditionally activated EpCAM-directed ADC ( CX-2051 ) with Phase 1 initiation in EpCAM positive tumors expected in the 1st half of 2024 -", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.081327, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.072655", "ticker_sentiment_score": "0.046793", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.180325", "ticker_sentiment_score": "0.070017", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.126784", "ticker_sentiment_score": "0.038576", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Outlines 2024 Company Priorities and Milestones", "url": "https://www.globenewswire.com/news-release/2024/01/04/2803919/37704/en/CytomX-Therapeutics-Outlines-2024-Company-Priorities-and-Milestones.html", "time_published": "20240104T130000", "authors": ["CytomX Therapeutics Inc."], "summary": "- CX-904 ( EGFRxCD3 T-cell engager ) initial Phase 1a dose escalation data anticipated in the 2nd half of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.083791, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.074518", "ticker_sentiment_score": "0.045805", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.166679", "ticker_sentiment_score": "0.060408", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.111574", "ticker_sentiment_score": "0.072076", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Moderna  ( MRNA )  Stock Price Was Up 13% on Tuesday", "url": "https://www.zacks.com/stock/news/2205244/why-moderna-mrna-stock-price-was-up-13-on-tuesday", "time_published": "20240103T185600", "authors": ["Zacks Equity Research"], "summary": "Moderna (MRNA) surges after analysts at Oppenheimer upgraded its rating in anticipation of the company marketing five products by 2026.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/34/973.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.12862, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.222022", "ticker_sentiment_score": "0.086244", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.570165", "ticker_sentiment_score": "0.270732", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SRPT", "relevance_score": "0.089797", "ticker_sentiment_score": "0.052721", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.04497", "ticker_sentiment_score": "0.045947", "ticker_sentiment_label": "Neutral"}]}, {"title": "MeiraGTx  ( MGTX )  Stock Surges 35% in a Month: Here's Why", "url": "https://www.zacks.com/stock/news/2204585/meiragtx-mgtx-stock-surges-35-in-a-month-heres-why", "time_published": "20240102T171700", "authors": ["Zacks Equity Research"], "summary": "MeiraGTx's (MGTX) shares surge on the sale of rights for a rare ocular disease gene therapy for up to $ 415 million. This funding helps MGTX extend its cash runway into mid-2026.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/7b/850.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.126725, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MGTX", "relevance_score": "0.665629", "ticker_sentiment_score": "0.269937", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.289576", "ticker_sentiment_score": "0.07981", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.118064", "ticker_sentiment_score": "0.110221", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.344074", "ticker_sentiment_score": "0.127683", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bausch Health  ( BHC )  Ulcerative Colitis Drug Meets Primary Goal", "url": "https://www.zacks.com/stock/news/2201653/bausch-health-bhc-ulcerative-colitis-drug-meets-primary-goal", "time_published": "20231222T152300", "authors": ["Zacks Equity Research"], "summary": "Bausch's (BHC) amiselimod achieves the primary and key secondary endpoints, including clinical and endoscopic measures, in the double-blind period of a phase II study.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.207605, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.249106", "ticker_sentiment_score": "0.09766", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHC", "relevance_score": "0.126119", "ticker_sentiment_score": "0.150736", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TRDA", "relevance_score": "0.249106", "ticker_sentiment_score": "0.084773", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.308504", "ticker_sentiment_score": "0.162382", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/12/21/2799945/37704/en/CytomX-Therapeutics-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html", "time_published": "20231221T130000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., Dec. 21, 2023 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present at the ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.101582", "ticker_sentiment_score": "-0.02539", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.201523", "ticker_sentiment_score": "-0.037842", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.201523", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36341721/cytomx-therapeutics-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference", "time_published": "20231221T130000", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Dec. 21, 2023 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present at the 42nd Annual ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.09402", "ticker_sentiment_score": "-0.023668", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.186738", "ticker_sentiment_score": "-0.0341", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.186738", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Moderna  ( MRNA ) , Merck Start 2nd Late-Study on Cancer Therapy", "url": "https://www.zacks.com/stock/news/2196987/moderna-mrna-merck-start-2nd-late-study-on-cancer-therapy", "time_published": "20231212T181700", "authors": ["Zacks Equity Research"], "summary": "The second late-stage study will evaluate Moderna (MRNA)/Merck's investigational cancer combination therapy in certain lung cancer patients. A late-stage study in melanoma indication is ongoing.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928139"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.102939, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.546745", "ticker_sentiment_score": "0.030291", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.178021", "ticker_sentiment_score": "0.126283", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.29234", "ticker_sentiment_score": "0.075936", "ticker_sentiment_label": "Neutral"}]}, {"title": "Sanofi  ( SNY )  Terminates Pompe Disease Deal as FTC Objects", "url": "https://www.zacks.com/stock/news/2196713/sanofi-sny-terminates-pompe-disease-deal-as-ftc-objects", "time_published": "20231212T142000", "authors": ["Zacks Equity Research"], "summary": "Sanofi (SNY) decides to end the licensing deal with Maze Therapeutics for MZE001, a phase II ready oral tablet for Pompe disease, due to the FTC's decision to block the deal.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/85/906.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.990678"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.048242, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVO", "relevance_score": "0.20698", "ticker_sentiment_score": "0.054815", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.273552", "ticker_sentiment_score": "0.074509", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.459624", "ticker_sentiment_score": "-0.021088", "ticker_sentiment_label": "Neutral"}]}, {"title": "Merck's  ( MRK )  Keytruda-Lynparza Combo Fails Lung Cancer Study", "url": "https://www.zacks.com/stock/news/2195640/mercks-mrk-keytruda-lynparza-combo-fails-lung-cancer-study", "time_published": "20231208T164400", "authors": ["Zacks Equity Research"], "summary": "After a late-stage study fails to show any improvement in its primary endpoints, Merck (MRK) decides to stop evaluating the Keytruda-Lynparza combination in metastatic squamous NSCLC.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.96136"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.062494, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AZN", "relevance_score": "0.24289", "ticker_sentiment_score": "-0.094988", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.18343", "ticker_sentiment_score": "0.129012", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.300946", "ticker_sentiment_score": "0.077697", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pfizer  ( PFE ) , Arvinas Post Upbeat Data From Breast Cancer Study", "url": "https://www.zacks.com/stock/news/2194285/pfizer-pfe-arvinas-post-upbeat-data-from-breast-cancer-study", "time_published": "20231206T161800", "authors": ["Zacks Equity Research"], "summary": "Interim data from an early-stage study shows that treatment with Pfizer (PFE)/Arvinas' (ARVN) breast cancer combination therapy demonstrates encouraging clinical activity in heavily pre-treated patients.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.095793, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.318897", "ticker_sentiment_score": "0.083659", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.194763", "ticker_sentiment_score": "0.13483", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.318897", "ticker_sentiment_score": "0.002365", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.318897", "ticker_sentiment_score": "-0.035797", "ticker_sentiment_label": "Neutral"}]}, {"title": "Alterity  ( ATHE )  Up on Preclinical Parkinson's Treatment Data", "url": "https://www.zacks.com/stock/news/2193796/alterity-athe-up-on-preclinical-parkinsons-treatment-data", "time_published": "20231205T181900", "authors": ["Zacks Equity Research"], "summary": "Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.993781"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.12557, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.318074", "ticker_sentiment_score": "0.078787", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHE", "relevance_score": "0.256989", "ticker_sentiment_score": "0.143695", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.194242", "ticker_sentiment_score": "0.149691", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.256989", "ticker_sentiment_score": "0.114272", "ticker_sentiment_label": "Neutral"}]}, {"title": "CRISPR  ( CRSP )  to Focus on Next-Generation CAR T Pipeline", "url": "https://www.zacks.com/stock/news/2193794/crispr-crsp-to-focus-on-next-generation-car-t-pipeline", "time_published": "20231205T181500", "authors": ["Zacks Equity Research"], "summary": "Based on early data from ongoing clinical studies, CRISPR (CRSP) has decided to focus on the development of its next-generation CAR T pipeline and discontinue its first-generation CAR T candidates.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e2/2838.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.165226, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.094576", "ticker_sentiment_score": "0.035504", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSP", "relevance_score": "0.233556", "ticker_sentiment_score": "0.085501", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.233556", "ticker_sentiment_score": "0.065273", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.141448", "ticker_sentiment_score": "0.126402", "ticker_sentiment_label": "Neutral"}]}, {"title": "Vanda  ( VNDA )  Rises as FDA Accepts NDA for Gastroparesis Drug", "url": "https://www.zacks.com/stock/news/2193518/vanda-vnda-rises-as-fda-accepts-nda-for-gastroparesis-drug", "time_published": "20231205T141700", "authors": ["Zacks Equity Research"], "summary": "The FDA accepts Vanda's (VNDA) new drug application (\"NDA\") for tradipitant for treating the symptoms of gastroparesis. The company's shares rise in after-hours trading.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.113235, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.34974", "ticker_sentiment_score": "0.047676", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.34974", "ticker_sentiment_score": "0.131554", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSSMY", "relevance_score": "0.060236", "ticker_sentiment_score": "-0.046941", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNDA", "relevance_score": "0.12013", "ticker_sentiment_score": "0.009785", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.294446", "ticker_sentiment_score": "0.158774", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "J&J's  ( JNJ )  Bladder Cancer Drug Gets FDA's Breakthrough Tag", "url": "https://www.zacks.com/stock/news/2193403/jjs-jnj-bladder-cancer-drug-gets-fdas-breakthrough-tag", "time_published": "20231205T124000", "authors": ["Zacks Equity Research"], "summary": "FDA grants Breakthrough Therapy Designation to J&J's (JNJ) TAR-200 for high-risk non-muscle-invasive bladder cancer based on data from the phase IIb SunRISe-1 study.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.983605"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": -0.044131, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVO", "relevance_score": "0.229149", "ticker_sentiment_score": "0.05945", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.302243", "ticker_sentiment_score": "0.082988", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.302243", "ticker_sentiment_score": "-0.111678", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is it a Good Idea to Invest in AC Immune  ( ACIU )  Stock Now?", "url": "https://www.zacks.com/stock/news/2193345/is-it-a-good-idea-to-invest-in-ac-immune-aciu-stock-now", "time_published": "20231205T105900", "authors": ["Zacks Equity Research"], "summary": "Here, we discuss some reasons why investing in AC Immune (ACIU) stock now may turn out to be a prudent move.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/07/905.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.162188, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ACIU", "relevance_score": "0.472959", "ticker_sentiment_score": "0.172325", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LLY", "relevance_score": "0.213674", "ticker_sentiment_score": "0.050324", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.282234", "ticker_sentiment_score": "0.14456", "ticker_sentiment_label": "Neutral"}]}, {"title": "Apellis  ( APLS )  Rides on Syfovre to Fuel Growth Amid Rivalry", "url": "https://www.zacks.com/stock/news/2193043/apellis-apls-rides-on-syfovre-to-fuel-growth-amid-rivalry", "time_published": "20231204T154500", "authors": ["Zacks Equity Research"], "summary": "Apellis' (APLS) marketed products, Syfovre and Empaveli, continue to remain the growth drivers since launch. However, stiff competition in the target markets remains a woe.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/57/40404.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.186032, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALNY", "relevance_score": "0.113062", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLS", "relevance_score": "0.277748", "ticker_sentiment_score": "0.188969", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.330286", "ticker_sentiment_score": "0.045698", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.277748", "ticker_sentiment_score": "0.155752", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AstraZeneca  ( AZN )  to Discontinue Two Studies on Lokelma", "url": "https://www.zacks.com/stock/news/2192314/astrazeneca-azn-to-discontinue-two-studies-on-lokelma", "time_published": "20231201T162700", "authors": ["Zacks Equity Research"], "summary": "Owing to increased enrollment timelines and low event rates, AstraZeneca (AZN) plans to stop the STABILIZE-CKD and DIALIZE-Outcomes phase III evidence studies for the hyperkalemia drug Lokelma.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/e5/1416.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.026523, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.443626", "ticker_sentiment_score": "0.056386", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.443626", "ticker_sentiment_score": "0.056432", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.305058", "ticker_sentiment_score": "0.018063", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.376005", "ticker_sentiment_score": "0.18837", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annovis Bio  ( ANVS )  Stock Surges 38% in a Month: Here's Why", "url": "https://www.zacks.com/stock/news/2192301/annovis-bio-anvs-stock-surges-38-in-a-month-heres-why", "time_published": "20231201T161200", "authors": ["Zacks Equity Research"], "summary": "Annovis' (ANVS) shares surge on the successful development of its lead candidate in Alzheimer's disease.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.132141, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LLY", "relevance_score": "0.235366", "ticker_sentiment_score": "0.116995", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.235366", "ticker_sentiment_score": "0.069513", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANVS", "relevance_score": "0.324902", "ticker_sentiment_score": "0.006998", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.142565", "ticker_sentiment_score": "0.146836", "ticker_sentiment_label": "Neutral"}]}, {"title": "AbbVie  ( ABBV )  Posts Encouraging Data From Lung Cancer Study", "url": "https://www.zacks.com/stock/news/2191706/abbvie-abbv-posts-encouraging-data-from-lung-cancer-study", "time_published": "20231130T165600", "authors": ["Zacks Equity Research"], "summary": "Data from a mid-stage study on AbbVie's (ABBV) experimental ADC drug demonstrates compelling clinical benefits across key endpoints in certain lung cancer patients.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/d5/8276.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.097728, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.453501", "ticker_sentiment_score": "0.089073", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.293741", "ticker_sentiment_score": "0.078444", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.11983", "ticker_sentiment_score": "0.132592", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.236972", "ticker_sentiment_score": "0.133777", "ticker_sentiment_label": "Neutral"}]}, {"title": "FDA Accepts Karuna's  ( KRTX )  NDA Filing for Schizophrenia Drug", "url": "https://www.zacks.com/stock/news/2191704/fda-accepts-karunas-krtx-nda-filing-for-schizophrenia-drug", "time_published": "20231130T165400", "authors": ["Zacks Equity Research"], "summary": "If approved, Karuna's (KRTX) KarXT will be the first new mechanism of action to treat schizophrenia in several decades. A final decision is expected in September 2024.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.993781"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.120906, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KRTX", "relevance_score": "0.247334", "ticker_sentiment_score": "0.135242", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.247334", "ticker_sentiment_score": "0.064494", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.149966", "ticker_sentiment_score": "0.125619", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.199037", "ticker_sentiment_score": "0.093293", "ticker_sentiment_label": "Neutral"}]}, {"title": "Adaptimmune  ( ADAP )  Rises as GSK Transfers T-Cell Therapy IND", "url": "https://www.zacks.com/stock/news/2191582/adaptimmune-adap-rises-as-gsk-transfers-t-cell-therapy-ind", "time_published": "20231130T155200", "authors": ["Zacks Equity Research"], "summary": "Adaptimmune (ADAP) shares rise as GSK transfers IND for letetresgene autoluecel (lete-cel), which is being developed for treating synovial sarcoma and myxoid/round cell liposarcoma.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/57/40404.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.136388, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.448842", "ticker_sentiment_score": "0.062924", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.308891", "ticker_sentiment_score": "0.108306", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSK", "relevance_score": "0.448842", "ticker_sentiment_score": "0.274233", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.380591", "ticker_sentiment_score": "0.202964", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Emergent  ( EBS )  Gets $75M BARDA Contract for Anthrax Vaccine", "url": "https://www.zacks.com/stock/news/2191044/emergent-ebs-gets-75m-barda-contract-for-anthrax-vaccine", "time_published": "20231129T165600", "authors": ["Zacks Equity Research"], "summary": "The BARDA is exercising an option to procure additional doses of Emergent BioSolutions' (EBS) recently approved anthrax vaccine. Deliveries will likely be completed by the end of first-quarter 2024.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.983605"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.116139, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.248851", "ticker_sentiment_score": "0.066696", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.150906", "ticker_sentiment_score": "0.12865", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.200273", "ticker_sentiment_score": "0.283159", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.200273", "ticker_sentiment_score": "0.114046", "ticker_sentiment_label": "Neutral"}]}, {"title": "Immunovant  ( IMVT )  Up on Positive Initial IMVT-1402 MAD Study Data", "url": "https://www.zacks.com/stock/news/2190953/immunovant-imvt-up-on-positive-initial-imvt-1402-mad-study-data", "time_published": "20231129T152200", "authors": ["Zacks Equity Research"], "summary": "Immunovant (IMVT) posts encouraging initial results from the 600 mg MAD cohort of its early-stage study on IMVT-1402. Stock rises.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.024237, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IMVT", "relevance_score": "0.720006", "ticker_sentiment_score": "-0.054618", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.381949", "ticker_sentiment_score": "0.050853", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.381949", "ticker_sentiment_score": "0.053573", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.322233", "ticker_sentiment_score": "0.170252", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SpringWorks  ( SWTX )  Rises on FDA Nod for Desmoid Tumor Drug", "url": "https://www.zacks.com/stock/news/2190950/springworks-swtx-rises-on-fda-nod-for-desmoid-tumor-drug", "time_published": "20231129T152000", "authors": ["Zacks Equity Research"], "summary": "The FDA approves SpringWorks' (SWTX) Ogsiveo (nirogacestat) for the treatment of adult patients with desmoid tumors. Shares rise.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/608.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.086604, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.419153", "ticker_sentiment_score": "0.054286", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.419153", "ticker_sentiment_score": "0.057186", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.354572", "ticker_sentiment_score": "0.182946", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SWTX", "relevance_score": "0.146025", "ticker_sentiment_score": "0.126398", "ticker_sentiment_label": "Neutral"}]}, {"title": "GSK: 3 Pharma Stocks on the Rise - It's Time to Buy Now", "url": "https://stocknews.com/news/gsk-eton-ctmx-arwr-srra-3-pharma-stocks-on-the-rise-its-time-to/", "time_published": "20231128T164445", "authors": ["StockNews.com Staff"], "summary": "Given growing healthcare expenditure globally owing to the aging population and increasing prevalence of chronic and rare diseases, the sustained demand for innovative drugs and treatments positions the pharma industry for continued growth and expansion.", "banner_image": "https://stocknews.com/wp-content/uploads/2022/01/Mangeet-Kaur-Bouns_Image-4.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Earnings", "relevance_score": "0.999999"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.226194, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ARWR", "relevance_score": "0.04917", "ticker_sentiment_score": "0.157041", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.218598", "ticker_sentiment_score": "0.142313", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.024597", "ticker_sentiment_score": "0.082215", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETON", "relevance_score": "0.146767", "ticker_sentiment_score": "0.072512", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSK", "relevance_score": "0.311449", "ticker_sentiment_score": "0.33935", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Xenon  ( XENE )  Up on Top-Line Data From MDD Drug Phase II Study", "url": "https://www.zacks.com/stock/news/2190420/xenon-xene-up-on-top-line-data-from-mdd-drug-phase-ii-study", "time_published": "20231128T161700", "authors": ["Zacks Equity Research"], "summary": "Xenon (XENE) posts top-line data from a phase II proof-of-concept study evaluating its pipeline candidate, XEN1101, for treating moderate-to-severe major depressive disorder. Stock rises.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.090948, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.369685", "ticker_sentiment_score": "0.049662", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.369685", "ticker_sentiment_score": "0.052319", "ticker_sentiment_label": "Neutral"}, {"ticker": "XENE", "relevance_score": "0.127456", "ticker_sentiment_score": "-0.119875", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.311631", "ticker_sentiment_score": "0.201505", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "TC BioPharm  ( TCBP )  Falls Despite FDA Clearing IND for AML Drug", "url": "https://www.zacks.com/stock/news/2190409/tc-biopharm-tcbp-falls-despite-fda-clearing-ind-for-aml-drug", "time_published": "20231128T160500", "authors": ["Zacks Equity Research"], "summary": "The FDA clears TC BioPharm's (TCBP) investigational new drug application seeking approval to begin a clinical study on its pipeline candidate, TCB008, for treating acute myeloid leukemia. Stock declines.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/5d/2633.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.189363, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "TCBP", "relevance_score": "0.487021", "ticker_sentiment_score": "0.303469", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.42503", "ticker_sentiment_score": "0.054804", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.42503", "ticker_sentiment_score": "0.057731", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.359707", "ticker_sentiment_score": "0.224415", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "GSK's Blenrep Combo Meets PFS Endpoint in Head-to-Head Study", "url": "https://www.zacks.com/stock/news/2189947/gsks-blenrep-combo-meets-pfs-endpoint-in-head-to-head-study", "time_published": "20231127T182200", "authors": ["Zacks Equity Research"], "summary": "GSK announces positive data from the DREAMM-7 head-to-head phase III study evaluating Blenrep for second-line treatment of relapsed or refractory multiple myeloma. The study meets its primary endpoint.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.123252, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LGND", "relevance_score": "0.323927", "ticker_sentiment_score": "0.236542", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.323927", "ticker_sentiment_score": "-0.03312", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSK", "relevance_score": "0.323927", "ticker_sentiment_score": "0.161591", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.261818", "ticker_sentiment_score": "0.083326", "ticker_sentiment_label": "Neutral"}]}, {"title": "CRISPR  ( CRSP )  Rises More Than 40% in Past 3 Months: Here's Why", "url": "https://www.zacks.com/stock/news/2189212/crispr-crsp-rises-more-than-40-in-past-3-months-heres-why", "time_published": "20231124T165000", "authors": ["Zacks Equity Research"], "summary": "CRISPR (CRSP) expects a potential approval for its gene-edited therapy, Casgevy (exa-cel) in the United States for treating two debilitating blood disorders. The drug has been recently approved in the United Kingdom.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/58/608.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.220874, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.07445", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDIT", "relevance_score": "0.244723", "ticker_sentiment_score": "0.159358", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRSP", "relevance_score": "0.303175", "ticker_sentiment_score": "0.177061", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.359881", "ticker_sentiment_score": "0.051295", "ticker_sentiment_label": "Neutral"}]}, {"title": "Vertex  ( VRTX )  Gets EU Nod for Kaftrio Use in 2-5 Year Kids", "url": "https://www.zacks.com/stock/news/2189211/vertex-vrtx-gets-eu-nod-for-kaftrio-use-in-2-5-year-kids", "time_published": "20231124T164800", "authors": ["Zacks Equity Research"], "summary": "The European Commission approves Vertex's (VRTX) Kaftrio for expanded use to treat children aged two to five years with cystic fibrosis.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/62/5473.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.9545"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.173075, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.20698", "ticker_sentiment_score": "0.151862", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LGND", "relevance_score": "0.400265", "ticker_sentiment_score": "0.320331", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.400265", "ticker_sentiment_score": "0.055432", "ticker_sentiment_label": "Neutral"}]}, {"title": "Freeline  ( FRLN )  Shares Rise on Merger Agreement With Syncona", "url": "https://www.zacks.com/stock/news/2188517/freeline-frln-shares-rise-on-merger-agreement-with-syncona", "time_published": "20231123T160300", "authors": ["Zacks Equity Research"], "summary": "Freeline Therapeutics (FRLN) is set to be acquired by Syncona Ltd. The transaction is expected to be closed in the first quarter of 2024. Shares rise.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/86/1981.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Earnings", "relevance_score": "0.998626"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.217237, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "LGND", "relevance_score": "0.392948", "ticker_sentiment_score": "0.299311", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.392948", "ticker_sentiment_score": "0.051882", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRLN", "relevance_score": "0.136113", "ticker_sentiment_score": "0.156486", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.331765", "ticker_sentiment_score": "0.171736", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Immix  ( IMMX )  CAR-T Therapy IND Cleared by FDA, Stock Down", "url": "https://www.zacks.com/stock/news/2187964/immix-immx-car-t-therapy-ind-cleared-by-fda-stock-down", "time_published": "20231122T161000", "authors": ["Zacks Equity Research"], "summary": "The FDA clears Immix's (IMMX) investigational new drug application for BCMA CAR-T cell therapy, NXC-201, to expand clinical studies in relapsed/refractory AL amyloidosis to the United States. Stock falls.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default199.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.998626"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.098225, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LGND", "relevance_score": "0.401331", "ticker_sentiment_score": "0.301134", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.401331", "ticker_sentiment_score": "0.052647", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.139265", "ticker_sentiment_score": "0.054537", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.339046", "ticker_sentiment_score": "0.174543", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why You May Invest in Puma Biotechnology  ( PBYI )  Stock", "url": "https://www.zacks.com/stock/news/2186786/heres-why-you-may-invest-in-puma-biotechnology-pbyi-stock", "time_published": "20231120T164700", "authors": ["Zacks Equity Research"], "summary": "Here, we discuss some reasons why investing in Puma Biotechnology (PBYI) stock now may turn out to be a more prudent move than ever.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/57/40404.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.024485, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LGND", "relevance_score": "0.323078", "ticker_sentiment_score": "0.205626", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.323078", "ticker_sentiment_score": "-0.007122", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.468029", "ticker_sentiment_score": "0.031328", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Upgraded to Strong Buy: What Does It Mean for the Stock?", "url": "https://www.zacks.com/stock/news/2183493/cytomx-therapeutics-ctmx-upgraded-to-strong-buy-what-does-it-mean-for-the-stock", "time_published": "20231113T170005", "authors": ["Zacks Equity Research"], "summary": "CytomX Therapeutics (CTMX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default306.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}], "overall_sentiment_score": 0.311735, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.364275", "ticker_sentiment_score": "0.355061", "ticker_sentiment_label": "Bullish"}]}, {"title": "CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update", "url": "https://www.globenewswire.com/news-release/2023/11/07/2775653/37704/en/CytomX-Therapeutics-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html", "time_published": "20231107T211500", "authors": ["CytomX Therapeutics Inc."], "summary": "- CX-904 ( EGFRxCD3 T-cell engager ) initial Phase 1 dose escalation data anticipated in the first half of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.033385, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.089729", "ticker_sentiment_score": "0.013733", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.089729", "ticker_sentiment_score": "0.013733", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.107575", "ticker_sentiment_score": "0.029993", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35658764/cytomx-therapeutics-reports-third-quarter-2023-financial-results-and-provides-business-update", "time_published": "20231107T211500", "authors": ["Globe Newswire"], "summary": "- CX-904 ( EGFRxCD3 T-cell engager ) initial Phase 1 dose escalation data anticipated in the first half of 2024 - - CX-2051 ( EpCAM-directed ADC ) comprehensive preclinical profile presented at 14th Annual World ADC Conference; IND filing on track for year-end -", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.033338, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.087503", "ticker_sentiment_score": "0.040952", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.104911", "ticker_sentiment_score": "0.04202", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.104911", "ticker_sentiment_score": "0.014344", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b at the SITC 2023 Annual Meeting - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35487786/cytomx-therapeutics-to-present-preclinical-data-for-conditionally-activated-interferon-alpha-2b-at", "time_published": "20231030T120000", "authors": ["Globe Newswire"], "summary": "- IND filing for CX-801 anticipated by the end of 2023 - SOUTH SAN FRANCISCO, Calif., Oct. 30, 2023 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.007243, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.043579", "ticker_sentiment_score": "-0.008973", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.087027", "ticker_sentiment_score": "-0.009532", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.215319", "ticker_sentiment_score": "0.005188", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Presents Preclinical Profile of EpCAM-directed Antibody Drug Conjugate CX-2051 at 2023 World ADC Conference", "url": "https://www.globenewswire.com/news-release/2023/10/18/2762767/37704/en/CytomX-Therapeutics-Presents-Preclinical-Profile-of-EpCAM-directed-Antibody-Drug-Conjugate-CX-2051-at-2023-World-ADC-Conference.html", "time_published": "20231018T203000", "authors": ["CytomX Therapeutics Inc."], "summary": "- CX-2051 is tailored for treatment of EpCAM-expressing cancers by matching target expression and tumor sensitivity with a topoisomerase-1 inhibitor payload ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.028895, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.036926", "ticker_sentiment_score": "-0.00888", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.073773", "ticker_sentiment_score": "-0.00924", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.183059", "ticker_sentiment_score": "-0.059197", "ticker_sentiment_label": "Neutral"}]}, {"title": "CD3 Antibody Clinical Trials Market Opportunity Insight", "url": "https://www.benzinga.com/pressreleases/23/10/g35212251/cd3-antibody-clinical-trials-market-opportunity-insight", "time_published": "20231012T062602", "authors": ["Globe Newswire"], "summary": "Delhi, Oct. 12, 2023 ( GLOBE NEWSWIRE ) -- Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028 Report Highlights: Global CD3 Antibodies Market Opportunity: > USD 5 Billion By 2028 Global & Regional Market Trends Analysis", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.161647"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.23994, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MGNX", "relevance_score": "0.047278", "ticker_sentiment_score": "0.188605", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TLSA", "relevance_score": "0.047278", "ticker_sentiment_score": "-0.087996", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.047278", "ticker_sentiment_score": "0.188605", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "XNCR", "relevance_score": "0.047278", "ticker_sentiment_score": "0.188605", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCAB", "relevance_score": "0.047278", "ticker_sentiment_score": "0.188605", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period  ( 2023-2032 ) , Examines DelveInsight | Key Companies to Watch - Roche, AbbVie, AstraZeneca, BeiGene, GlaxoSmithKline, Genentech, Eli Lilly, Novartis", "url": "https://www.prnewswire.com/news-releases/triple-negative-breast-cancer-market-to-accelerate-substantially-during-the-forecast-period-20232032-examines-delveinsight--key-companies-to-watch---roche-abbvie-astrazeneca-beigene-glaxosmithkline-genentech-eli-lilly--301918858.html", "time_published": "20230906T210100", "authors": ["LLP", "DelveInsight Business Research"], "summary": "Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period ( 2023-2032 ) , Examines ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": -0.032041, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VINC", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.022494", "ticker_sentiment_score": "-0.053504", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKXJF", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.06741", "ticker_sentiment_score": "0.006065", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUSN", "relevance_score": "0.022494", "ticker_sentiment_score": "-0.053504", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSKYF", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.022494", "ticker_sentiment_score": "-0.053504", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTX", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKESF", "relevance_score": "0.022494", "ticker_sentiment_score": "-0.053504", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.06741", "ticker_sentiment_score": "-0.109639", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLDX", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBPHF", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMP", "relevance_score": "0.022494", "ticker_sentiment_score": "-0.053504", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCUS", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNA", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOVA", "relevance_score": "0.022494", "ticker_sentiment_score": "-0.053504", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.04497", "ticker_sentiment_score": "0.005975", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXEL", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGIO", "relevance_score": "0.022494", "ticker_sentiment_score": "-0.053504", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCAB", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.022494", "ticker_sentiment_score": "-0.053504", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVSQ", "relevance_score": "0.022494", "ticker_sentiment_score": "0.023078", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Loses -13.45% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner", "url": "https://www.zacks.com/stock/news/2140745/cytomx-therapeutics-ctmx-loses--1345-in-4-weeks-heres-why-a-trend-reversal-may-be-around-the-corner", "time_published": "20230825T133505", "authors": ["Zacks Equity Research"], "summary": "The heavy selling pressure might have exhausted for CytomX Therapeutics (CTMX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default266.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.998356"}], "overall_sentiment_score": 0.177767, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.48028", "ticker_sentiment_score": "0.220312", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/23/08/g33723142/cytomx-therapeutics-to-present-at-the-h-c-wainwright-immune-cell-engager-virtual-conference", "time_published": "20230810T200500", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Aug. 10, 2023 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the H.C.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.045606, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.092569", "ticker_sentiment_score": "-0.001079", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.183895", "ticker_sentiment_score": "-0.001551", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.272788", "ticker_sentiment_score": "0.13455", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Raised to \"Buy\" at StockNews.com", "url": "https://www.defenseworld.net/2023/08/10/cytomx-therapeutics-nasdaqctmx-raised-to-buy-at-stocknews-com.html", "time_published": "20230810T085244", "authors": ["Defense World Staff"], "summary": "CytomX Therapeutics ( NASDAQ:CTMX - Get Free Report ) was upgraded by analysts at StockNews.com from a \"hold\" rating to a \"buy\" rating in a research report issued on Thursday. Separately, Wedbush restated a \"neutral\" rating and issued a $2.00 target price on shares of CytomX Therapeutics in a ...", "banner_image": "https://www.marketbeat.com/logos/cytomx-therapeutics-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.119292, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VIRT", "relevance_score": "0.068502", "ticker_sentiment_score": "0.156102", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.80274", "ticker_sentiment_score": "0.199957", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBS", "relevance_score": "0.136499", "ticker_sentiment_score": "0.189708", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Reports Q2 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2133884/cytomx-therapeutics-ctmx-reports-q2-loss-tops-revenue-estimates", "time_published": "20230808T213014", "authors": ["Zacks Equity Research"], "summary": "CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of 89.47% and 42.30%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default78.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.137651, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SPRO", "relevance_score": "0.204647", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.396052", "ticker_sentiment_score": "0.171518", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update", "url": "https://www.globenewswire.com/news-release/2023/08/08/2721181/37704/en/CytomX-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html", "time_published": "20230808T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "- CX-904 ( EGFRxCD3 ) initial Phase 1 dose escalation data anticipated first half of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.082895, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.089595", "ticker_sentiment_score": "0.089007", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAZZ", "relevance_score": "0.017955", "ticker_sentiment_score": "0.049295", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.017955", "ticker_sentiment_score": "0.049295", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.017955", "ticker_sentiment_score": "0.049295", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.035902", "ticker_sentiment_score": "0.043602", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.05383", "ticker_sentiment_score": "0.043999", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.05383", "ticker_sentiment_score": "0.008003", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Downgraded by StockNews.com to Hold", "url": "https://www.defenseworld.net/2023/08/06/cytomx-therapeutics-nasdaqctmx-downgraded-by-stocknews-com-to-hold.html", "time_published": "20230806T091911", "authors": ["Defense World Staff"], "summary": "StockNews.com downgraded shares of CytomX Therapeutics ( NASDAQ:CTMX - Free Report ) from a buy rating to a hold rating in a research report report published on Wednesday. CTMX stock opened at $1.69 on Wednesday. The company has a fifty day moving average price of $1.69 and a two-hundred day ...", "banner_image": "https://www.marketbeat.com/logos/cytomx-therapeutics-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.204762, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.809093", "ticker_sentiment_score": "0.338803", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Stock Rating Lowered by StockNews.com", "url": "https://www.defenseworld.net/2023/08/04/cytomx-therapeutics-nasdaqctmx-stock-rating-lowered-by-stocknews-com.html", "time_published": "20230804T062443", "authors": ["Defense World Staff"], "summary": "CytomX Therapeutics ( NASDAQ:CTMX - Get Free Report ) was downgraded by research analysts at StockNews.com from a \"buy\" rating to a \"hold\" rating in a report released on Wednesday. Shares of NASDAQ:CTMX opened at $1.68 on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/cytomx-therapeutics-inc-logo.png", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.980922"}, {"topic": "Earnings", "relevance_score": "0.938238"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.139677, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PRU", "relevance_score": "0.069697", "ticker_sentiment_score": "0.151241", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.779232", "ticker_sentiment_score": "0.231266", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SYM", "relevance_score": "0.069697", "ticker_sentiment_score": "-0.004054", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBS", "relevance_score": "0.138863", "ticker_sentiment_score": "0.185218", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Exelixis  ( EXEL )  Tops Q2 Earnings and Revenue Estimates", "url": "https://www.zacks.com/stock/news/2130720/exelixis-exel-tops-q2-earnings-and-revenue-estimates", "time_published": "20230801T215511", "authors": ["Zacks Equity Research"], "summary": "Exelixis (EXEL) delivered earnings and revenue surprises of 40.91% and 4.74%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default63.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.191511, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EXEL", "relevance_score": "0.405651", "ticker_sentiment_score": "0.277402", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.20997", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Is CytomX Therapeutics  ( CTMX )  Stock Shooting Higher Today - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/markets/equities/23/06/33079372/why-is-cytomx-therapeutics-stock-shooting-higher-today", "time_published": "20230630T152637", "authors": ["Nabaparna Bhattacharya"], "summary": "CytomX Therapeutics, Inc CTMX inked a pact with BVF Partners L.P. for a private placement resulting in initial gross proceeds of approximately $30 million.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/30/ctmx.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.093954, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.139265", "ticker_sentiment_score": "0.110653", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.517168", "ticker_sentiment_score": "-0.032618", "ticker_sentiment_label": "Neutral"}]}, {"title": "Zymeworks Appoints New Director - Zymeworks  ( NASDAQ:ZYME ) ", "url": "https://www.benzinga.com/pressreleases/23/06/g33066902/zymeworks-appoints-new-director", "time_published": "20230629T200500", "authors": ["Globe Newswire"], "summary": "VANCOUVER, British Columbia, June 29, 2023 ( GLOBE NEWSWIRE ) -- Zymeworks Inc. ZYME, a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced the appointment of Mr. Carlos E. Campoy to its board of directors effective as of June 30, 2023.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.204861, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "JAZZ", "relevance_score": "0.032294", "ticker_sentiment_score": "0.063641", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGNE", "relevance_score": "0.096671", "ticker_sentiment_score": "0.071177", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.032294", "ticker_sentiment_score": "0.079842", "ticker_sentiment_label": "Neutral"}]}, {"title": "Here's Why You Should Add ImmunoGen  ( IMGN )  to Your Portfolio Now", "url": "https://www.zacks.com/stock/news/2097447/heres-why-you-should-add-immunogen-imgn-to-your-portfolio-now", "time_published": "20230519T150900", "authors": ["Zacks Investment Research"], "summary": "ImmunoGen's (IMGN) recently launched drug, Elahere, is expected to generate incremental revenues for the company and boost its top-line growth in the next few years.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/57/40404.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.22034, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MGNX", "relevance_score": "0.073098", "ticker_sentiment_score": "-0.028545", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGN", "relevance_score": "0.537018", "ticker_sentiment_score": "0.299255", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.145583", "ticker_sentiment_score": "0.002652", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.073098", "ticker_sentiment_score": "0.138138", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Reports Q1 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2092733/cytomx-therapeutics-ctmx-reports-q1-loss-tops-revenue-estimates", "time_published": "20230509T213513", "authors": ["Zacks Investment Research"], "summary": "CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of 68.75% and 5.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default243.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.119131, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AGLE", "relevance_score": "0.209365", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.404563", "ticker_sentiment_score": "0.098379", "ticker_sentiment_label": "Neutral"}]}, {"title": "Codexis  ( CDXS )  Reports Q1 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2090536/codexis-cdxs-reports-q1-loss-lags-revenue-estimates", "time_published": "20230504T230514", "authors": ["Zacks Investment Research"], "summary": "Codexis (CDXS) delivered earnings and revenue surprises of -17.24% and 11.34%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default30.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.100869, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CDXS", "relevance_score": "0.401331", "ticker_sentiment_score": "0.043952", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.207571", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Certara, Inc.  ( CERT )  Earnings Expected to Grow: What to Know Ahead of Next Week's Release", "url": "https://www.zacks.com/stock/news/2087492/certara-inc-cert-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release", "time_published": "20230501T140101", "authors": ["Zacks Investment Research"], "summary": "Certara, Inc. (CERT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default0.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.163074, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CERT", "relevance_score": "0.261117", "ticker_sentiment_score": "0.217921", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.175859", "ticker_sentiment_score": "-0.002859", "ticker_sentiment_label": "Neutral"}]}, {"title": "Will CytomX Therapeutics  ( CTMX )  Report Negative Q1 Earnings? What You Should Know", "url": "https://www.zacks.com/stock/news/2085976/will-cytomx-therapeutics-ctmx-report-negative-q1-earnings-what-you-should-know", "time_published": "20230427T140320", "authors": ["Zacks Investment Research"], "summary": "CytomX Therapeutics (CTMX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default162.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.128687, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.258808", "ticker_sentiment_score": "0.02171", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.087663", "ticker_sentiment_score": "-0.002077", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Rating Increased to Hold at StockNews.com", "url": "https://www.defenseworld.net/2023/04/01/cytomx-therapeutics-nasdaqctmx-rating-increased-to-hold-at-stocknews-com.html", "time_published": "20230401T052648", "authors": ["Defense World Staff"], "summary": "CytomX Therapeutics ( NASDAQ:CTMX ) Rating Increased to Hold at ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=CTMX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.243497, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BRZE", "relevance_score": "0.081552", "ticker_sentiment_score": "0.101311", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.875421", "ticker_sentiment_score": "0.411224", "ticker_sentiment_label": "Bullish"}, {"ticker": "UBS", "relevance_score": "0.162255", "ticker_sentiment_score": "0.236081", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Walgreens, McCormick rise; Invesco Mortgage, CytomX fall", "url": "https://apnews.com/article/financial-markets-stocks-wall-street-62e81c0ad79234af9aca55348dd7426e", "time_published": "20230328T201541", "authors": [], "summary": "Walgreens, McCormick rise. Invesco Mortgage, CytomX fall The Associated Press ...", "banner_image": "https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png", "source": "Associated Press", "category_within_source": "Markets", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.244401, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BABA", "relevance_score": "0.31482", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.31482", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVR", "relevance_score": "0.31482", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.31482", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.31482", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why CytomX Therapeutics  ( CTMX )  Shares Are Falling Today - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/general/biotech/23/03/31531824/abbvie-walks-away-from-cytomx-partnership-but-garnering-attention-of-big-pharma-partners", "time_published": "20230328T153514", "authors": ["Vandana Singh"], "summary": "CytomX Therapeutics Inc CTMX will weigh its options for CX-2029, a CD71-directed antibody-drug conjugate, after AbbVie Inc ABBV decided not to advance the drug into additional studies. CytomX and AbbVie have also concluded their research activities under a 2016 Discovery License and Collaboration ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/28/ctmx_logo_dark__d8d313a56b93966616d4a30b15c9bd27.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.035592, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALPMF", "relevance_score": "0.277433", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.62523", "ticker_sentiment_score": "0.10564", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.405651", "ticker_sentiment_score": "0.15048", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.140896", "ticker_sentiment_score": "0.161862", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.277433", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket - Accelerate Diagnostics  ( NASDAQ:AXDX ) , Biodexa Pharmaceuticals  ( NASDAQ:BDRX ) ", "url": "https://www.benzinga.com/news/23/03/31528044/why-freightcar-america-shares-are-trading-lower-by-8-here-are-20-stocks-moving-premarket", "time_published": "20230328T123341", "authors": ["Lisa Levin"], "summary": "Biodexa Pharmaceuticals BDRX shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday. Codiak BioSciences, Inc. CDAK gained 27% to $0.2419 in pre-market trading. Codiak BioSciences shares dropped around 57% on Monday after the company voluntarily filed for protection under ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/28/freightcar_america_-_logo.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.105824, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BRDS", "relevance_score": "0.146916", "ticker_sentiment_score": "0.265073", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSTR", "relevance_score": "0.073773", "ticker_sentiment_score": "0.196039", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SIDU", "relevance_score": "0.218817", "ticker_sentiment_score": "-0.067572", "ticker_sentiment_label": "Neutral"}, {"ticker": "VORB", "relevance_score": "0.218817", "ticker_sentiment_score": "0.117644", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRMA", "relevance_score": "0.218817", "ticker_sentiment_score": "-0.19033", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CTMX", "relevance_score": "0.146916", "ticker_sentiment_score": "-0.188406", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PVH", "relevance_score": "0.146916", "ticker_sentiment_score": "0.312461", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IVR", "relevance_score": "0.146916", "ticker_sentiment_score": "0.045604", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.146916", "ticker_sentiment_score": "-0.342162", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WISA", "relevance_score": "0.146916", "ticker_sentiment_score": "-0.221145", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ONCS", "relevance_score": "0.146916", "ticker_sentiment_score": "-0.083906", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.073773", "ticker_sentiment_score": "0.03567", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIEW", "relevance_score": "0.146916", "ticker_sentiment_score": "0.246273", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FRSX", "relevance_score": "0.146916", "ticker_sentiment_score": "-0.015131", "ticker_sentiment_label": "Neutral"}, {"ticker": "SI-P-A", "relevance_score": "0.146916", "ticker_sentiment_score": "0.243763", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CDAK", "relevance_score": "0.218817", "ticker_sentiment_score": "0.176072", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTXR", "relevance_score": "0.218817", "ticker_sentiment_score": "-0.232213", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RAIL", "relevance_score": "0.218817", "ticker_sentiment_score": "-0.19854", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AXDX", "relevance_score": "0.218817", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDTX", "relevance_score": "0.218817", "ticker_sentiment_score": "0.260426", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LGHL", "relevance_score": "0.146916", "ticker_sentiment_score": "0.366745", "ticker_sentiment_label": "Bullish"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Reports Q4 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2070995/cytomx-therapeutics-ctmx-reports-q4-loss-lags-revenue-estimates", "time_published": "20230327T213504", "authors": ["Zacks Investment Research"], "summary": "CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -100% and 94.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default219.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.13094, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SPRO", "relevance_score": "0.205225", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.397098", "ticker_sentiment_score": "0.108321", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update", "url": "https://www.globenewswire.com/news-release/2023/03/27/2635245/37704/en/CytomX-Therapeutics-Reports-Full-Year-2022-Financial-Results-and-Provides-Business-Update.html", "time_published": "20230327T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "- Internal focus on next generation therapeutic pipeline including ongoing Phase 1 for CX-904 ( EGFRxCD3 ) and anticipated IND filings for CX-2051 ( EpCAM-directed ADC ) and CX-801 ( Interferon alpha-2b ) in the second half of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.094758, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CORZQ", "relevance_score": "0.015851", "ticker_sentiment_score": "0.047794", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.047528", "ticker_sentiment_score": "0.055674", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.094887", "ticker_sentiment_score": "0.054027", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.126284", "ticker_sentiment_score": "0.05576", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.063341", "ticker_sentiment_score": "0.01913", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket - Berkshire Grey  ( NASDAQ:BGRY ) , Allarity Therapeutics  ( NASDAQ:ALLR ) ", "url": "https://www.benzinga.com/news/23/03/31508672/why-motorsport-games-shares-are-trading-lower-by-over-10-here-are-20-stocks-moving-premarket", "time_published": "20230327T115915", "authors": ["Lisa Levin"], "summary": "Coeptis Therapeutics Holdings, Inc. COEP shares rose 38.5% to $2.05 in pre-market trading after gaining 8% on Friday. First Republic Bank FRC gained 25.5% to $15.51 in pre-market trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/27/image27.jpeg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.063315, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BRDS", "relevance_score": "0.147366", "ticker_sentiment_score": "-0.01516", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACW", "relevance_score": "0.219477", "ticker_sentiment_score": "0.293316", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NBSE", "relevance_score": "0.147366", "ticker_sentiment_score": "-0.236638", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VIRI", "relevance_score": "0.147366", "ticker_sentiment_score": "-0.22153", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CTMX", "relevance_score": "0.219477", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAR", "relevance_score": "0.147366", "ticker_sentiment_score": "-0.055348", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.147366", "ticker_sentiment_score": "-0.055348", "ticker_sentiment_label": "Neutral"}, {"ticker": "COEP", "relevance_score": "0.147366", "ticker_sentiment_score": "0.348895", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MSGM", "relevance_score": "0.147366", "ticker_sentiment_score": "-0.301782", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALLR", "relevance_score": "0.219477", "ticker_sentiment_score": "0.012171", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSFC", "relevance_score": "0.147366", "ticker_sentiment_score": "-0.01516", "ticker_sentiment_label": "Neutral"}, {"ticker": "SI-P-A", "relevance_score": "0.147366", "ticker_sentiment_score": "0.006469", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.147366", "ticker_sentiment_score": "0.271793", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IOVA", "relevance_score": "0.219477", "ticker_sentiment_score": "0.297987", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GBNH", "relevance_score": "0.147366", "ticker_sentiment_score": "-0.261765", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GMVD", "relevance_score": "0.147366", "ticker_sentiment_score": "0.388124", "ticker_sentiment_label": "Bullish"}, {"ticker": "FRC", "relevance_score": "0.219477", "ticker_sentiment_score": "0.084985", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFTBF", "relevance_score": "0.074001", "ticker_sentiment_score": "0.218452", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FFIE", "relevance_score": "0.147366", "ticker_sentiment_score": "0.113406", "ticker_sentiment_label": "Neutral"}, {"ticker": "JG", "relevance_score": "0.219477", "ticker_sentiment_score": "0.240212", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SMX", "relevance_score": "0.147366", "ticker_sentiment_score": "-0.3506", "ticker_sentiment_label": "Bearish"}]}, {"title": "StockNews.com CytomX Therapeutics  ( NASDAQ:CTMX )  to be Sold", "url": "https://beststocks.com/stocknews-com-cytomx-therapeutics-nasdaqctmx-to/", "time_published": "20230325T194117", "authors": ["Ronald Kaufman"], "summary": "CytomX Therapeutics ( NASDAQ: CTMX ) , which StockNews.com had previously given a \"hold\" recommendation, was given a \"sell\" rating in a research report that was distributed to clients and investors on Friday. BMO Capital Markets increased their price objective on CytomX Therapeutics stock from ...", "banner_image": "https://beststocks.com/wp-content/uploads/2023/02/business-news-today-750x375.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "beststocks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.172074, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.175221", "ticker_sentiment_score": "0.232919", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DSSMY", "relevance_score": "0.088147", "ticker_sentiment_score": "-0.148936", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.849882", "ticker_sentiment_score": "0.166042", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Rating Lowered to Sell at StockNews.com", "url": "https://www.defenseworld.net/2023/03/24/cytomx-therapeutics-nasdaqctmx-rating-lowered-to-sell-at-stocknews-com.html", "time_published": "20230324T052641", "authors": ["Defense World Staff"], "summary": "CytomX Therapeutics ( NASDAQ:CTMX ) Rating Lowered to Sell at ... Defense World ...", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=CTMX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.264634, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.160633", "ticker_sentiment_score": "0.245261", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.871557", "ticker_sentiment_score": "0.442273", "ticker_sentiment_label": "Bullish"}]}, {"title": "CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023 - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/23/03/g31466980/cytomx-therapeutics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-27-2023", "time_published": "20230322T232333", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., March 22, 2023 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of conditionally activated, localized biologics, today announced that it will report full year 2022 financial results on Monday, March 27, 2023, after the close of U.S. markets.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.028678, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.172097", "ticker_sentiment_score": "-0.036731", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.33628", "ticker_sentiment_score": "-0.051278", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.086556", "ticker_sentiment_score": "-0.026407", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.172097", "ticker_sentiment_score": "-0.036731", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 27, 2023", "url": "https://www.globenewswire.com/news-release/2023/03/22/2632792/37704/en/CytomX-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2022-Financial-Results-on-March-27-2023.html", "time_published": "20230322T232300", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., March 22, 2023 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of conditionally activated, localized biologics, today announced that it will report full year 2022 financial results on Monday, March 27, 2023, after the close of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.031199, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.184598", "ticker_sentiment_score": "-0.041876", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.273807", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.092927", "ticker_sentiment_score": "-0.029116", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.184598", "ticker_sentiment_score": "-0.041876", "ticker_sentiment_label": "Neutral"}]}, {"title": "Castle Biosciences, Inc.  ( CSTL )  Reports Q4 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2060093/castle-biosciences-inc-cstl-reports-q4-loss-tops-revenue-estimates", "time_published": "20230301T003509", "authors": ["Zacks Investment Research"], "summary": "Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 14.29% and 4.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default79.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.151606, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CSTL", "relevance_score": "0.399204", "ticker_sentiment_score": "0.204184", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.206392", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at Upcoming March Investor Conferences - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/23/02/g31103016/cytomx-therapeutics-to-present-at-upcoming-march-investor-conferences", "time_published": "20230228T210500", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the following investor ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.002403, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.165031", "ticker_sentiment_score": "-0.037087", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.165031", "ticker_sentiment_score": "0.090149", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.245339", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.082963", "ticker_sentiment_score": "-0.027199", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.165031", "ticker_sentiment_score": "-0.037087", "ticker_sentiment_label": "Neutral"}]}, {"title": "NeoGenomics  ( NEO )  Reports Q4 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2058195/neogenomics-neo-reports-q4-loss-tops-revenue-estimates", "time_published": "20230223T150505", "authors": ["Zacks Investment Research"], "summary": "NeoGenomics (NEO) delivered earnings and revenue surprises of 60% and 6.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default50.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.130729, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NEO", "relevance_score": "0.405651", "ticker_sentiment_score": "0.136621", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.20997", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Beyond Air, Inc.  ( XAIR )  Reports Q3 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2052563/beyond-air-inc-xair-reports-q3-loss-lags-revenue-estimates", "time_published": "20230209T222510", "authors": ["Zacks Investment Research"], "summary": "Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -2.38% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default50.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.124429, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "XAIR", "relevance_score": "0.410059", "ticker_sentiment_score": "0.081143", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.212425", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results", "url": "https://www.globenewswire.com/news-release/2023/02/03/2601193/0/en/Regeneron-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-and-Operating-Results.html", "time_published": "20230203T113000", "authors": ["Inc.", "Regeneron Pharmaceuticals"], "summary": "TARRYTOWN, N.Y., Feb. 03, 2023 ( GLOBE NEWSWIRE ) -- Regeneron Pharmaceuticals, Inc. ( NASDAQ: REGN ) today announced financial results for the fourth quarter and full year 2022 and provided a business update.", "banner_image": "https://ml.globenewswire.com/Resource/Download/add5ebc7-88c9-49dc-8834-abbb07c622d1?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.98396"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.182733, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MSBHF", "relevance_score": "0.010985", "ticker_sentiment_score": "0.030474", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.010985", "ticker_sentiment_score": "0.076094", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.032946", "ticker_sentiment_score": "0.049912", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACET", "relevance_score": "0.010985", "ticker_sentiment_score": "0.068859", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.076777", "ticker_sentiment_score": "0.071363", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:JPY", "relevance_score": "0.010985", "ticker_sentiment_score": "0.127916", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:EUR", "relevance_score": "0.010985", "ticker_sentiment_score": "0.127916", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:USD", "relevance_score": "0.010985", "ticker_sentiment_score": "0.127916", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Announces Milestone Achievement in Probody\u00ae T-Cell Engaging Bispecific  ( TCB )  Collaboration with Astellas", "url": "https://www.globenewswire.com/news-release/2023/01/26/2595893/37704/en/CytomX-Therapeutics-Announces-Milestone-Achievement-in-Probody-T-Cell-Engaging-Bispecific-TCB-Collaboration-with-Astellas.html", "time_published": "20230126T120000", "authors": ["CytomX Therapeutics Inc."], "summary": "-Achievement of clinical candidate is the first in the multi-target collaboration and triggers a $5 million milestone payment to ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.069908, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.068209", "ticker_sentiment_score": "-0.02641", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.169437", "ticker_sentiment_score": "0.207431", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.034136", "ticker_sentiment_score": "-0.025463", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.068209", "ticker_sentiment_score": "-0.02641", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at the B. Riley Securities Virtual Annual Oncology Investor Conference", "url": "https://www.benzinga.com/pressreleases/23/01/g30450762/cytomx-therapeutics-to-present-at-the-b-riley-securities-virtual-annual-oncology-investor-conferen", "time_published": "20230117T210500", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Jan. 17, 2023 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present at the B.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": -0.043281, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.157483", "ticker_sentiment_score": "-0.053591", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.157483", "ticker_sentiment_score": "-0.011986", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.07913", "ticker_sentiment_score": "-0.040319", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.157483", "ticker_sentiment_score": "-0.053591", "ticker_sentiment_label": "Neutral"}]}, {"title": "5 Most Expensive Health Care Stocks You Should Worry About - Alterity Therapeutics  ( NASDAQ:ATHE ) , Cellectis  ( NASDAQ:CLLS ) ", "url": "https://www.benzinga.com/news/23/01/30389571/5-most-expensive-health-care-stocks-you-should-worry-about", "time_published": "20230112T140141", "authors": ["Lisa Levin"], "summary": "The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/01/12/image27.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.260326, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.360752", "ticker_sentiment_score": "-0.053615", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRRX", "relevance_score": "0.360752", "ticker_sentiment_score": "0.116326", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.124164", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.360752", "ticker_sentiment_score": "0.409482", "ticker_sentiment_label": "Bullish"}, {"ticker": "ATHE", "relevance_score": "0.360752", "ticker_sentiment_score": "0.210407", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CLLS", "relevance_score": "0.360752", "ticker_sentiment_score": "0.471673", "ticker_sentiment_label": "Bullish"}]}, {"title": "Tesla, Moderna And These 2 Stocks Insiders Are Selling - Albemarle  ( NYSE:ALB ) , Hewlett Packard  ( NYSE:HPE ) ", "url": "https://www.benzinga.com/news/23/01/30332910/tesla-moderna-and-these-2-stocks-insiders-are-selling", "time_published": "20230109T140336", "authors": ["Lisa Levin"], "summary": "The US economy added 223,000 jobs in December, the least since December 2020, following a revised 256,000 increase in November, and above market estimates of 200,000. Investors, meanwhile, focused on some notable insider trades.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/01/09/image-tesla3.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.181358, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "HPQ", "relevance_score": "0.331765", "ticker_sentiment_score": "0.195864", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.085324", "ticker_sentiment_score": "0.186363", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSLA", "relevance_score": "0.407844", "ticker_sentiment_score": "0.306489", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HPE", "relevance_score": "0.407844", "ticker_sentiment_score": "0.227621", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRNA", "relevance_score": "0.407844", "ticker_sentiment_score": "0.166328", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALB", "relevance_score": "0.407844", "ticker_sentiment_score": "0.210526", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "AbbVie cuts earnings forecast due to milestone payments", "url": "https://www.marketwatch.com/story/abbvie-cuts-earnings-forecast-due-to-milestone-payments-11673048665", "time_published": "20230106T235200", "authors": ["Wallace Witkowski"], "summary": "AbbVie Inc. lowered its outlook for the quarter and year late Friday for research and development expenses and milestone payments to partners.", "banner_image": "https://images.mktw.net/im-264386/social", "source": "MarketWatch", "category_within_source": "Top Stories", "source_domain": "www.marketwatch.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.128481, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.817578", "ticker_sentiment_score": "0.216647", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIIB", "relevance_score": "0.132368", "ticker_sentiment_score": "0.096377", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.261117", "ticker_sentiment_score": "0.155819", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Dow Jumps 700 Points; S&P 500 Rises Over 2% - Aehr Test Systems  ( NASDAQ:AEHR ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ", "url": "https://www.benzinga.com/news/earnings/23/01/30316154/dow-jumps-700-points-s-p-500-rises-over-2", "time_published": "20230106T194324", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday. The Dow traded up 2.14% to 33,634.19 while the NASDAQ rose 2.54% to 10,566.63. The S&P 500 also rose, gaining, 2.30% to 3,895.60.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/01/06/image45.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.109408, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AEHR", "relevance_score": "0.104911", "ticker_sentiment_score": "0.165388", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GRPH", "relevance_score": "0.104911", "ticker_sentiment_score": "0.031134", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.104911", "ticker_sentiment_score": "0.196989", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.05257", "ticker_sentiment_score": "0.031033", "ticker_sentiment_label": "Neutral"}, {"ticker": "KKPCF", "relevance_score": "0.05257", "ticker_sentiment_score": "0.296863", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LOOP", "relevance_score": "0.104911", "ticker_sentiment_score": "0.178305", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPGI", "relevance_score": "0.05257", "ticker_sentiment_score": "-0.061955", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.05257", "ticker_sentiment_score": "0.071651", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.1568", "ticker_sentiment_score": "0.385093", "ticker_sentiment_label": "Bullish"}, {"ticker": "FATE", "relevance_score": "0.104911", "ticker_sentiment_score": "0.034993", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.05257", "ticker_sentiment_score": "0.071651", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.05257", "ticker_sentiment_score": "0.181645", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.05257", "ticker_sentiment_score": "-0.093159", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX  ( CTMX )  Up 55% on Strategic Partnership With Moderna", "url": "https://www.zacks.com/stock/news/2036409/cytomx-ctmx-up-55-on-strategic-partnership-with-moderna", "time_published": "20230106T184600", "authors": ["Zacks Investment Research"], "summary": "CytomX (CTMX) inks an agreement with Moderna to develop therapeutics for oncology and non-oncology conditions. The company also provides its business outlook for 2023.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/71/1337.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.11724, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.450165", "ticker_sentiment_score": "0.265246", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ABBV", "relevance_score": "0.381755", "ticker_sentiment_score": "0.074788", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.381755", "ticker_sentiment_score": "0.079226", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge - Aehr Test Systems  ( NASDAQ:AEHR ) , ATAI Life Sciences  ( NASDAQ:ATAI ) ", "url": "https://www.benzinga.com/news/earnings/23/01/30313745/nasdaq-gains-1-5-fate-therapeutics-shares-plunge", "time_published": "20230106T170106", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday. The Dow traded up 1.69% to 33,488.01 while the NASDAQ rose 1.52% to 10,461.92. The S&P 500 also rose, gaining, 1.67% to 3,871.65. Check This Out: 5 Tech Stocks That Are Flying - And May ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/01/06/image41.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.576289"}], "overall_sentiment_score": 0.10729, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AEHR", "relevance_score": "0.10607", "ticker_sentiment_score": "0.165969", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GRPH", "relevance_score": "0.10607", "ticker_sentiment_score": "0.031259", "ticker_sentiment_label": "Neutral"}, {"ticker": "CENX", "relevance_score": "0.10607", "ticker_sentiment_score": "0.179015", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.10607", "ticker_sentiment_score": "0.197681", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.053153", "ticker_sentiment_score": "0.031041", "ticker_sentiment_label": "Neutral"}, {"ticker": "KKPCF", "relevance_score": "0.053153", "ticker_sentiment_score": "0.296912", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SPGI", "relevance_score": "0.053153", "ticker_sentiment_score": "-0.061971", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.158519", "ticker_sentiment_score": "0.387476", "ticker_sentiment_label": "Bullish"}, {"ticker": "FATE", "relevance_score": "0.10607", "ticker_sentiment_score": "0.035141", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.053153", "ticker_sentiment_score": "0.181717", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.053153", "ticker_sentiment_score": "0.037587", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:HT", "relevance_score": "0.053153", "ticker_sentiment_score": "0.037587", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why CytomX Therapeutics  ( CTMX )  Shares Are Soaring Today - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/general/biotech/23/01/30310896/cytomx-shares-move-higher-on-collaborating-pact-with-this-famed-covid-19-vaccine-maker", "time_published": "20230106T153029", "authors": ["Vandana Singh"], "summary": "Moderna Inc MRNA and CytomX Therapeutics Inc CTMX announced a collaboration and licensing agreement to create mRNA-based conditionally activated therapies utilizing Moderna's mRNA technologies and CytomX's Probody therapeutic platform.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/01/06/ctmx_logo_dark__d8d313a56b93966616d4a30b15c9bd27.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.249361, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.7887", "ticker_sentiment_score": "0.610894", "ticker_sentiment_label": "Bullish"}, {"ticker": "REGN", "relevance_score": "0.382925", "ticker_sentiment_score": "-0.17108", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CTMX", "relevance_score": "0.546745", "ticker_sentiment_score": "0.508679", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why Graphite Bio Shares Are Trading Lower By 50%; Here Are 20 Stocks Moving Premarket - ABVC BioPharma  ( NASDAQ:ABVC ) , Acasti Pharma  ( NASDAQ:ACST ) ", "url": "https://www.benzinga.com/news/23/01/30309039/why-graphite-bio-shares-are-trading-lower-by-50-here-are-20-stocks-moving-premarket", "time_published": "20230106T130036", "authors": ["Lisa Levin"], "summary": "OncoCyte Corporation OCX rose 89.2% to $0.70 in pre-market trading. Oncocyte, last month, announced an over 40% reduction of its workforce to realign the team towards key products that address larger markets. Spruce Biosciences, Inc. SPRB shares rose 84% to $2.30 in pre-market trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/01/06/image47.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.865346"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.024085, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HKD", "relevance_score": "0.127119", "ticker_sentiment_score": "0.148947", "ticker_sentiment_label": "Neutral"}, {"ticker": "VYNT", "relevance_score": "0.18967", "ticker_sentiment_score": "0.08997", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.119692", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGAM", "relevance_score": "0.127119", "ticker_sentiment_score": "0.194653", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ORTX", "relevance_score": "0.18967", "ticker_sentiment_score": "0.169684", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRI", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.164906", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CTMX", "relevance_score": "0.127119", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSUN", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.130218", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWE", "relevance_score": "0.127119", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.18967", "ticker_sentiment_score": "0.134698", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCX", "relevance_score": "0.18967", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.105372", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.368429", "ticker_sentiment_label": "Bearish"}, {"ticker": "OBLG", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.12586", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.18967", "ticker_sentiment_score": "0.32866", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FATE", "relevance_score": "0.127119", "ticker_sentiment_score": "0.109122", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABVC", "relevance_score": "0.18967", "ticker_sentiment_score": "-0.071249", "ticker_sentiment_label": "Neutral"}, {"ticker": "KKPCF", "relevance_score": "0.063763", "ticker_sentiment_score": "0.22341", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MEGL", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.13841", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.063763", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACST", "relevance_score": "0.127119", "ticker_sentiment_score": "-0.084665", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFTR", "relevance_score": "0.127119", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Moderna, CytomX to collaborate on mRNA-based therapies", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-cytomx-announce-mrna-collaboration-2023-01-05/", "time_published": "20230105T213200", "authors": ["Reuters"], "summary": "Jan 5 ( Reuters ) - Moderna Inc ( MRNA.O ) on Thursday announced a $35 million licensing deal with CytomX Therapeutics ( CTMX.O ) for the development of certain investigational messenger RNA-based therapies.", "banner_image": "https://cloudfront-us-east-2.images.arcpublishing.com/reuters/URFXNJW47FIGLFPM6EQDK7ZUP4.jpg", "source": "Reuters", "category_within_source": "Business", "source_domain": "www.reuters.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.055684, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRNA", "relevance_score": "0.552443", "ticker_sentiment_score": "0.036635", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.295867", "ticker_sentiment_score": "0.177099", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX and Moderna Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics - CytomX Therapeutics  ( NASDAQ:CTMX ) , Moderna  ( NASDAQ:MRNA ) ", "url": "https://www.benzinga.com/pressreleases/23/01/g30301606/cytomx-and-moderna-announce-strategic-research-collaboration-for-mrna-based-conditionally-activate", "time_published": "20230105T210500", "authors": ["Globe Newswire"], "summary": "Collaboration will combine Moderna's mRNA technology with CytomX's Probody\u00ae Platform to generate and develop therapeutics for oncology and non-oncology conditions CytomX to receive $35 million upfront payment with the potential for additional research, milestone, and royalty payments", "banner_image": "", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.05501, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.04476", "ticker_sentiment_score": "-0.026954", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.022389", "ticker_sentiment_score": "0.019176", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.067095", "ticker_sentiment_score": "0.06913", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNA", "relevance_score": "0.326211", "ticker_sentiment_score": "0.103769", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.04476", "ticker_sentiment_score": "-0.026954", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Outline 2023 Company Priorities and Provide Pipeline Update on January 5, 2023", "url": "https://www.globenewswire.com/news-release/2022/12/22/2578939/37704/en/CytomX-Therapeutics-to-Outline-2023-Company-Priorities-and-Provide-Pipeline-Update-on-January-5-2023.html", "time_published": "20221222T220000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., Dec. 22, 2022 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that it plans to outline its pipeline priorities for 2023 and provide a data update for the ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.036057, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.17715", "ticker_sentiment_score": "-0.042279", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.17715", "ticker_sentiment_score": "-0.042279", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.17715", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2022/12/20/2577524/37704/en/CytomX-Therapeutics-to-Present-at-the-41st-Annual-J-P-Morgan-Healthcare-Conference.html", "time_published": "20221220T220000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., Dec. 20, 2022 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present at the ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.04832, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.163909", "ticker_sentiment_score": "-0.059659", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.163909", "ticker_sentiment_score": "-0.059659", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.163909", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/22/12/g30153373/cytomx-therapeutics-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference", "time_published": "20221220T220000", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Dec. 20, 2022 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy, D.Phil., president, chief executive officer, and chairman, will present at the 41st Annual ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.043289, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.153961", "ticker_sentiment_score": "-0.054343", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.153961", "ticker_sentiment_score": "-0.054343", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.153961", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present Phase 2 Data for Praluzatamab Ravtansine  ( CX-2009 )  in Patients with Advanced Breast Cancer at the San Antonio Breast Cancer Symposium - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/22/12/g29999143/cytomx-therapeutics-to-present-phase-2-data-for-praluzatamab-ravtansine-cx-2009-in-patients-with-a", "time_published": "20221207T213000", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Dec. 07, 2022 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of conditionally activated oncology therapeutics, today announced that Phase 2 data for CX-2009, a conditionally activated antibody drug conjugate ( ADC ) targeting CD166, will ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.119671, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.120733", "ticker_sentiment_score": "-0.047412", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.120733", "ticker_sentiment_score": "-0.047412", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.238718", "ticker_sentiment_score": "-0.113579", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present Phase 2 Data for Praluzatamab Ravtansine  ( CX-2009 )  in Patients with Advanced Breast Cancer at the San Antonio Breast Cancer Symposium", "url": "https://www.globenewswire.com/news-release/2022/12/07/2569745/37704/en/CytomX-Therapeutics-to-Present-Phase-2-Data-for-Praluzatamab-Ravtansine-CX-2009-in-Patients-with-Advanced-Breast-Cancer-at-the-San-Antonio-Breast-Cancer-Symposium.html", "time_published": "20221207T213000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., Dec. 07, 2022 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that Phase 2 data for CX-2009, a conditionally activated antibody drug conjugate ( ADC ) targeting ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.077099, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.069596", "ticker_sentiment_score": "-0.041707", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.069596", "ticker_sentiment_score": "-0.041707", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.104228", "ticker_sentiment_score": "-0.162137", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Biotech Stock Roundup: CTMX Surges on REGN's Deal, APLS Up on Regulatory Update", "url": "https://www.zacks.com/stock/news/2021539/biotech-stock-roundup-ctmx-surges-on-regns-deal-apls-up-on-regulatory-update", "time_published": "20221123T171800", "authors": ["Zacks Investment Research"], "summary": "Updates from CTMX and APLS are the key highlights from the biotech sector during the past week.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/04/837.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.223158, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APLS", "relevance_score": "0.108466", "ticker_sentiment_score": "0.024476", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.214937", "ticker_sentiment_score": "0.269678", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.214937", "ticker_sentiment_score": "0.209327", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "REGN", "relevance_score": "0.162073", "ticker_sentiment_score": "0.171015", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIIB", "relevance_score": "0.054359", "ticker_sentiment_score": "0.040989", "ticker_sentiment_label": "Neutral"}]}, {"title": "Best Penny Stocks To Buy Now? 5 Biotech Stocks To Watch This Week", "url": "https://pennystocks.com/featured/2022/11/21/best-penny-stocks-to-buy-now-5-biotech-stocks-to-watch-this-week/", "time_published": "20221121T175936", "authors": ["J. Phillip"], "summary": "Penny stocks are shares of companies trading for less than $5, which makes them excellent targets for day traders. Their lower price also makes them ideal for some investors to want to leap at potentially grassroots opportunities. While the latter is few and far between, the former is something ...", "banner_image": "https://pennystocks.com/wp-content/uploads/2022/11/best-biotech-penny-stocks-to-buy-this-week.jpg", "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.999864"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.186244, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALPMF", "relevance_score": "0.035035", "ticker_sentiment_score": "0.133248", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.035035", "ticker_sentiment_score": "0.407189", "ticker_sentiment_label": "Bullish"}, {"ticker": "CTMX", "relevance_score": "0.070002", "ticker_sentiment_score": "0.041554", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXL", "relevance_score": "0.104835", "ticker_sentiment_score": "0.023454", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.139467", "ticker_sentiment_score": "0.111531", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Upgraded to Hold by StockNews.com", "url": "https://www.etfdailynews.com/2022/11/19/cytomx-therapeutics-nasdaqctmx-upgraded-to-hold-by-stocknews-com/", "time_published": "20221119T082444", "authors": ["MarketBeat News"], "summary": "CytomX Therapeutics ( NASDAQ:CTMX - Get Rating ) was upgraded by equities research analysts at StockNews.com from a \"sell\" rating to a \"hold\" rating in a research report issued on Saturday. Other equities research analysts also recently issued reports about the stock.", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=CTMX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.212603, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.136113", "ticker_sentiment_score": "0.193781", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.068306", "ticker_sentiment_score": "-0.034073", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.854923", "ticker_sentiment_score": "0.359687", "ticker_sentiment_label": "Bullish"}, {"ticker": "JPM", "relevance_score": "0.068306", "ticker_sentiment_score": "0.048166", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRRM", "relevance_score": "0.068306", "ticker_sentiment_score": "0.037289", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX  ( CTMX )  Stock Surges on Oncology Deal With Regeneron", "url": "https://www.zacks.com/stock/news/2020092/cytomx-ctmx-stock-surges-on-oncology-deal-with-regeneron", "time_published": "20221118T181800", "authors": ["Zacks Investment Research"], "summary": "CytomX (CTMX) gets a boost after its deal with Regeneron for the development of investigational next-generation bispecific immunotherapies.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/86/1981.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.155976, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.325924", "ticker_sentiment_score": "-0.037741", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.220809", "ticker_sentiment_score": "0.254083", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "REGN", "relevance_score": "0.220809", "ticker_sentiment_score": "0.254083", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMGN", "relevance_score": "0.325924", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.220809", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks making the biggest moves midday: Bath & Body Works, Norwegian Cruise Line, Macy's and more", "url": "https://www.cnbc.com/2022/11/17/stocks-making-the-biggest-moves-midday-bath-body-works-norwegian-cruise-line-macys-and-more.html", "time_published": "20221117T182031", "authors": ["Alex Harring"], "summary": "These are the stocks posting the largest moves in midday trading.", "banner_image": "https://image.cnbcfm.com/api/v1/image/105774105-1551739069101gettyimages-1035935822.jpeg?v=1668699233", "source": "CNBC", "category_within_source": "Market Insider", "source_domain": "www.cnbc.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}, {"topic": "Earnings", "relevance_score": "0.997335"}], "overall_sentiment_score": 0.189396, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "C", "relevance_score": "0.093653", "ticker_sentiment_score": "-0.062521", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.093653", "ticker_sentiment_score": "0.242822", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.093653", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGX", "relevance_score": "0.093653", "ticker_sentiment_score": "-0.062521", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.093653", "ticker_sentiment_score": "0.263154", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KSS", "relevance_score": "0.18602", "ticker_sentiment_score": "0.150929", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BBWI", "relevance_score": "0.18602", "ticker_sentiment_score": "0.100972", "ticker_sentiment_label": "Neutral"}, {"ticker": "M", "relevance_score": "0.18602", "ticker_sentiment_score": "0.287369", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why CytomX  ( CTMX )  Shares Are Jumping Today - Regeneron Pharmaceuticals  ( NASDAQ:REGN ) ", "url": "https://www.benzinga.com/general/biotech/22/11/29766139/cytomx-shares-jump-after-cancer-therapy-pact-with-pharma-major-regeneron", "time_published": "20221117T161402", "authors": ["Vandana Singh"], "summary": "CytomX Therapeutics Inc CTMX and Regeneron Pharmaceuticals Inc REGN announced a collaboration and licensing agreement to create conditionally-activated bispecific cancer therapies. The collaboration will utilize CytomX's Probody therapeutic platform and Regeneron's Veloci-Bi bispecific antibody ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/11/17/cytomx-logo-jpg.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.191854, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "REGN", "relevance_score": "0.398148", "ticker_sentiment_score": "0.111084", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.703273", "ticker_sentiment_score": "0.328014", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Heska To $165? Plus BTIG Cuts PT On This Stock By 67% - CytomX Therapeutics  ( NASDAQ:CTMX ) , Elanco Animal Health  ( NYSE:ELAN ) ", "url": "https://www.benzinga.com/news/22/11/29699762/heska-to-165-plus-btig-cuts-pt-on-this-stock-by-67", "time_published": "20221114T132114", "authors": ["Lisa Levin"], "summary": "BTIG cut the price target on Gain Therapeutics, Inc. GANX from $30 to $10. BTIG analyst Thomas Shrader maintained a Buy rating on the stock. Gain Therapeutics shares rose 1.3% to close at $3.21 on Friday. Piper Sandler cut the price target for Heska Corporation HSKA from $170 to $165.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/11/14/image18.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.043717, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HSKA", "relevance_score": "0.491878", "ticker_sentiment_score": "-0.194015", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MTH", "relevance_score": "0.491878", "ticker_sentiment_score": "0.721202", "ticker_sentiment_label": "Bullish"}, {"ticker": "CTMX", "relevance_score": "0.491878", "ticker_sentiment_score": "0.0382", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELAN", "relevance_score": "0.491878", "ticker_sentiment_score": "0.33559", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GANX", "relevance_score": "0.491878", "ticker_sentiment_score": "0.009476", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBIX", "relevance_score": "0.491878", "ticker_sentiment_score": "-0.328278", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SLGL", "relevance_score": "0.491878", "ticker_sentiment_score": "-0.307156", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Stock Rating Lowered by StockNews.com", "url": "https://www.etfdailynews.com/2022/11/13/cytomx-therapeutics-nasdaqctmx-stock-rating-lowered-by-stocknews-com/", "time_published": "20221113T063044", "authors": ["MarketBeat News"], "summary": "CytomX Therapeutics ( NASDAQ:CTMX - Get Rating ) was downgraded by equities research analysts at StockNews.com from a \"hold\" rating to a \"sell\" rating in a report released on Friday. Other analysts also recently issued research reports about the stock.", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=CTMX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.044997, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "JPM", "relevance_score": "0.122269", "ticker_sentiment_score": "0.005822", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.876064", "ticker_sentiment_score": "0.078758", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Reports Q3 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2015670/cytomx-therapeutics-ctmx-reports-q3-loss-misses-revenue-estimates", "time_published": "20221108T223519", "authors": ["Zacks Investment Research"], "summary": "CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -9.38% and 9.20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default190.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.091775, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ICVX", "relevance_score": "0.208764", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.40348", "ticker_sentiment_score": "-0.033108", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present Preclinical Data for Conditionally Activated Interferon Alpha-2b  ( CX-801 )  at the SITC 2022 Annual Meeting", "url": "https://www.globenewswire.com/news-release/2022/11/07/2550277/37704/en/CytomX-Therapeutics-to-Present-Preclinical-Data-for-Conditionally-Activated-Interferon-Alpha-2b-CX-801-at-the-SITC-2022-Annual-Meeting.html", "time_published": "20221107T211500", "authors": ["CytomX Therapeutics Inc."], "summary": "- IND filing for CX-801 is anticipated in the second half of 2023 - - IND filing for CX-801 is anticipated in the second half of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.031509, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.07031", "ticker_sentiment_score": "-0.043812", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.07031", "ticker_sentiment_score": "-0.043812", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.140076", "ticker_sentiment_score": "0.015432", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at Upcoming November Investor Conferences", "url": "https://www.globenewswire.com/news-release/2022/11/02/2547066/37704/en/CytomX-Therapeutics-to-Present-at-Upcoming-November-Investor-Conferences.html", "time_published": "20221102T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., Nov. 02, 2022 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.06034, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.166743", "ticker_sentiment_score": "-0.06039", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.166743", "ticker_sentiment_score": "-0.06039", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.247838", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at Upcoming November Investor Conferences - CytomX Therapeutics  ( NASDAQ:CTMX ) ", "url": "https://www.benzinga.com/pressreleases/22/11/g29532629/cytomx-therapeutics-to-present-at-upcoming-november-investor-conferences", "time_published": "20221102T201500", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., Nov. 02, 2022 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. CTMX, a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the following investor ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.052733, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.143415", "ticker_sentiment_score": "-0.052044", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.143415", "ticker_sentiment_score": "-0.052044", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.213674", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Travere Therapeutics  ( TVTX )  Reports Q3 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/1998898/travere-therapeutics-tvtx-reports-q3-loss-tops-revenue-estimates", "time_published": "20221027T211512", "authors": ["Zacks Investment Research"], "summary": "Travere (TVTX) delivered earnings and revenue surprises of -12.37% and 4.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default106.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.098636, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TVTX", "relevance_score": "0.14131", "ticker_sentiment_score": "-0.064653", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.210579", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Announces Phase 1 Data Update for anti-CTLA-4 Probody\u00ae Therapeutic BMS-986249", "url": "https://www.globenewswire.com/news-release/2022/09/12/2513952/37704/en/CytomX-Therapeutics-Announces-Phase-1-Data-Update-for-anti-CTLA-4-Probody-Therapeutic-BMS-986249.html", "time_published": "20220912T120000", "authors": ["CytomX Therapeutics Inc."], "summary": "- Presentation at ESMO 2022 by Collaborator, Bristol Myers Squibb -- BMS-986249 Phase 2 study ongoing ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.062447, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.076602", "ticker_sentiment_score": "-0.056691", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.114682", "ticker_sentiment_score": "-0.055283", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.152499", "ticker_sentiment_score": "-0.025944", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Presents Overview of Conditionally-Activated Antibody-Drug Conjugate  ( ADC )  Programs Including Next Generation EpCAM-Targeting CX-2051", "url": "https://www.globenewswire.com/news-release/2022/09/07/2512047/37704/en/CytomX-Therapeutics-Presents-Overview-of-Conditionally-Activated-Antibody-Drug-Conjugate-ADC-Programs-Including-Next-Generation-EpCAM-Targeting-CX-2051.html", "time_published": "20220907T220500", "authors": ["CytomX Therapeutics Inc."], "summary": "- Presentation at World ADC Conference in San Diego ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.0, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ADCT", "relevance_score": "0.029728", "ticker_sentiment_score": "0.143088", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.059415", "ticker_sentiment_score": "-0.056235", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.1185", "ticker_sentiment_score": "-0.046001", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.059415", "ticker_sentiment_score": "-0.056235", "ticker_sentiment_label": "Neutral"}]}, {"title": " ( AHI ) ,  ( ALNA )  - Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket", "url": "https://www.benzinga.com/news/22/09/28752577/why-dwac-is-trading-lower-by-around-19-here-are-32-stocks-moving-premarket", "time_published": "20220906T104131", "authors": ["Lisa Levin"], "summary": "First Wave BioPharma, Inc. FWBI shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday. Organovo Holdings, Inc. ONVO rose 25.1% to $2.89 in pre-market trading. Tian Ruixiang Holdings Ltd TIRX shares rose 24% to $0.85 in pre-market trading after declining around 5% on Friday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/09/06/image26.jpeg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.982687"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.055466, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALNA", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.305198", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRTD", "relevance_score": "0.170878", "ticker_sentiment_score": "0.058934", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHI", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.075069", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.005868", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.151393", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KPRX", "relevance_score": "0.114409", "ticker_sentiment_score": "0.120794", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.114409", "ticker_sentiment_score": "0.186172", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NFE", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIVE", "relevance_score": "0.170878", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBSV", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.005868", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMST", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.207029", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DWAC", "relevance_score": "0.114409", "ticker_sentiment_score": "0.096721", "ticker_sentiment_label": "Neutral"}, {"ticker": "NINE", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.01446", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.305198", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TENX", "relevance_score": "0.057352", "ticker_sentiment_score": "-0.199999", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TIRX", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.048287", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXL", "relevance_score": "0.170878", "ticker_sentiment_score": "0.069589", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCN", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.14803", "ticker_sentiment_label": "Neutral"}, {"ticker": "KUKE", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.306319", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GOGL", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.424357", "ticker_sentiment_label": "Bearish"}, {"ticker": "IDEX", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.00582", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIAF", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.170878", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.114409", "ticker_sentiment_score": "0.310801", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PXMD", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.209757", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RUBY", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.057352", "ticker_sentiment_score": "-0.004008", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONVO", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHLR", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Financial Results for the Second Quarter Ended June 30, 2022 and Provides Pipeline Update", "url": "https://www.globenewswire.com/news-release/2022/08/15/2498065/0/en/Pyxis-Oncology-Reports-Financial-Results-for-the-Second-Quarter-Ended-June-30-2022-and-Provides-Pipeline-Update.html", "time_published": "20220815T110000", "authors": ["Pyxis Oncology"], "summary": "\u2022 Prioritized pipeline to focus on most advanced programs while maintaining financial flexibility to pursue business development opportunities ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.137052, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.024597", "ticker_sentiment_score": "0.003808", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.356268", "ticker_sentiment_score": "0.193997", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BDIMF", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDTX", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}, {"ticker": "XLO", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Rating Increased to Hold at StockNews.com", "url": "https://www.defenseworld.net/2022/08/07/cytomx-therapeutics-nasdaqctmx-rating-increased-to-hold-at-stocknews-com.html", "time_published": "20220807T054641", "authors": ["admin"], "summary": "CytomX Therapeutics ( NASDAQ:CTMX - Get Rating ) was upgraded by analysts at StockNews.com from a \"sell\" rating to a \"hold\" rating in a research report issued to clients and investors on Friday. Other analysts also recently issued reports about the company.", "banner_image": "https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&Symbol=CTMX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.99977"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.117969, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CRON", "relevance_score": "0.059194", "ticker_sentiment_score": "-0.036039", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.059194", "ticker_sentiment_score": "-0.036039", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.059194", "ticker_sentiment_score": "0.02501", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.818658", "ticker_sentiment_score": "0.200016", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Q2 2022 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2022/08/05/cytomx-therapeutics-ctmx-q2-2022-earnings-call-tra/", "time_published": "20220805T123040", "authors": ["Motley Fool Transcribing"], "summary": "CTMX earnings call for the period ending June 30, 2022.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.205895, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.034497", "ticker_sentiment_score": "0.011633", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.011502", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.011502", "ticker_sentiment_score": "0.285902", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GHGUF", "relevance_score": "0.011502", "ticker_sentiment_score": "0.071235", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.023002", "ticker_sentiment_score": "0.094858", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Reports Q2 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/1964263/cytomx-therapeutics-ctmx-reports-q2-loss-lags-revenue-estimates", "time_published": "20220804T214514", "authors": ["Zacks Investment Research"], "summary": "CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -2.78% and 1.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default153.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.133873, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.137671", "ticker_sentiment_score": "0.103896", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.397098", "ticker_sentiment_score": "0.079507", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update", "url": "https://www.globenewswire.com/news-release/2022/08/04/2492842/37704/en/CytomX-Therapeutics-Reports-Second-Quarter-2022-Financial-Results-and-Provides-Business-Update.html", "time_published": "20220804T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "- Recently-announced company restructuring focuses internal efforts on wholly-owned next-generation conditionally activated therapeutics, extending cash runway to ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.024094, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.098416", "ticker_sentiment_score": "0.001092", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.098416", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.078805", "ticker_sentiment_score": "0.018531", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Present at Upcoming Virtual August Investor Conferences", "url": "https://www.globenewswire.com/news-release/2022/08/03/2491316/37704/en/CytomX-Therapeutics-to-Present-at-Upcoming-Virtual-August-Investor-Conferences.html", "time_published": "20220803T120000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 ( GLOBE NEWSWIRE ) -- CytomX Therapeutics, Inc. ( Nasdaq: CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will virtually participate in ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.081931, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.19117", "ticker_sentiment_score": "-0.088654", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.19117", "ticker_sentiment_score": "-0.088654", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.19117", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "ANI Pharmaceuticals  ( ANIP )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?", "url": "https://www.zacks.com/stock/news/1961336/ani-pharmaceuticals-anip-expected-to-beat-earnings-estimates-can-the-stock-move-higher", "time_published": "20220801T140108", "authors": ["Zacks Investment Research"], "summary": "ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default26.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.174699, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANIP", "relevance_score": "0.087503", "ticker_sentiment_score": "0.079335", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.173958", "ticker_sentiment_score": "0.078049", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Expected to Beat Earnings Estimates: Can the Stock Move Higher?", "url": "https://www.zacks.com/stock/news/1959762/cytomx-therapeutics-ctmx-expected-to-beat-earnings-estimates-can-the-stock-move-higher", "time_published": "20220728T140237", "authors": ["Zacks Investment Research"], "summary": "CytomX Therapeutics (CTMX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default226.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.156568, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AEZS", "relevance_score": "0.173645", "ticker_sentiment_score": "0.029827", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.257895", "ticker_sentiment_score": "0.144261", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures", "url": "https://www.benzinga.com/general/biotech/22/07/28062629/the-daily-biotech-pulse-much-awaited-fda-nod-for-novavaxs-covid-19-shot-dsmb-suggests-contrafect-", "time_published": "20220714T130111", "authors": ["Vandana Singh"], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours: The FDA granted emergency use authorization to Novavax Inc NVAX's adjuvanted COVID-19 vaccine ( NVX-CoV2373 ) as a two-dose primary series for active immunization for individuals 18 years of age and over.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/14/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.040737, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "TBPH", "relevance_score": "0.114137", "ticker_sentiment_score": "0.182638", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RPRX", "relevance_score": "0.114137", "ticker_sentiment_score": "0.182638", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BGNE", "relevance_score": "0.114137", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.114137", "ticker_sentiment_score": "0.116579", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.114137", "ticker_sentiment_score": "0.096488", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTRN", "relevance_score": "0.114137", "ticker_sentiment_score": "0.197222", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BLU", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.046622", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRNS", "relevance_score": "0.114137", "ticker_sentiment_score": "0.096488", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVA", "relevance_score": "0.114137", "ticker_sentiment_score": "0.182638", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CFRX", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.133953", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMYT", "relevance_score": "0.057215", "ticker_sentiment_score": "-0.157457", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVAX", "relevance_score": "0.057215", "ticker_sentiment_score": "0.059099", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.114137", "ticker_sentiment_score": "0.056425", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSK", "relevance_score": "0.114137", "ticker_sentiment_score": "-0.067536", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.114137", "ticker_sentiment_score": "0.056425", "ticker_sentiment_label": "Neutral"}, {"ticker": "THTX", "relevance_score": "0.114137", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "DMAC: 4 Downgraded Stocks to Stay Away From in July", "url": "https://stocknews.com/news/dmac-ctmx-cash-lob-4-downgraded-stocks-to-stay-away-from-in-july/", "time_published": "20220708T162339", "authors": [], "summary": "This year, the stock market recorded the worst first half in more than five decades due to investor's concerns over a potential economic slowdown. The Federal Reserve's aggressive monetary policy tightening to tame the multi-decade high inflation has primarily made investors and analysts worried ...", "banner_image": "https://stocknews.com/wp-content/uploads/2021/01/Chart-trending-downward-man-suit-scaled.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.769861"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999998"}, {"topic": "Earnings", "relevance_score": "0.999896"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.053055, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.181409", "ticker_sentiment_score": "-0.024422", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMAC", "relevance_score": "0.251866", "ticker_sentiment_score": "0.083652", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASH", "relevance_score": "0.181409", "ticker_sentiment_score": "0.189303", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GHGUF", "relevance_score": "0.036587", "ticker_sentiment_score": "0.085664", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.28636", "ticker_sentiment_score": "0.136015", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq Surges 250 Points; Crude Oil Rises Sharply", "url": "https://www.benzinga.com/news/earnings/22/07/27992230/nasdaq-surges-250-points-crude-oil-rises-sharply", "time_published": "20220707T190149", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite jumping 250 points following the release of data on initial jobless claims. The Dow traded up 1.04% to 31,359.65 while the NASDAQ rose 2.24% to 11,616.84. The S&P also rose, gaining, 1.47% to 3,901.54.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/07/image48.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.002314, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AREB", "relevance_score": "0.174377", "ticker_sentiment_score": "0.004527", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNLF", "relevance_score": "0.174377", "ticker_sentiment_score": "0.006402", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBOW", "relevance_score": "0.116772", "ticker_sentiment_score": "0.03869", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.174377", "ticker_sentiment_score": "0.003563", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROV", "relevance_score": "0.116772", "ticker_sentiment_score": "0.002032", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.174377", "ticker_sentiment_score": "0.00053", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSS", "relevance_score": "0.116772", "ticker_sentiment_score": "0.002032", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHIP", "relevance_score": "0.058544", "ticker_sentiment_score": "0.123618", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMAC", "relevance_score": "0.116772", "ticker_sentiment_score": "0.00445", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMHI", "relevance_score": "0.116772", "ticker_sentiment_score": "0.03869", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:KRW", "relevance_score": "0.231057", "ticker_sentiment_score": "0.006677", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Jumps More Than 200 Points; Samsung Sees This Much Surge In Quarterly Revenue", "url": "https://www.benzinga.com/news/earnings/22/07/27990031/dow-jumps-more-than-200-points-samsung-sees-this-much-surge-in-quarterly-revenue", "time_published": "20220707T161116", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims. The Dow traded up 0.77% to 31,275.90 while the NASDAQ rose 1.71% to 11,556.29. The S&P also rose, gaining, 1.13% to 3,888.56.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/07/image20.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.011069, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AREB", "relevance_score": "0.167671", "ticker_sentiment_score": "0.004741", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNLF", "relevance_score": "0.167671", "ticker_sentiment_score": "0.006402", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.167671", "ticker_sentiment_score": "0.005113", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROV", "relevance_score": "0.112243", "ticker_sentiment_score": "0.00247", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.167671", "ticker_sentiment_score": "0.000955", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSS", "relevance_score": "0.112243", "ticker_sentiment_score": "0.00247", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHIP", "relevance_score": "0.056261", "ticker_sentiment_score": "0.191547", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DMAC", "relevance_score": "0.112243", "ticker_sentiment_score": "0.005668", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLMT", "relevance_score": "0.167671", "ticker_sentiment_score": "0.035723", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:KRW", "relevance_score": "0.222276", "ticker_sentiment_score": "0.006677", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill", "url": "https://www.benzinga.com/general/biotech/22/07/27983728/the-daily-biotech-pulse-mercks-potential-seagen-buyout-expected-in-weeks-fda-holds-diamedicas-str", "time_published": "20220707T140337", "authors": ["Vandana Singh"], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours: Merck & Co Inc. MRK is in advanced talks to acquire Seagen Inc. SGEN. A purchase agreement is expected in the next few weeks, according to the Wall Street Journal citing people familiar with the matter.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/07/screen_shot_2022-07-07_at_10.02.51_am.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.002141, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.130358", "ticker_sentiment_score": "0.003271", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.130358", "ticker_sentiment_score": "-5.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADVM", "relevance_score": "0.19445", "ticker_sentiment_score": "0.002388", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.130358", "ticker_sentiment_score": "-0.002046", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.130358", "ticker_sentiment_score": "0.002096", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXEL", "relevance_score": "0.25726", "ticker_sentiment_score": "0.012546", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.065399", "ticker_sentiment_score": "-0.002046", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMAC", "relevance_score": "0.19445", "ticker_sentiment_score": "0.024579", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGEN", "relevance_score": "0.130358", "ticker_sentiment_score": "0.001058", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.130358", "ticker_sentiment_score": "0.014352", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.130358", "ticker_sentiment_score": "0.00639", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX's Breast Cancer Candidate Meets Primary Goal Of Objective Response Rate", "url": "https://www.benzinga.com/general/biotech/22/07/27982198/cytomxs-breast-cancer-candidate-meets-primary-goal-of-objective-response-rate", "time_published": "20220707T101529", "authors": ["Vandana Singh"], "summary": "CytomX Therapeutics Inc's CTMX Phase 2 study of praluzatamab ravtansine in hormone receptor-positive ( HR+ ) /human epidermal growth factor receptor 2 ( HER2 ) -non-amplified breast cancer ( Arm A ) met its primary efficacy endpoint of confirmed objective response rate ( ORR ) of more than 10%.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/07/aapharma.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.044738, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.465478", "ticker_sentiment_score": "0.001653", "ticker_sentiment_label": "Neutral"}]}, {"title": "U.S. Stock Futures Edge Higher After Fed Minutes", "url": "https://www.benzinga.com/news/earnings/22/07/27982324/u-s-stock-futures-edge-higher-after-fed-minutes", "time_published": "20220707T090756", "authors": ["Lisa Levin"], "summary": "U.S. stock futures traded slightly higher in early pre-market trade on Thursday following the release of Wednesday's Fed meeting minutes, suggesting inflation remains the central bank's top priority. The Challenger job-cut report for June is scheduled for release at 7:30 a.m.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/07/image32.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.682689"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.25"}], "overall_sentiment_score": -0.00878, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HESG", "relevance_score": "0.063594", "ticker_sentiment_score": "0.000501", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.189175", "ticker_sentiment_score": "0.00969", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIND", "relevance_score": "0.126784", "ticker_sentiment_score": "0.024543", "ticker_sentiment_label": "Neutral"}, {"ticker": "USNA", "relevance_score": "0.126784", "ticker_sentiment_score": "0.000501", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.126784", "ticker_sentiment_score": "0.029836", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCE", "relevance_score": "0.126784", "ticker_sentiment_score": "0.020763", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.126784", "ticker_sentiment_score": "0.020763", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Announces Phase 2 Results for Praluzatamab Ravtansine in Breast Cancer", "url": "https://www.globenewswire.com/news-release/2022/07/06/2475436/37704/en/CytomX-Therapeutics-Announces-Phase-2-Results-for-Praluzatamab-Ravtansine-in-Breast-Cancer.html", "time_published": "20220706T200500", "authors": ["CytomX Therapeutics Inc."], "summary": "- Study meets primary endpoint of objective response rate in HR+/HER2-non-amplified breast cancer ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.162531, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.041545", "ticker_sentiment_score": "0.290945", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.041545", "ticker_sentiment_score": "0.290945", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.082977", "ticker_sentiment_score": "0.000161", "ticker_sentiment_label": "Neutral"}]}, {"title": "NeoGenomics  ( NEO )  Surges 6.4%: Is This an Indication of Further Gains?", "url": "https://www.zacks.com/stock/news/1944243/neogenomics-neo-surges-64-is-this-an-indication-of-further-gains", "time_published": "20220627T123300", "authors": ["Zacks Investment Research"], "summary": "NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default305.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.001163, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NEO", "relevance_score": "0.482078", "ticker_sentiment_score": "0.0078", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.482078", "ticker_sentiment_score": "0.001978", "ticker_sentiment_label": "Neutral"}]}, {"title": "Aptose Appoints Fletcher Payne as Senior Vice President, Chief Financial Officer", "url": "https://investingnews.com/aptose-appoints-fletcher-payne-as-senior-vice-president-chief-financial-officer/", "time_published": "20220627T121256", "authors": [], "summary": "Aptose Biosciences Inc. ( \"Aptose\" or the \"Company\" ) ( NASDAQ: APTO, TSX: APS ) , a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced the appointment of Mr. Fletcher Payne to the position of ...", "banner_image": "https://mms.businesswire.com/media/20220427005982/en/1436129/4/Product_Image.jpg", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.051692, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APTO", "relevance_score": "0.117928", "ticker_sentiment_score": "0.056456", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVAX", "relevance_score": "0.039438", "ticker_sentiment_score": "0.008323", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.039438", "ticker_sentiment_score": "0.008323", "ticker_sentiment_label": "Neutral"}]}, {"title": "Aptose Appoints Fletcher Payne as Senior Vice President, Chief Financial Officer", "url": "https://www.globenewswire.com/news-release/2022/06/27/2469416/35575/en/Aptose-Appoints-Fletcher-Payne-as-Senior-Vice-President-Chief-Financial-Officer.html", "time_published": "20220627T113000", "authors": ["Inc.", "Aptose Biosciences"], "summary": "SAN DIEGO and TORONTO, June 27, 2022 ( GLOBE NEWSWIRE ) -- Aptose Biosciences Inc. ( \"Aptose\" or the \"Company\" ) ( NASDAQ: APTO, TSX: APS ) , a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced the ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/3f4ab307-5947-4ef1-b5b5-c2c66933728a?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.043306, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APTO", "relevance_score": "0.116348", "ticker_sentiment_score": "0.05526", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVAX", "relevance_score": "0.038906", "ticker_sentiment_score": "0.008323", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.038906", "ticker_sentiment_score": "0.008323", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Lowered to \"Sell\" at StockNews.com", "url": "https://www.etfdailynews.com/2022/05/27/cytomx-therapeutics-nasdaqctmx-lowered-to-sell-at-stocknews-com/", "time_published": "20220527T052252", "authors": ["MarketBeat News"], "summary": "CytomX Therapeutics ( NASDAQ:CTMX - Get Rating ) was downgraded by StockNews.com from a \"hold\" rating to a \"sell\" rating in a note issued to investors on Friday. CTMX has been the subject of several other reports.", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&Symbol=CTMX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.etfdailynews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.012341, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.835236", "ticker_sentiment_score": "-0.012341", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOV", "relevance_score": "0.058287", "ticker_sentiment_score": "0.007611", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.058287", "ticker_sentiment_score": "-0.046196", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.116264", "ticker_sentiment_score": "0.009438", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Thursday", "url": "https://www.benzinga.com/markets/options/22/05/27422270/52-weeks-high-and-low-article", "time_published": "20220526T161527", "authors": ["Benzinga Insights"], "summary": "On Thursday, 94 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Medtronic ( NYSE:MDT ) was the biggest company on a market cap basis to set a new 52-week low. Performance Shipping ( NASDAQ:PSHG ) was the smallest company when considering market cap to set a new 52-w", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_9380.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.011819, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CNTG", "relevance_score": "0.072913", "ticker_sentiment_score": "0.000525", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.001475", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.024334", "ticker_sentiment_score": "-0.000986", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000479", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKYI", "relevance_score": "0.048646", "ticker_sentiment_score": "0.015604", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.001343", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDB", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.018766", "ticker_sentiment_label": "Neutral"}, {"ticker": "SISI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.00196", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIVE", "relevance_score": "0.048646", "ticker_sentiment_score": "0.008847", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.004728", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.001793", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.278085", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GLUE", "relevance_score": "0.048646", "ticker_sentiment_score": "0.0087", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.024334", "ticker_sentiment_score": "-0.010991", "ticker_sentiment_label": "Neutral"}, {"ticker": "SECO", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000229", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYDEV", "relevance_score": "0.048646", "ticker_sentiment_score": "0.000178", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.00796", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.165177", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MDT", "relevance_score": "0.097111", "ticker_sentiment_score": "0.057725", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCCI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.003766", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTHR", "relevance_score": "0.048646", "ticker_sentiment_score": "0.026773", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.026404", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.048646", "ticker_sentiment_score": "0.011329", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALBO", "relevance_score": "0.048646", "ticker_sentiment_score": "0.033583", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.005106", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.011382", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.048646", "ticker_sentiment_score": "0.008038", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.263816", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AUTO", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.006287", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.048646", "ticker_sentiment_score": "0.001458", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRCA", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.328832", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AYLA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.04831", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRXT", "relevance_score": "0.048646", "ticker_sentiment_score": "0.010365", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.002322", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTTA", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.013279", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.048646", "ticker_sentiment_score": "0.015792", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVO", "relevance_score": "0.048646", "ticker_sentiment_score": "0.004355", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.0124", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000809", "ticker_sentiment_label": "Neutral"}, {"ticker": "NN", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.045491", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.048646", "ticker_sentiment_score": "0.008556", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.048646", "ticker_sentiment_score": "0.00015", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERI", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000371", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.024334", "ticker_sentiment_score": "0.010365", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.048646", "ticker_sentiment_score": "0.010999", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRR", "relevance_score": "0.048646", "ticker_sentiment_score": "4.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.304069", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CYCC", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.001231", "ticker_sentiment_label": "Neutral"}, {"ticker": "YRD", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.001611", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUSN", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.003561", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLL", "relevance_score": "0.048646", "ticker_sentiment_score": "0.005648", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALOT", "relevance_score": "0.048646", "ticker_sentiment_score": "0.034797", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.048646", "ticker_sentiment_score": "0.056144", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUL", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.01067", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.048646", "ticker_sentiment_score": "0.031609", "ticker_sentiment_label": "Neutral"}, {"ticker": "UHAL", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.003901", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.009053", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.048646", "ticker_sentiment_score": "0.003493", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.00472", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVDL", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.017898", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.00163", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.352546", "ticker_sentiment_label": "Bearish"}, {"ticker": "CRNX", "relevance_score": "0.048646", "ticker_sentiment_score": "0.007099", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUT", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.035012", "ticker_sentiment_label": "Neutral"}, {"ticker": "OVID", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.007563", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSHG", "relevance_score": "0.097111", "ticker_sentiment_score": "0.097808", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALA", "relevance_score": "0.048646", "ticker_sentiment_score": "0.063248", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHC", "relevance_score": "0.048646", "ticker_sentiment_score": "0.001411", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNGY", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.005391", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKU", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.006577", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCTL", "relevance_score": "0.048646", "ticker_sentiment_score": "0.002033", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.048646", "ticker_sentiment_score": "0.004891", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOT", "relevance_score": "0.048646", "ticker_sentiment_score": "0.000275", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBAC", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000741", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUO", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000585", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAVA", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.000186", "ticker_sentiment_label": "Neutral"}, {"ticker": "MANU", "relevance_score": "0.048646", "ticker_sentiment_score": "0.044162", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.048646", "ticker_sentiment_score": "0.000438", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.048646", "ticker_sentiment_score": "0.008555", "ticker_sentiment_label": "Neutral"}, {"ticker": "JACK", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.005257", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNON", "relevance_score": "0.048646", "ticker_sentiment_score": "-0.078959", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Initiates Dosing in Early-Stage Study Of Solid Tumor Settings", "url": "https://www.benzinga.com/general/biotech/22/05/27417467/cytomx-therapeutics-initiates-dosing-in-early-stage-study-of-solid-tumor-settings", "time_published": "20220526T141813", "authors": ["Ragothaman Srinivasan"], "summary": "CytomX Therapeutics, Inc. ( NASDAQ: CTMX ) initiated enrolment by dosing first patient in a Phase 1 dose-escalation study of CX-904 for patients with advanced solid tumors. CX-904 is a conditionally activated T-cell-engaging bispecific ( TCB ) designed to target the epidermal growth factor recep", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/26/bz-pharma_0.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.052779, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.586747", "ticker_sentiment_score": "0.014665", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Downgrades CytomX Therapeutics  ( NASDAQ:CTMX )  to Sell", "url": "https://www.defenseworld.net/2022/05/12/stocknews-com-downgrades-cytomx-therapeutics-nasdaqctmx-to-sell.html", "time_published": "20220512T131241", "authors": ["admin"], "summary": "StockNews.com downgraded shares of CytomX Therapeutics ( NASDAQ:CTMX - Get Rating ) from a hold rating to a sell rating in a report issued on Wednesday morning.", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&Symbol=CTMX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.007376, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "WEN", "relevance_score": "0.053461", "ticker_sentiment_score": "0.007611", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.053461", "ticker_sentiment_score": "0.007611", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.053461", "ticker_sentiment_score": "0.010795", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.820106", "ticker_sentiment_score": "0.007376", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALMFF", "relevance_score": "0.106683", "ticker_sentiment_score": "0.015826", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.053461", "ticker_sentiment_score": "0.010795", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.106683", "ticker_sentiment_score": "0.015826", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Q1 2022 Earnings Call Transcript", "url": "https://www.fool.com/earnings/call-transcripts/2022/05/06/cytomx-therapeutics-ctmx-q1-2022-earnings-call-tra/", "time_published": "20220507T023041", "authors": ["Motley Fool Transcribing"], "summary": "CTMX earnings call for the period ending March 31, 2022.", "banner_image": "https://g.foolcdn.com/misc-assets/fool-transcripts-logo.png", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.359353, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.021161", "ticker_sentiment_score": "0.229837", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.014108", "ticker_sentiment_score": "0.061269", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.007054", "ticker_sentiment_score": "0.936475", "ticker_sentiment_label": "Bullish"}]}, {"title": "Stocks That Hit 52-Week Lows On Friday", "url": "https://www.benzinga.com/markets/options/22/05/27050916/52-weeks-high-and-low-article", "time_published": "20220506T160650", "authors": ["Benzinga Insights"], "summary": "On Friday, 1043 companies hit new 52-week lows.\nInteresting Points From Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Amazon.com  ( NASDAQ:AMZN ) .\nThe smallest company by market cap to set a new 52-week low was Digital Brands Group  ( NASDAQ:DBGI ) .\nDigital B", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8140.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.018654, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AVIR", "relevance_score": "0.005467", "ticker_sentiment_score": "8e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "PATH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.014739", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007715", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001369", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002362", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001586", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015322", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007408", "ticker_sentiment_label": "Neutral"}, {"ticker": "XXII", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009055", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004464", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004759", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.01506", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011593", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001593", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006114", "ticker_sentiment_label": "Neutral"}, {"ticker": "BILL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.474612", "ticker_sentiment_label": "Bearish"}, {"ticker": "QTWO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012224", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOLD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.024001", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.002733", "ticker_sentiment_score": "0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011692", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001746", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYZN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001565", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001468", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007395", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.002733", "ticker_sentiment_score": "0.002022", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00383", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001562", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAMP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015383", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.129948", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRIX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006773", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004773", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001338", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCEL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.034278", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCAB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000513", "ticker_sentiment_label": "Neutral"}, {"ticker": "UIS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.040341", "ticker_sentiment_label": "Neutral"}, {"ticker": "BB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012428", "ticker_sentiment_label": "Neutral"}, {"ticker": "EJH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001005", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001112", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016909", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.036375", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.023456", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000242", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006596", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009028", "ticker_sentiment_label": "Neutral"}, {"ticker": "BL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00231", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008036", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGND", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00032", "ticker_sentiment_label": "Neutral"}, {"ticker": "S", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.01088", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001986", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002803", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.024212", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAPT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014222", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003095", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACEL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001119", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.005467", "ticker_sentiment_score": "0.052688", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.0082", "ticker_sentiment_score": "-0.007807", "ticker_sentiment_label": "Neutral"}, {"ticker": "CECE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005194", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013762", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005592", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005844", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBKR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009328", "ticker_sentiment_label": "Neutral"}, {"ticker": "USIO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012453", "ticker_sentiment_label": "Neutral"}, {"ticker": "VISL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004647", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVLR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004948", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.024503", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002076", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYMD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000807", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFSL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00089", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005297", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEXAF", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.004931", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRDN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013388", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNES", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.23749", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BKSY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002256", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003607", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRKA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011872", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRT", "relevance_score": "0.005467", "ticker_sentiment_score": "-8.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFFN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00252", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.013198", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDUS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020137", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020564", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005341", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZTA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01126", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00157", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004358", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALXO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005188", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVET", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012266", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001055", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.311797", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMZN", "relevance_score": "0.010933", "ticker_sentiment_score": "0.03713", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLPX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000599", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009637", "ticker_sentiment_label": "Neutral"}, {"ticker": "VMW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003057", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017429", "ticker_sentiment_label": "Neutral"}, {"ticker": "RARE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.014996", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.029089", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001112", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003114", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.0008", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.016288", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014144", "ticker_sentiment_label": "Neutral"}, {"ticker": "TALK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008835", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.022839", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002688", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01261", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCTI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000697", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005777", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABEO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017979", "ticker_sentiment_label": "Neutral"}, {"ticker": "LITM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.031719", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001659", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADIL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00094", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.080114", "ticker_sentiment_label": "Neutral"}, {"ticker": "EA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012633", "ticker_sentiment_label": "Neutral"}, {"ticker": "EH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000665", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNDM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004234", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001816", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003547", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000255", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.236976", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MTEM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010779", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDWR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003915", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01322", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.04504", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003646", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003051", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYOV", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005439", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.034088", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPLK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015781", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007337", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.018307", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVGW", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013234", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00024", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.035619", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLSP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000154", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006624", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015607", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000819", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001435", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001422", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPRO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.013934", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.268097", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ENS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012076", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.013666", "ticker_sentiment_score": "0.006812", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNGX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.009472", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.07076", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001962", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.273034", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SLGC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016342", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006369", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRWG", "relevance_score": "0.005467", "ticker_sentiment_score": "-6.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017042", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002798", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUNA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005366", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004709", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.058432", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.031278", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003189", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBLU", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.027782", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.005467", "ticker_sentiment_score": "0.013102", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010952", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.226453", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AVPT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01004", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008074", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLZE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.061768", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.040384", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNLX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000491", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001721", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00805", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.034103", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXTI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012549", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007001", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQDT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01047", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.199823", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GTH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006255", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006344", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.027141", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000398", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.022958", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006198", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.044346", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNDI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.014461", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00032", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTEA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.251893", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EGHT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.076938", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006349", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002389", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.409825", "ticker_sentiment_label": "Bearish"}, {"ticker": "SLS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000645", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004714", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001534", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLMD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00345", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNDA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001229", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVLT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016298", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008228", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPAA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.048692", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009323", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005174", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006195", "ticker_sentiment_label": "Neutral"}, {"ticker": "IR", "relevance_score": "0.005467", "ticker_sentiment_score": "2e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.084388", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.094167", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000887", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.009445", "ticker_sentiment_label": "Neutral"}, {"ticker": "OEG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000875", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGNX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003603", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAMF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.027567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIMV", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004583", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.0292", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001993", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.119529", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000954", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.04525", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002805", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.033035", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007984", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYNT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000961", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012775", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBGI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.025156", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.03279", "ticker_sentiment_score": "-0.036069", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006809", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004931", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000607", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011983", "ticker_sentiment_label": "Neutral"}, {"ticker": "TARS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003726", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONQ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000361", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.002733", "ticker_sentiment_score": "0.006114", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005723", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011699", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015929", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOXF", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002884", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001268", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAFN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000318", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLOB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.043899", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008608", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBCI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007081", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKIL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.02263", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002717", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBIO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.258621", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "COO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00397", "ticker_sentiment_label": "Neutral"}, {"ticker": "OFIX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006809", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002062", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012228", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.02661", "ticker_sentiment_label": "Neutral"}, {"ticker": "INKT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000997", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011193", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPLD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.013174", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006793", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006695", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004219", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006041", "ticker_sentiment_label": "Neutral"}, {"ticker": "IART", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004581", "ticker_sentiment_label": "Neutral"}, {"ticker": "XFOR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005917", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002869", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00512", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013203", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007206", "ticker_sentiment_label": "Neutral"}, {"ticker": "LE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003064", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000646", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000239", "ticker_sentiment_label": "Neutral"}, {"ticker": "TARA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.265921", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "USX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000322", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMDA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.043956", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002616", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003623", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014188", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.040211", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.027933", "ticker_sentiment_label": "Neutral"}, {"ticker": "NPCE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002119", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004457", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002266", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007082", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008507", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004771", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000108", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004933", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008819", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOAH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.03789", "ticker_sentiment_label": "Neutral"}, {"ticker": "KPLT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01756", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSII", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000825", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001977", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.698832", "ticker_sentiment_label": "Bearish"}, {"ticker": "DTIL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01385", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPSC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012995", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002907", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.002733", "ticker_sentiment_score": "0.001371", "ticker_sentiment_label": "Neutral"}, {"ticker": "AME", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012928", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006004", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTZ", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002859", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.030168", "ticker_sentiment_label": "Neutral"}, {"ticker": "ML", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013365", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000206", "ticker_sentiment_label": "Neutral"}, {"ticker": "EKSO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003713", "ticker_sentiment_label": "Neutral"}, {"ticker": "MQ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015197", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002744", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003802", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMMT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003118", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011322", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.088737", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001296", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002271", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.002733", "ticker_sentiment_score": "0.011699", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.032558", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010496", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016762", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00505", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.126406", "ticker_sentiment_label": "Neutral"}, {"ticker": "CENT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004043", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.231438", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATRC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005503", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003601", "ticker_sentiment_label": "Neutral"}, {"ticker": "NH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002642", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006202", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016006", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMCX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.322204", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006243", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001254", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004234", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRSH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001954", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-1.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.057756", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.314355", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TTC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.014229", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00678", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005629", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCTR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.11505", "ticker_sentiment_label": "Neutral"}, {"ticker": "COCP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003534", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.031284", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.085718", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006355", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007852", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001378", "ticker_sentiment_label": "Neutral"}, {"ticker": "LANC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004429", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.039126", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001517", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020486", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010664", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMED", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00714", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002944", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTBP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007612", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.056186", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDMO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005764", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.232694", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017063", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004039", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005847", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALDX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012919", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.018945", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002418", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNUS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.024422", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011084", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIHO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017889", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCPC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005167", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLDR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008599", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00153", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001835", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAYW", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001919", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007904", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVXL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000505", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.044445", "ticker_sentiment_label": "Neutral"}, {"ticker": "PH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007168", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000657", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007032", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009564", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTDR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004855", "ticker_sentiment_label": "Neutral"}, {"ticker": "FXLV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004686", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.013666", "ticker_sentiment_score": "0.045786", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLTO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008852", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUMZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007579", "ticker_sentiment_label": "Neutral"}, {"ticker": "FEIM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000683", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADVM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003623", "ticker_sentiment_label": "Neutral"}, {"ticker": "XSPA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.101736", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCNC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005012", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010982", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.005467", "ticker_sentiment_score": "7.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.02523", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012228", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRIO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011803", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003633", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011031", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMSI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.017866", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKLF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001304", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005449", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011765", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002028", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.005467", "ticker_sentiment_score": "-3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009228", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVRO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.176704", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ILMN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.019739", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.129262", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMBM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.016593", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.022574", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000153", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSQR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.043663", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002505", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.182188", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GMVD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002648", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCMI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003056", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNWK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012718", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLDN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000923", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012214", "ticker_sentiment_label": "Neutral"}, {"ticker": "RL", "relevance_score": "0.005467", "ticker_sentiment_score": "3.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.01715", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUBS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010254", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNEY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.028703", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008803", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001075", "ticker_sentiment_label": "Neutral"}, {"ticker": "SVC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003672", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.048687", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006639", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002373", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLDP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.028201", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIAN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000207", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00265", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDLB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005483", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRGO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.306708", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PENN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004995", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00298", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCRX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001646", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006674", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001419", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.021491", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001436", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.10492", "ticker_sentiment_label": "Neutral"}, {"ticker": "MANH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020113", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.050619", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006791", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTES", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010455", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.0063", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEAM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.181627", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TOUR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007888", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZEK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006728", "ticker_sentiment_label": "Neutral"}, {"ticker": "TU", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.039919", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMWB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.031993", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005647", "ticker_sentiment_label": "Neutral"}, {"ticker": "CROX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.039985", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.036653", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVRI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.016514", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.019148", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004549", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002594", "ticker_sentiment_label": "Neutral"}, {"ticker": "UA", "relevance_score": "0.0082", "ticker_sentiment_score": "0.002169", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000687", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.399338", "ticker_sentiment_label": "Bearish"}, {"ticker": "HBI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000129", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00448", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.02444", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001127", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001434", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIVE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002927", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005529", "ticker_sentiment_label": "Neutral"}, {"ticker": "PZZA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.216241", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EWTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00763", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFFP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007568", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006633", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.082156", "ticker_sentiment_label": "Neutral"}, {"ticker": "YETI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010178", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000321", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.021783", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.029358", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015918", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.123083", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOW", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.014079", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007326", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.231255", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CZR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.046173", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.342782", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IEX", "relevance_score": "0.002733", "ticker_sentiment_score": "0.003273", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000491", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000512", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007898", "ticker_sentiment_label": "Neutral"}, {"ticker": "HDB", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003474", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALKT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007337", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHCO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020501", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.20525", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RPAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001644", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004712", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARWR", "relevance_score": "0.005467", "ticker_sentiment_score": "-8.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.005839", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000117", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007389", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001608", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOCS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013813", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDGR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002045", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007048", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01293", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCTY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.05687", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008196", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002175", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIPO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011886", "ticker_sentiment_label": "Neutral"}, {"ticker": "WATT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006975", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017878", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMUX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008648", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLVX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000955", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.002733", "ticker_sentiment_score": "0.002505", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGLB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.057288", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01479", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.002733", "ticker_sentiment_score": "0.011809", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000558", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006237", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000276", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.009272", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007028", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFTR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017277", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003805", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006874", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.0073", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020156", "ticker_sentiment_label": "Neutral"}, {"ticker": "PALI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005603", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWKS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.018675", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.23752", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TBBK", "relevance_score": "0.013666", "ticker_sentiment_score": "-0.002262", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006014", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.020063", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.017", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.01275", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCYC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.336826", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AXDX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010578", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRDX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002879", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.005467", "ticker_sentiment_score": "0.055874", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.082372", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETQ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.213356", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LOB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000114", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBSE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.030308", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012338", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.025703", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007697", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00717", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004579", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.027221", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001411", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.007341", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDEX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003273", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.030723", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020412", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000575", "ticker_sentiment_label": "Neutral"}, {"ticker": "THMO", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000982", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCOR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010626", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002645", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELAN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.019388", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.240893", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APVO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000495", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005445", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.030796", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTEC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001647", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003242", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMIH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002191", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSLY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.045238", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOMD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.038477", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPG", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002797", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRGB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.280251", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BLKB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001232", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.391783", "ticker_sentiment_label": "Bearish"}, {"ticker": "WEN", "relevance_score": "0.0082", "ticker_sentiment_score": "-0.001309", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNPR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002166", "ticker_sentiment_label": "Neutral"}, {"ticker": "REPL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011409", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTGT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000715", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTP", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000289", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.009802", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020128", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPGF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.01843", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011116", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOXX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015744", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOUT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000576", "ticker_sentiment_label": "Neutral"}, {"ticker": "NATR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002942", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010036", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006359", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012079", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00086", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSWI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005483", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.020431", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLKN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004394", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00472", "ticker_sentiment_label": "Neutral"}, {"ticker": "DARE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.05572", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011858", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRVS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.292269", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ETSY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.034284", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00684", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLBY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004989", "ticker_sentiment_label": "Neutral"}, {"ticker": "JYNT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00026", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.219197", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CPRI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.008358", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSKD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.033578", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNNE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00735", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000205", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBRA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.178497", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ORTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001855", "ticker_sentiment_label": "Neutral"}, {"ticker": "FROG", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001322", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007702", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUCD", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001374", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAGE", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.279642", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ADAP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.015143", "ticker_sentiment_label": "Neutral"}, {"ticker": "DASH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011593", "ticker_sentiment_label": "Neutral"}, {"ticker": "UEIC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.028225", "ticker_sentiment_label": "Neutral"}, {"ticker": "KVHI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004326", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000334", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMBL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.003913", "ticker_sentiment_label": "Neutral"}, {"ticker": "LILA", "relevance_score": "0.0082", "ticker_sentiment_score": "-0.001145", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTW", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.191057", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EDR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007616", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.005467", "ticker_sentiment_score": "0.053682", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.036612", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003554", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBKB", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001143", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.015375", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.007141", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPO", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000252", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.00079", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.008964", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTRP", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000741", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLLS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012085", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.005467", "ticker_sentiment_score": "0.001698", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.012988", "ticker_sentiment_label": "Neutral"}, {"ticker": "JJSF", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.05471", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYLA", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.00683", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLYS", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.004935", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEBR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.126513", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAMI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.000836", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIND", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.033769", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADBE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.012161", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALRM", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.006295", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOEV", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.002734", "ticker_sentiment_label": "Neutral"}, {"ticker": "TACT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011746", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLTR", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002102", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASAN", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.018369", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011543", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.464763", "ticker_sentiment_label": "Bearish"}, {"ticker": "WIX", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.010525", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006221", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004222", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.000752", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.316405", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LTCH", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003242", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002004", "ticker_sentiment_label": "Neutral"}, {"ticker": "JELD", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002491", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDC", "relevance_score": "0.005467", "ticker_sentiment_score": "0.002169", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBH", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.005907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGI", "relevance_score": "0.005467", "ticker_sentiment_score": "0.003344", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTEX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.066118", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNCE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.0198", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004344", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001654", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRHC", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001238", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTV", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010854", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDIMF", "relevance_score": "0.002733", "ticker_sentiment_score": "-0.006894", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014495", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.011586", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYT", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.030689", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEDS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.011337", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDAY", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.013645", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.004338", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRPT", "relevance_score": "0.005467", "ticker_sentiment_score": "0.006837", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPS", "relevance_score": "0.005467", "ticker_sentiment_score": "0.032635", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWBI", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.001855", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTR", "relevance_score": "0.005467", "ticker_sentiment_score": "-0.287692", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SGTX", "relevance_score": "0.005467", "ticker_sentiment_score": "6e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNE", "relevance_score": "0.005467", "ticker_sentiment_score": "0.010302", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAIN", "relevance_score": "0.005467", "ticker_sentiment_score": "0.014747", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPID", "relevance_score": "0.005467", "ticker_sentiment_score": "0.039922", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:BGN", "relevance_score": "0.002733", "ticker_sentiment_score": "0.009564", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Reports Q1 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/1917319/cytomx-therapeutics-ctmx-reports-q1-loss-lags-revenue-estimates", "time_published": "20220505T222514", "authors": ["Zacks Investment Research"], "summary": "CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -5.71% and 21.42%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default22.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.099724, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CTMX", "relevance_score": "0.371062", "ticker_sentiment_score": "-0.083067", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.190918", "ticker_sentiment_score": "-0.330433", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "CytomX Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update", "url": "https://www.globenewswire.com/news-release/2022/05/05/2437387/37704/en/CytomX-Therapeutics-Reports-First-Quarter-2022-Financial-Results-and-Provides-Business-Update.html", "time_published": "20220505T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "- Patient enrollment completed in Arm A in the Phase 2 study of praluzatamab ravtansine in breast cancer, initial data for both Arms A and B on track for second half of 2022 -", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.16632, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.101273", "ticker_sentiment_score": "0.179309", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.081097", "ticker_sentiment_score": "0.185616", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.081097", "ticker_sentiment_score": "0.133562", "ticker_sentiment_label": "Neutral"}]}, {"title": "Earnings Scheduled For May 5, 2022", "url": "https://www.benzinga.com/news/earnings/22/05/27012606/earnings-scheduled-for-may-5-2022", "time_published": "20220505T084322", "authors": ["Benzinga Insights"], "summary": "Companies Reporting Before The Bell\n\u2022 Mirum Pharmaceuticals  ( NASDAQ:MIRM )  is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.\n\u2022 Bluegreen Vacations  ( NYSE:BVH )  is estimated to report quarterly earnings at $0.53 per share on revenue of $181.17 million.\n\u2022 Select", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/earnings_image_5384.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.967645"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.022883, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMRE", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000274", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWEN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.00266", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.023767", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRLP", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.031742", "ticker_sentiment_label": "Neutral"}, {"ticker": "XXII", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.033865", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRVB", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.033174", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNKO", "relevance_score": "0.009774", "ticker_sentiment_score": "9.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATEC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.120618", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.002785", "ticker_sentiment_label": "Neutral"}, {"ticker": "BILL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.106897", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYCR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002335", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000179", "ticker_sentiment_label": "Neutral"}, {"ticker": "AL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001183", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.008431", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.036075", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEM", "relevance_score": "0.009774", "ticker_sentiment_score": "0.00051", "ticker_sentiment_label": "Neutral"}, {"ticker": "XOS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.085762", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLOK", "relevance_score": "0.009774", "ticker_sentiment_score": "0.007158", "ticker_sentiment_label": "Neutral"}, {"ticker": "BE", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.165006", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GOLF", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001665", "ticker_sentiment_label": "Neutral"}, {"ticker": "VITL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.077112", "ticker_sentiment_label": "Neutral"}, {"ticker": "D", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.006666", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNL", "relevance_score": "0.009774", "ticker_sentiment_score": "1e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXP", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000651", "ticker_sentiment_label": "Neutral"}, {"ticker": "G", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000186", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000609", "ticker_sentiment_label": "Neutral"}, {"ticker": "H", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.202967", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.032605", "ticker_sentiment_label": "Neutral"}, {"ticker": "K", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000727", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVEE", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001214", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.002056", "ticker_sentiment_label": "Neutral"}, {"ticker": "HROW", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.028686", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.025881", "ticker_sentiment_label": "Neutral"}, {"ticker": "BV", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000843", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.111223", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZTS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.006065", "ticker_sentiment_label": "Neutral"}, {"ticker": "Y", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.059552", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.014661", "ticker_sentiment_score": "-0.000458", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXNX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.075692", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVLR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.015769", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000304", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYV", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.192898", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DVAX", "relevance_score": "0.009774", "ticker_sentiment_score": "0.006215", "ticker_sentiment_label": "Neutral"}, {"ticker": "CR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002353", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGAN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.06633", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000812", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDUS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.071728", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVET", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001123", "ticker_sentiment_label": "Neutral"}, {"ticker": "DH", "relevance_score": "0.009774", "ticker_sentiment_score": "0.004641", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.142271", "ticker_sentiment_label": "Neutral"}, {"ticker": "RARE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.180487", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "POST", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001209", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.044032", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYPS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.032051", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000807", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHC", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000123", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.053916", "ticker_sentiment_label": "Neutral"}, {"ticker": "ULH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001307", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDYN", "relevance_score": "0.009774", "ticker_sentiment_score": "-2.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000256", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPM", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000719", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.064006", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.044239", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000345", "ticker_sentiment_label": "Neutral"}, {"ticker": "ED", "relevance_score": "0.009774", "ticker_sentiment_score": "-8.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBDC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.010101", "ticker_sentiment_label": "Neutral"}, {"ticker": "TVTY", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000161", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001293", "ticker_sentiment_label": "Neutral"}, {"ticker": "TVTX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.06067", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000357", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.016303", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIO", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000132", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKYA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.044008", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.007426", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGS", "relevance_score": "0.009774", "ticker_sentiment_score": "0.002183", "ticker_sentiment_label": "Neutral"}, {"ticker": "EIGR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.008421", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPIC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.053738", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHEC", "relevance_score": "0.004887", "ticker_sentiment_score": "0.001414", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMB", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002123", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMCI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.007891", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLB", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000334", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNXN", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000779", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRBR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000347", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENG", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.061925", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBPH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.02157", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPRO", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001345", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRAI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.004493", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENV", "relevance_score": "0.009774", "ticker_sentiment_score": "0.002329", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIW", "relevance_score": "0.009774", "ticker_sentiment_score": "0.00051", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.029645", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCS", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000338", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLX", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000237", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRK", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.003968", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNM", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.00031", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOG", "relevance_score": "0.009774", "ticker_sentiment_score": "0.003013", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTG", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000322", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.164411", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AGL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.022066", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000314", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLZE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.038091", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.002224", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.059586", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.105977", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCID", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.115414", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002711", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000465", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIRM", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.132997", "ticker_sentiment_label": "Neutral"}, {"ticker": "LQDT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000694", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002291", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARGX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.066434", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.003975", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOUR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000317", "ticker_sentiment_label": "Neutral"}, {"ticker": "HR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000268", "ticker_sentiment_label": "Neutral"}, {"ticker": "PMTS", "relevance_score": "0.009774", "ticker_sentiment_score": "-5.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHAK", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.067541", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.076593", "ticker_sentiment_label": "Neutral"}, {"ticker": "RWAY", "relevance_score": "0.009774", "ticker_sentiment_score": "-3.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNDA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.016881", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPRX", "relevance_score": "0.009774", "ticker_sentiment_score": "0.00032", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.139794", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTHR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.002287", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMP", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000669", "ticker_sentiment_label": "Neutral"}, {"ticker": "OEC", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000146", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSIG", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001919", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGNX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.005205", "ticker_sentiment_label": "Neutral"}, {"ticker": "MELI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000394", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIMV", "relevance_score": "0.009774", "ticker_sentiment_score": "5.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002824", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADNT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.051814", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGPI", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERF", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001923", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRTS", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000165", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.089163", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLD", "relevance_score": "0.009774", "ticker_sentiment_score": "0.004619", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLL", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000502", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.053121", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.02501", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.009774", "ticker_sentiment_score": "0.00176", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRGRF", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.000619", "ticker_sentiment_label": "Neutral"}, {"ticker": "AJX", "relevance_score": "0.009774", "ticker_sentiment_score": "0.106795", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.036041", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOXF", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000123", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMB", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.008995", "ticker_sentiment_label": "Neutral"}, {"ticker": "KE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000485", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEMI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.03942", "ticker_sentiment_label": "Neutral"}, {"ticker": "COP", "relevance_score": "0.009774", "ticker_sentiment_score": "-5.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SATS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002221", "ticker_sentiment_label": "Neutral"}, {"ticker": "OGE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.003749", "ticker_sentiment_label": "Neutral"}, {"ticker": "USM", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.003277", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCK", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.00513", "ticker_sentiment_label": "Neutral"}, {"ticker": "OGN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.012323", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLMD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.004955", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.075557", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000125", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRTC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.095791", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.027305", "ticker_sentiment_label": "Neutral"}, {"ticker": "USX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.086031", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.041949", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001855", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.08649", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.009852", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.207566", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VVI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.056508", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001131", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000336", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFG", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000288", "ticker_sentiment_label": "Neutral"}, {"ticker": "MODV", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.003609", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRWD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000813", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.010116", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAIN", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000315", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMH", "relevance_score": "0.009774", "ticker_sentiment_score": "5.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.074713", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.007426", "ticker_sentiment_label": "Neutral"}, {"ticker": "MP", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000743", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNIT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000108", "ticker_sentiment_label": "Neutral"}, {"ticker": "MT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.007551", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTLP", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.033857", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRIN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.004045", "ticker_sentiment_label": "Neutral"}, {"ticker": "LESL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.037794", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.010111", "ticker_sentiment_label": "Neutral"}, {"ticker": "YELP", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.021321", "ticker_sentiment_label": "Neutral"}, {"ticker": "NH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.027975", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGLE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000718", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRLD", "relevance_score": "0.009774", "ticker_sentiment_score": "3.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.014502", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTM", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000232", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLPG", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.018072", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMCX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000677", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.043899", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCTR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000989", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.02504", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001113", "ticker_sentiment_label": "Neutral"}, {"ticker": "LANC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.00045", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.133826", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.061126", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSTO", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000194", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMEH", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000987", "ticker_sentiment_label": "Neutral"}, {"ticker": "BERY", "relevance_score": "0.009774", "ticker_sentiment_score": "0.007255", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHUY", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002107", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.028166", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATSG", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.00121", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALDX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001674", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.004423", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLDR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.144552", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEE", "relevance_score": "0.009774", "ticker_sentiment_score": "6.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODI", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000304", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000712", "ticker_sentiment_label": "Neutral"}, {"ticker": "OYST", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.388461", "ticker_sentiment_label": "Bearish"}, {"ticker": "APD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.007388", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLE", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001629", "ticker_sentiment_label": "Neutral"}, {"ticker": "UONE", "relevance_score": "0.014661", "ticker_sentiment_score": "-0.001527", "ticker_sentiment_label": "Neutral"}, {"ticker": "PH", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000618", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAMR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000594", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTDR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000331", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001744", "ticker_sentiment_label": "Neutral"}, {"ticker": "APO", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000413", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.010825", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSBD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002224", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.051044", "ticker_sentiment_label": "Neutral"}, {"ticker": "BALY", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.065812", "ticker_sentiment_label": "Neutral"}, {"ticker": "NJR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.004039", "ticker_sentiment_label": "Neutral"}, {"ticker": "REFR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.039697", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLQT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.071577", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZENV", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000188", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSM", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.170965", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SEAS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.046839", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000713", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGNY", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.0036", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSG", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001758", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRDO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000231", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMBM", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.004252", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.05251", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.079277", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002785", "ticker_sentiment_label": "Neutral"}, {"ticker": "RC", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000235", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLDN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001153", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.004083", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.107443", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUBS", "relevance_score": "0.009774", "ticker_sentiment_score": "0.002627", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPFI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.082981", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARW", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.004649", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDOG", "relevance_score": "0.009774", "ticker_sentiment_score": "0.002618", "ticker_sentiment_label": "Neutral"}, {"ticker": "PENN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.00518", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.063826", "ticker_sentiment_label": "Neutral"}, {"ticker": "SG", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.032868", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWK", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.006876", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEED", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.036534", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCRX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.056311", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.133367", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQ", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000312", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABUS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.063514", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWI", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000268", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLBS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.009397", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDEN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001727", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRTX", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000493", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGAP", "relevance_score": "0.004887", "ticker_sentiment_score": "0.003276", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002076", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPEN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.018242", "ticker_sentiment_label": "Neutral"}, {"ticker": "TC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000546", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.105687", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOVA", "relevance_score": "0.009774", "ticker_sentiment_score": "0.009925", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVH", "relevance_score": "0.009774", "ticker_sentiment_score": "1.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCUT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001074", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALHC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.055741", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000539", "ticker_sentiment_label": "Neutral"}, {"ticker": "SXI", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000431", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVRG", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000657", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRI", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000776", "ticker_sentiment_label": "Neutral"}, {"ticker": "CROX", "relevance_score": "0.009774", "ticker_sentiment_score": "0.002143", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDA", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000505", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000179", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBI", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000874", "ticker_sentiment_label": "Neutral"}, {"ticker": "PZZA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001395", "ticker_sentiment_label": "Neutral"}, {"ticker": "JWEL", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001", "ticker_sentiment_label": "Neutral"}, {"ticker": "PODD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000548", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNKD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.060486", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.0251", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCC", "relevance_score": "0.009774", "ticker_sentiment_score": "-3.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCY", "relevance_score": "0.009774", "ticker_sentiment_score": "0.005088", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.116151", "ticker_sentiment_label": "Neutral"}, {"ticker": "LASR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.038237", "ticker_sentiment_label": "Neutral"}, {"ticker": "KPTI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.146445", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNA", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000253", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTUS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001273", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGC", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000367", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALKT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.020985", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBRE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002988", "ticker_sentiment_label": "Neutral"}, {"ticker": "WD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002273", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.054487", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.001405", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000111", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOCS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000223", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBRV", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.066434", "ticker_sentiment_label": "Neutral"}, {"ticker": "WW", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.082527", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPRO", "relevance_score": "0.009774", "ticker_sentiment_score": "0.002484", "ticker_sentiment_label": "Neutral"}, {"ticker": "UFCS", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000247", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.079277", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCSM", "relevance_score": "0.009774", "ticker_sentiment_score": "0.003601", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.06339", "ticker_sentiment_label": "Neutral"}, {"ticker": "AORT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.013471", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTIM", "relevance_score": "0.009774", "ticker_sentiment_score": "0.520786", "ticker_sentiment_label": "Bullish"}, {"ticker": "LAUR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.022666", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONEW", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000651", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESMT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.003509", "ticker_sentiment_label": "Neutral"}, {"ticker": "WCC", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001466", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.008566", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATBP", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.098328", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARS", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000763", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXST", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.088978", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.053699", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYAD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.025861", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCSL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000466", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000294", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000936", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLED", "relevance_score": "0.009774", "ticker_sentiment_score": "0.00836", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAWW", "relevance_score": "0.009774", "ticker_sentiment_score": "-1.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEUS", "relevance_score": "0.009774", "ticker_sentiment_score": "0.00832", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.025435", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELY", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.046944", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSIT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.014558", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRVI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.00129", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBPB", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.088692", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCXI", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.011348", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZR", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.021717", "ticker_sentiment_label": "Neutral"}, {"ticker": "NATR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001051", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.018464", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBRG-P-I", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.043868", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.056844", "ticker_sentiment_label": "Neutral"}, {"ticker": "FET", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.021646", "ticker_sentiment_label": "Neutral"}, {"ticker": "JYNT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000284", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRK", "relevance_score": "0.009774", "ticker_sentiment_score": "0.00029", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTD", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000316", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEL", "relevance_score": "0.009774", "ticker_sentiment_score": "0.002165", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVEO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.047213", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.091088", "ticker_sentiment_label": "Neutral"}, {"ticker": "DASH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.202964", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UEIC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.00042", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTZ", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.147298", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVDX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.009364", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBX", "relevance_score": "0.009774", "ticker_sentiment_score": "0.001339", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCTY", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000633", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXRH", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000633", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDOT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000256", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTCC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.010162", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAH", "relevance_score": "0.009774", "ticker_sentiment_score": "6.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORT", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000513", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.097267", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALRM", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000577", "ticker_sentiment_label": "Neutral"}, {"ticker": "TREE", "relevance_score": "0.009774", "ticker_sentiment_score": "4.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATCN", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.120618", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRGP", "relevance_score": "0.009774", "ticker_sentiment_score": "6.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000234", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRP", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000917", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.002687", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.015641", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.07153", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGIO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.153508", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TDC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000646", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLAY", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.082195", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.033898", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAIL", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.104095", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBH", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.00445", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.025834", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRHC", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.02825", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNST", "relevance_score": "0.009774", "ticker_sentiment_score": "2.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMN", "relevance_score": "0.009774", "ticker_sentiment_score": "0.003348", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCJ", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.052039", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.099505", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAP", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.004193", "ticker_sentiment_label": "Neutral"}, {"ticker": "BECN", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.003701", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOGO", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.000861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000884", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTB", "relevance_score": "0.009774", "ticker_sentiment_score": "-1.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDUS", "relevance_score": "0.009774", "ticker_sentiment_score": "4.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIR", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000789", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNE", "relevance_score": "0.009774", "ticker_sentiment_score": "-0.11415", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAIN", "relevance_score": "0.009774", "ticker_sentiment_score": "0.000209", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:RON", "relevance_score": "0.004887", "ticker_sentiment_score": "-0.000278", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/markets/options/22/05/26995541/52-weeks-high-and-low-article", "time_published": "20220504T162909", "authors": ["Benzinga Insights"], "summary": "During Wednesday's trading, 435 companies set new 52-week lows.\nKey Facts About Today's 52-Week Lows:\nThe largest company by market cap to hit a new 52-week low was S&P Global  ( NYSE:SPGI ) .\nReshape Lifesciences  ( NASDAQ:RSLS )  was the smallest company by market cap to set a new 52-week low.\nCon", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7937.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.022592, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.012359", "ticker_sentiment_score": "-7.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIAV", "relevance_score": "0.012359", "ticker_sentiment_score": "0.011687", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005739", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.012359", "ticker_sentiment_score": "0.007071", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.514715", "ticker_sentiment_label": "Bearish"}, {"ticker": "NCNA", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.020296", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.01974", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.029272", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000183", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDC", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.005106", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRIO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.006187", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.004405", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.012359", "ticker_sentiment_score": "0.003921", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.004193", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTWO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.00815", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOLD", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.004291", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001726", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.012359", "ticker_sentiment_score": "0.003508", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.012359", "ticker_sentiment_score": "0.037105", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYZN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.005911", "ticker_sentiment_label": "Neutral"}, {"ticker": "AI", "relevance_score": "0.012359", "ticker_sentiment_score": "0.007139", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.00784", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAG", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.01054", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.014705", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSTX", "relevance_score": "0.012359", "ticker_sentiment_score": "0.009441", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMG", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.004517", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCI", "relevance_score": "0.012359", "ticker_sentiment_score": "0.027347", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRCA", "relevance_score": "0.012359", "ticker_sentiment_score": "0.060787", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMVD", "relevance_score": "0.012359", "ticker_sentiment_score": "0.012266", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNWK", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002051", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.027295", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIR", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005785", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAI", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.019767", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002305", "ticker_sentiment_label": "Neutral"}, {"ticker": "B", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.003471", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAY", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.30529", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LIQT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.020579", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOHO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.019415", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAY", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.023996", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005059", "ticker_sentiment_label": "Neutral"}, {"ticker": "BL", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.031876", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATE", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.006863", "ticker_sentiment_label": "Neutral"}, {"ticker": "IESC", "relevance_score": "0.012359", "ticker_sentiment_score": "0.011416", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.012359", "ticker_sentiment_score": "0.00527", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDLB", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.057428", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRGO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.040255", "ticker_sentiment_label": "Neutral"}, {"ticker": "HNGR", "relevance_score": "0.012359", "ticker_sentiment_score": "0.008869", "ticker_sentiment_label": "Neutral"}, {"ticker": "BV", "relevance_score": "0.012359", "ticker_sentiment_score": "0.004353", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCM", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.020334", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAPT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.011893", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.012359", "ticker_sentiment_score": "0.031981", "ticker_sentiment_label": "Neutral"}, {"ticker": "SJ", "relevance_score": "0.012359", "ticker_sentiment_score": "0.010455", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMD", "relevance_score": "0.012359", "ticker_sentiment_score": "0.008395", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.012359", "ticker_sentiment_score": "0.003664", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGLS", "relevance_score": "0.012359", "ticker_sentiment_score": "0.002085", "ticker_sentiment_label": "Neutral"}, {"ticker": "UDMY", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.297325", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BUR", "relevance_score": "0.012359", "ticker_sentiment_score": "0.002016", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.012359", "ticker_sentiment_score": "0.002102", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.00566", "ticker_sentiment_label": "Neutral"}, {"ticker": "HQI", "relevance_score": "0.012359", "ticker_sentiment_score": "0.040037", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.012359", "ticker_sentiment_score": "0.006849", "ticker_sentiment_label": "Neutral"}, {"ticker": "INST", "relevance_score": "0.012359", "ticker_sentiment_score": "0.000223", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVLR", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001788", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMTV", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000209", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNES", "relevance_score": "0.012359", "ticker_sentiment_score": "0.009477", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKSY", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.032102", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002663", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.001319", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.012129", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPF", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.039706", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALXO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.007768", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001498", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.02909", "ticker_sentiment_label": "Neutral"}, {"ticker": "TT", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001644", "ticker_sentiment_label": "Neutral"}, {"ticker": "TU", "relevance_score": "0.00618", "ticker_sentiment_score": "-0.006506", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.459908", "ticker_sentiment_label": "Bearish"}, {"ticker": "JNCE", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.007014", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.040063", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.02826", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.445547", "ticker_sentiment_label": "Bearish"}, {"ticker": "PRM", "relevance_score": "0.012359", "ticker_sentiment_score": "0.002304", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.009499", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.012359", "ticker_sentiment_score": "0.004369", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002804", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000559", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.011699", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.022798", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABEO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.031039", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.000852", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVL", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.003499", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIOX", "relevance_score": "0.012359", "ticker_sentiment_score": "0.024301", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFFP", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.037747", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005087", "ticker_sentiment_label": "Neutral"}, {"ticker": "EML", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.023983", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMR", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002543", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.030666", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDB", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.003135", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBCP", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.003831", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005202", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.00618", "ticker_sentiment_score": "-0.003613", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGS", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.010035", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002878", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.012359", "ticker_sentiment_score": "0.007344", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBIO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.02283", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.011767", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.012359", "ticker_sentiment_score": "0.076927", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.012359", "ticker_sentiment_score": "0.009896", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.012359", "ticker_sentiment_score": "0.003985", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHG", "relevance_score": "0.012359", "ticker_sentiment_score": "0.003694", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.024714", "ticker_sentiment_score": "-0.002139", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.01747", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.021374", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000721", "ticker_sentiment_label": "Neutral"}, {"ticker": "WK", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.001319", "ticker_sentiment_label": "Neutral"}, {"ticker": "DGHI", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.007916", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIDE", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.006404", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.012359", "ticker_sentiment_score": "0.006091", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.012359", "ticker_sentiment_score": "0.00434", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMUX", "relevance_score": "0.012359", "ticker_sentiment_score": "0.010144", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVPT", "relevance_score": "0.012359", "ticker_sentiment_score": "0.000107", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVLV", "relevance_score": "0.012359", "ticker_sentiment_score": "0.018715", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.025741", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002057", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNLX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.009841", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTIM", "relevance_score": "0.012359", "ticker_sentiment_score": "0.195122", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COLL", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.020481", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.005556", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.012359", "ticker_sentiment_score": "0.000195", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.01151", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.00618", "ticker_sentiment_score": "-0.539111", "ticker_sentiment_label": "Bearish"}, {"ticker": "CPNG", "relevance_score": "0.012359", "ticker_sentiment_score": "0.009067", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTH", "relevance_score": "0.012359", "ticker_sentiment_score": "-2.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "REKR", "relevance_score": "0.012359", "ticker_sentiment_score": "0.013947", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISRG", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.351539", "ticker_sentiment_label": "Bearish"}, {"ticker": "NRC", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.353444", "ticker_sentiment_label": "Bearish"}, {"ticker": "CARS", "relevance_score": "0.012359", "ticker_sentiment_score": "0.02052", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.005439", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRA", "relevance_score": "0.012359", "ticker_sentiment_score": "0.086432", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.004133", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002825", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.010608", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMS", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.241489", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EDSA", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002098", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGHT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.016728", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.012359", "ticker_sentiment_score": "0.008619", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.00618", "ticker_sentiment_score": "0.004369", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.006631", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARA", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.008377", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.012359", "ticker_sentiment_score": "0.003441", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNST", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.00177", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHAK", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.006128", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETZ", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.00638", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBSE", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.026337", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIP", "relevance_score": "0.012359", "ticker_sentiment_score": "0.012839", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSV", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.030427", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001609", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.006103", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.012359", "ticker_sentiment_score": "0.009004", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDEX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.003613", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.009885", "ticker_sentiment_label": "Neutral"}, {"ticker": "THMO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.009334", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005318", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.012359", "ticker_sentiment_score": "0.039003", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVB", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.035525", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBGI", "relevance_score": "0.012359", "ticker_sentiment_score": "0.007459", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRGB", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.003646", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLKB", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.015357", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.061734", "ticker_sentiment_score": "-0.004362", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.012284", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONM", "relevance_score": "0.012359", "ticker_sentiment_score": "0.042182", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005221", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.001212", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCR", "relevance_score": "0.00618", "ticker_sentiment_score": "0.006673", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONQ", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.010304", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.010581", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAFN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.065581", "ticker_sentiment_label": "Neutral"}, {"ticker": "KD", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.00418", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHR", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.001362", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005422", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSC", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.005338", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBIO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.001508", "ticker_sentiment_label": "Neutral"}, {"ticker": "COO", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001858", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.012359", "ticker_sentiment_score": "0.00027", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.003927", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.012359", "ticker_sentiment_score": "0.000198", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.001416", "ticker_sentiment_label": "Neutral"}, {"ticker": "DARE", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.038017", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRN", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001564", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWW", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.008482", "ticker_sentiment_label": "Neutral"}, {"ticker": "JYNT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.00899", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFST", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.448119", "ticker_sentiment_label": "Bearish"}, {"ticker": "XFOR", "relevance_score": "0.012359", "ticker_sentiment_score": "0.003529", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.368298", "ticker_sentiment_label": "Bearish"}, {"ticker": "LE", "relevance_score": "0.012359", "ticker_sentiment_score": "0.002554", "ticker_sentiment_label": "Neutral"}, {"ticker": "TARA", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.463951", "ticker_sentiment_label": "Bearish"}, {"ticker": "RSKD", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.043962", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBRA", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000858", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCL", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000479", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRUG", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.035772", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.00618", "ticker_sentiment_score": "-0.026492", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.012359", "ticker_sentiment_score": "0.023697", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBIO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000137", "ticker_sentiment_label": "Neutral"}, {"ticker": "FROG", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.007918", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.004368", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALR", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000841", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.003087", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.001345", "ticker_sentiment_label": "Neutral"}, {"ticker": "DASH", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.331705", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FTCH", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.02996", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.012359", "ticker_sentiment_score": "0.120041", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.00618", "ticker_sentiment_score": "-0.622395", "ticker_sentiment_label": "Bearish"}, {"ticker": "MF", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000671", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.009494", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.383086", "ticker_sentiment_label": "Bearish"}, {"ticker": "THRX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.039604", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSP", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.016812", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.001178", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMMT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.009435", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.539111", "ticker_sentiment_label": "Bearish"}, {"ticker": "CORZ", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.364666", "ticker_sentiment_label": "Bearish"}, {"ticker": "FTRP", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.009966", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSLS", "relevance_score": "0.024714", "ticker_sentiment_score": "0.043706", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001834", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTL", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.365553", "ticker_sentiment_label": "Bearish"}, {"ticker": "RAIN", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.000731", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYLA", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.010293", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOEV", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.012445", "ticker_sentiment_label": "Neutral"}, {"ticker": "TACT", "relevance_score": "0.012359", "ticker_sentiment_score": "0.008078", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRC", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005369", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.006467", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTX", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001326", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.001682", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.012359", "ticker_sentiment_score": "0.011658", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDRX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002781", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.012359", "ticker_sentiment_score": "0.007131", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.00011", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLF", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.008731", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.011254", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.009672", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.012359", "ticker_sentiment_score": "0.003088", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGFV", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.002033", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001653", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENLV", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.007033", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMED", "relevance_score": "0.012359", "ticker_sentiment_score": "0.007962", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.040944", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPGI", "relevance_score": "0.012359", "ticker_sentiment_score": "0.057665", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.00137", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWBR", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.013614", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.018262", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.005485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.012359", "ticker_sentiment_score": "0.004886", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.012359", "ticker_sentiment_score": "0.004613", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALDX", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.005459", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDIMF", "relevance_score": "0.00618", "ticker_sentiment_score": "-0.000845", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.396571", "ticker_sentiment_label": "Bearish"}, {"ticker": "HGTY", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.01261", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIHO", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.008723", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEDS", "relevance_score": "0.012359", "ticker_sentiment_score": "0.007404", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTRY", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.006326", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDAY", "relevance_score": "0.012359", "ticker_sentiment_score": "0.010303", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODI", "relevance_score": "0.012359", "ticker_sentiment_score": "0.001382", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUP", "relevance_score": "0.012359", "ticker_sentiment_score": "0.005016", "ticker_sentiment_label": "Neutral"}, {"ticker": "IOT", "relevance_score": "0.012359", "ticker_sentiment_score": "-0.013015", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPS", "relevance_score": "0.012359", "ticker_sentiment_score": "0.006159", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.012359", "ticker_sentiment_score": "0.003452", "ticker_sentiment_label": "Neutral"}, {"ticker": "NWBI", "relevance_score": "0.012359", "ticker_sentiment_score": "0.002409", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.012359", "ticker_sentiment_score": "0.000636", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Thursday", "url": "https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article", "time_published": "20220428T193101", "authors": ["Benzinga Insights"], "summary": "During Thursday, 849 stocks hit new 52-week lows.\nAreas of Significance In Today's 52-Week Lows:\nJPMorgan Chase  ( NYSE:JPM )  was the largest company by market cap to set a new 52-week low.\nReshape Lifesciences  ( NASDAQ:RSLS )  was the smallest company by market cap to set a new 52-week low.\nSio G", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7522.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.021657, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AGLE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002281", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010868", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.051153", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXGL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.020002", "ticker_sentiment_label": "Neutral"}, {"ticker": "SESN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001297", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001586", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.034523", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005054", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003889", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVCN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000308", "ticker_sentiment_label": "Neutral"}, {"ticker": "EZFL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACCD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01882", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTWO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008662", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006733", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.021285", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOLD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002203", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002017", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007303", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012398", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.019531", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYZN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001166", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOTV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011619", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002441", "ticker_sentiment_label": "Neutral"}, {"ticker": "AI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003785", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010394", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.012869", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRCA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002878", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.01536", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.09366", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.026358", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004437", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.012377", "ticker_sentiment_label": "Neutral"}, {"ticker": "BB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005977", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLIC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000659", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001762", "ticker_sentiment_label": "Neutral"}, {"ticker": "B", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.280809", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVEC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002518", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002847", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.053296", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.184467", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AGNC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002529", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLUE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.02574", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012377", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKSC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.013957", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007971", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005462", "ticker_sentiment_label": "Neutral"}, {"ticker": "BL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.03367", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTG-P-A", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.00353", "ticker_sentiment_label": "Neutral"}, {"ticker": "IESC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007197", "ticker_sentiment_label": "Neutral"}, {"ticker": "HNGR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008845", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.023679", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014395", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAPT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002753", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006444", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.464253", "ticker_sentiment_label": "Bearish"}, {"ticker": "VLN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.035858", "ticker_sentiment_label": "Neutral"}, {"ticker": "THO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004071", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRBY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.027313", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.00966", "ticker_sentiment_score": "0.031456", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001412", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005658", "ticker_sentiment_label": "Neutral"}, {"ticker": "THR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACB", "relevance_score": "0.00644", "ticker_sentiment_score": "-8.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005037", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDOC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005137", "ticker_sentiment_label": "Neutral"}, {"ticker": "CG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00836", "ticker_sentiment_label": "Neutral"}, {"ticker": "CO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.020067", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCYO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007729", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFSL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.031805", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001207", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002327", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKSY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008137", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.025595", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016186", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRKA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000959", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFFN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017589", "ticker_sentiment_label": "Neutral"}, {"ticker": "JVA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003678", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005154", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009037", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005288", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.068816", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005635", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.019773", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALXO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000155", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVET", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008461", "ticker_sentiment_label": "Neutral"}, {"ticker": "DD", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005528", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006444", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQNS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.033398", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012047", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVGI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001089", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000395", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLGY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001825", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.358811", "ticker_sentiment_label": "Bearish"}, {"ticker": "TALK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002357", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001446", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRNT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006099", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.017331", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004456", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYMT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002967", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSC", "relevance_score": "0.00644", "ticker_sentiment_score": "-8.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "UVSP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.408395", "ticker_sentiment_label": "Bearish"}, {"ticker": "MEIP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00379", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005402", "ticker_sentiment_label": "Neutral"}, {"ticker": "EB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002922", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002056", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006569", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEMD", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002422", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.307504", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AKYA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005977", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQ", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.190274", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VXRT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012793", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVNT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003586", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYOV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015811", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011528", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000356", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00583", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008284", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002677", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007335", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016626", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLOW", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016852", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003946", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.01674", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.051774", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003562", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006995", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYRN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001235", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.016099", "ticker_sentiment_score": "0.000365", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00168", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014433", "ticker_sentiment_label": "Neutral"}, {"ticker": "YVR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012297", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006397", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001728", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005832", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.274058", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005263", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004799", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010016", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.313902", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JBLU", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.0142", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.128943", "ticker_sentiment_label": "Neutral"}, {"ticker": "GM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016135", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.088384", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000408", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007721", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSGM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005385", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.023342", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.014783", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010298", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005922", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010701", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.022519", "ticker_sentiment_label": "Neutral"}, {"ticker": "VQS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015316", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007842", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005287", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004948", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.031777", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTRS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000338", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.040385", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002522", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLIO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004033", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNDI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000223", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012589", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGHT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005658", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005238", "ticker_sentiment_label": "Neutral"}, {"ticker": "ODC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014061", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.057268", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010071", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003083", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011378", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007585", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.036257", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001596", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCCI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018017", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000455", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009049", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.0005", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002313", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWFL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001152", "ticker_sentiment_label": "Neutral"}, {"ticker": "IR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00207", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005897", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008301", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.02132", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.047516", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYME", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001047", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000992", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007742", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.045056", "ticker_sentiment_score": "-0.039952", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDYA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002427", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004625", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004819", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004075", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.00322", "ticker_sentiment_score": "0.003168", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.019221", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.00322", "ticker_sentiment_score": "0.003889", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPZ", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000785", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACMR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.036915", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004755", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.021416", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001461", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.023262", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBIO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003233", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001071", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007419", "ticker_sentiment_label": "Neutral"}, {"ticker": "COO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010804", "ticker_sentiment_label": "Neutral"}, {"ticker": "JANX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006094", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001681", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00142", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010704", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBTYA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007945", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004548", "ticker_sentiment_label": "Neutral"}, {"ticker": "XYL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003057", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001939", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014414", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007562", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTH", "relevance_score": "0.00644", "ticker_sentiment_score": "0.044631", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005078", "ticker_sentiment_label": "Neutral"}, {"ticker": "XFOR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.058081", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00482", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000592", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017275", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008621", "ticker_sentiment_label": "Neutral"}, {"ticker": "TARA", "relevance_score": "0.00644", "ticker_sentiment_score": "5.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003303", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00889", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.058715", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.00322", "ticker_sentiment_score": "0.009115", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001569", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012337", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005202", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004386", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001913", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWBI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.019907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004371", "ticker_sentiment_label": "Neutral"}, {"ticker": "KPLT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017303", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFVN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005891", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00938", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010959", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.016789", "ticker_sentiment_label": "Neutral"}, {"ticker": "MC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.01549", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.021198", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000766", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.00322", "ticker_sentiment_score": "0.038901", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.00644", "ticker_sentiment_score": "0.064194", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.011992", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000203", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCGN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.035857", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00493", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.00644", "ticker_sentiment_score": "0.030028", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTLT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014657", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.011702", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMMT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.022992", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXPE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003719", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010361", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.247008", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATRO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004395", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMPZF", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.000785", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015331", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.00644", "ticker_sentiment_score": "0.015207", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001779", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007614", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.2485", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HYFM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003282", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.303739", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ATRA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003442", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHTR", "relevance_score": "0.00644", "ticker_sentiment_score": "-6.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNPO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.011162", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018135", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.013317", "ticker_sentiment_label": "Neutral"}, {"ticker": "JRSH", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006791", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001135", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.017654", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00485", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007165", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.021419", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000103", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005578", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPWH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.297525", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SNSE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.308404", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EXPI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008762", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008116", "ticker_sentiment_label": "Neutral"}, {"ticker": "HEAR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004224", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00141", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTGX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005985", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000164", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004364", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDMO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000157", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000309", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017341", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003922", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLDR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005918", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00708", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.00644", "ticker_sentiment_score": "0.012733", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012832", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVXL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004002", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.036996", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.017498", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010161", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00247", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.050789", "ticker_sentiment_label": "Neutral"}, {"ticker": "FXLV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000109", "ticker_sentiment_label": "Neutral"}, {"ticker": "APM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.129275", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010264", "ticker_sentiment_label": "Neutral"}, {"ticker": "APO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009655", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLTO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.039903", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLWS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001927", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADVM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRKN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002391", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATUS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.062391", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006279", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001177", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRIO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.24289", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VIASP", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.033144", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.024129", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000264", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005125", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001545", "ticker_sentiment_label": "Neutral"}, {"ticker": "NERV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000655", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLAB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008408", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018191", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.260944", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EDIT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.185343", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HOVNP", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.001198", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000532", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSIS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001848", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSQR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.034412", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012081", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007044", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORGO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002426", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.038823", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCMI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.03039", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNWK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002313", "ticker_sentiment_label": "Neutral"}, {"ticker": "METX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005866", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006519", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOPN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.027821", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005082", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPFI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004159", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012641", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002503", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006289", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000852", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.289452", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BCRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001262", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMD", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004555", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTCR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001152", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002655", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABUS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.034847", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNAY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000574", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001906", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLBS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.023652", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.018104", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.051778", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002389", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009245", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003323", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYLN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.022809", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTHM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005711", "ticker_sentiment_label": "Neutral"}, {"ticker": "VATE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009453", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010312", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKNA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000688", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001735", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000362", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTES", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003686", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.035833", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLFC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.018451", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007251", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.047583", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001743", "ticker_sentiment_label": "Neutral"}, {"ticker": "TT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004613", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZEK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002141", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.031966", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002118", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAHC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001708", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007752", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.058722", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009879", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005535", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.136158", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010107", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRON", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010125", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004776", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004479", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008591", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011976", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003862", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIOX", "relevance_score": "0.012879", "ticker_sentiment_score": "0.014893", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFFP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00645", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009999", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAMP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.013867", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.042532", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012683", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCYT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004674", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPAY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.313368", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UIHC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005697", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004001", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008404", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003396", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008654", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008734", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003688", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015215", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015197", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHCO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002305", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.232892", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SGMO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01443", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011081", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.00966", "ticker_sentiment_score": "0.016109", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008519", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004443", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.483287", "ticker_sentiment_label": "Bearish"}, {"ticker": "JHX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005663", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001129", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008587", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004656", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.012189", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONEM", "relevance_score": "0.00644", "ticker_sentiment_score": "1.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00039", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKH", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.018104", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.012081", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002528", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGLB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.017864", "ticker_sentiment_label": "Neutral"}, {"ticker": "APTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004375", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006895", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.008331", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010551", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007688", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003421", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002207", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBNK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009462", "ticker_sentiment_label": "Neutral"}, {"ticker": "XL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011915", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.00966", "ticker_sentiment_score": "-0.067565", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008956", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00507", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004562", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01589", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.046627", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010676", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.291855", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SYRS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002652", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.022807", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004658", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001601", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011385", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000193", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.061352", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.012879", "ticker_sentiment_score": "-0.016805", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.07013", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.015306", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011352", "ticker_sentiment_label": "Neutral"}, {"ticker": "FERG", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.015702", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.295317", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HITI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009579", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.016795", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001951", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.314688", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NBSE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.005048", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.00644", "ticker_sentiment_score": "-1.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008158", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002177", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.422294", "ticker_sentiment_label": "Bearish"}, {"ticker": "CASI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006025", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001969", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009758", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003887", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRCL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.379884", "ticker_sentiment_label": "Bearish"}, {"ticker": "AMPS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.013062", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.036445", "ticker_sentiment_label": "Neutral"}, {"ticker": "THMO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008476", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00404", "ticker_sentiment_label": "Neutral"}, {"ticker": "APVO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007763", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.00322", "ticker_sentiment_score": "0.01077", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOMD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006053", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTWK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005566", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNPR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00194", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBF", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008142", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003191", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.008375", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.026217", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOXX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004531", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.038289", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004252", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.024299", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBGI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00208", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003016", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.023636", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001062", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSWI", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010534", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDNT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.349308", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CMMB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000851", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.289778", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SITE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002207", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006519", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBP", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.005795", "ticker_sentiment_label": "Neutral"}, {"ticker": "STIM", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.025041", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001118", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004295", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006385", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.011008", "ticker_sentiment_label": "Neutral"}, {"ticker": "DARE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.102936", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00468", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002031", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZME", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00167", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITGR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000564", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.027052", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.004104", "ticker_sentiment_label": "Neutral"}, {"ticker": "PROF", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.29215", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RCKT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001976", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNNE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002981", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSTK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000678", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCL", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000647", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.223806", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ORTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.26176", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FROG", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008082", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.006139", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002993", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTP", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00473", "ticker_sentiment_label": "Neutral"}, {"ticker": "TITN", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008995", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHL", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.020238", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014937", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.301571", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SUNW", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007301", "ticker_sentiment_label": "Neutral"}, {"ticker": "KVHI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.013646", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005207", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.000912", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMAX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.036118", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.00644", "ticker_sentiment_score": "0.013837", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007376", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSAT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.003988", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01138", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.241618", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TSHA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.009824", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENIA", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00923", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010619", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001246", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010105", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEAV", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009262", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSLS", "relevance_score": "0.012879", "ticker_sentiment_score": "0.043389", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.00644", "ticker_sentiment_score": "0.012508", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.005582", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.05691", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANVS", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009011", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNSO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003337", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAMI", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.007677", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.335982", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MLNK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.002448", "ticker_sentiment_label": "Neutral"}, {"ticker": "EEX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.020371", "ticker_sentiment_label": "Neutral"}, {"ticker": "TREE", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.001355", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHB", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.025186", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.007849", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.00213", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.00322", "ticker_sentiment_score": "0.031001", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.012879", "ticker_sentiment_score": "0.013326", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.052358", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.00644", "ticker_sentiment_score": "0.00032", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.361636", "ticker_sentiment_label": "Bearish"}, {"ticker": "SWTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.001458", "ticker_sentiment_label": "Neutral"}, {"ticker": "VHC", "relevance_score": "0.00644", "ticker_sentiment_score": "0.003614", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002191", "ticker_sentiment_label": "Neutral"}, {"ticker": "XLO", "relevance_score": "0.00644", "ticker_sentiment_score": "0.009634", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.000606", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.006603", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008334", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.029289", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRHC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010461", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDIMF", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.005397", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.010025", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAK", "relevance_score": "0.00644", "ticker_sentiment_score": "0.05356", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPS", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.014929", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.010665", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBNH", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.01932", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVFC", "relevance_score": "0.00644", "ticker_sentiment_score": "-0.004869", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.00644", "ticker_sentiment_score": "0.013625", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAX", "relevance_score": "0.00644", "ticker_sentiment_score": "0.008095", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCZ", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.015944", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIR", "relevance_score": "0.00644", "ticker_sentiment_score": "0.002046", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:BGN", "relevance_score": "0.00322", "ticker_sentiment_score": "-0.050789", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.00322", "ticker_sentiment_score": "0.003323", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics to Report First Quarter 2022 Financial Results on May 5, 2022", "url": "https://www.globenewswire.com/news-release/2022/04/28/2431297/37704/en/CytomX-Therapeutics-to-Report-First-Quarter-2022-Financial-Results-on-May-5-2022.html", "time_published": "20220428T120000", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., April  28, 2022   ( GLOBE NEWSWIRE )  -- CytomX Therapeutics, Inc.  ( Nasdaq: CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that it will report first quarter 2022 financial results on Thursday, May 5, 2022, after the clo", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.211244, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.174398", "ticker_sentiment_score": "0.273357", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.174398", "ticker_sentiment_score": "0.273357", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.258991", "ticker_sentiment_score": "0.011355", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics  ( NASDAQ:CTMX )  Stock Rating Upgraded by StockNews.com", "url": "https://www.defenseworld.net/2022/04/28/cytomx-therapeutics-nasdaqctmx-stock-rating-upgraded-by-stocknews-com.html", "time_published": "20220428T084645", "authors": ["admin"], "summary": "StockNews.com upgraded shares of CytomX Therapeutics  ( NASDAQ:CTMX - Get Rating )  from a sell rating to a hold rating in a report issued on Wednesday morning.", "banner_image": "https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&Symbol=CTMX", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.459462"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.00861, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MCQEF", "relevance_score": "0.0601", "ticker_sentiment_score": "0.024301", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.11986", "ticker_sentiment_score": "0.007611", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.0601", "ticker_sentiment_score": "-0.008727", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.825258", "ticker_sentiment_score": "0.00861", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.0601", "ticker_sentiment_score": "-0.008727", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADP", "relevance_score": "0.0601", "ticker_sentiment_score": "0.007611", "ticker_sentiment_label": "Neutral"}, {"ticker": "RJF", "relevance_score": "0.0601", "ticker_sentiment_score": "0.024301", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/markets/options/22/04/26844275/52-weeks-high-and-low-article", "time_published": "20220427T184104", "authors": ["Benzinga Insights"], "summary": "Wednesday's session saw 784 companies set new 52-week lows.\nKey Facts About Today's 52-Week Lows:\nMeta Platforms  ( NASDAQ:FB )  was the biggest company by market cap to set a new 52-week low.\nNova Lifestyle  ( NASDAQ:NVFY )  was the smallest, in terms of market cap, to set a new 52-week low.\nMolecu", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7415.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.024509, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SSNT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012617", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.003478", "ticker_sentiment_score": "0.003342", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008877", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006223", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.021661", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014715", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACCO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.301882", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OLMA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003767", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCOR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.071126", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000191", "ticker_sentiment_label": "Neutral"}, {"ticker": "EZFL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008227", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOLD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.018875", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.022985", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013583", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001136", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOTV", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017693", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003147", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.58381", "ticker_sentiment_label": "Bearish"}, {"ticker": "HESG", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.00143", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001921", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOFT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.031163", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKTS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000296", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00588", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001682", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001729", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCAB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007262", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015432", "ticker_sentiment_label": "Neutral"}, {"ticker": "BB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.026903", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016763", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVEC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009395", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001861", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014376", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSSS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014383", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001933", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013438", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003147", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKSI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.0037", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001666", "ticker_sentiment_label": "Neutral"}, {"ticker": "HROW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014681", "ticker_sentiment_label": "Neutral"}, {"ticker": "U", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003278", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.023457", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.0031", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.019862", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004911", "ticker_sentiment_label": "Neutral"}, {"ticker": "THO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000745", "ticker_sentiment_label": "Neutral"}, {"ticker": "TURN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002435", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.010434", "ticker_sentiment_score": "-0.004274", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.255918", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UDMY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.03117", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001731", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009732", "ticker_sentiment_label": "Neutral"}, {"ticker": "THR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.058424", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005755", "ticker_sentiment_label": "Neutral"}, {"ticker": "CG", "relevance_score": "0.006956", "ticker_sentiment_score": "6e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016143", "ticker_sentiment_label": "Neutral"}, {"ticker": "VISL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000427", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCYO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008727", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.018398", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008787", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017364", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZNC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001128", "ticker_sentiment_label": "Neutral"}, {"ticker": "JVA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010822", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002926", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001709", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.347475", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "STRO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.302553", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CVET", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001024", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.011476", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004284", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.027416", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.041488", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014789", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007839", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLGY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004665", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007459", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000842", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012938", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADV", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009804", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYMT", "relevance_score": "0.006956", "ticker_sentiment_score": "-3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.011807", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.117271", "ticker_sentiment_label": "Neutral"}, {"ticker": "EB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000242", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.232673", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LABP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012649", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007016", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000682", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004064", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000564", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000332", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.013321", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006026", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006966", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.018373", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.021739", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.034726", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.100714", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001337", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00081", "ticker_sentiment_label": "Neutral"}, {"ticker": "FB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.115496", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004041", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014346", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVFY", "relevance_score": "0.013912", "ticker_sentiment_score": "0.068673", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004443", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSCO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010667", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006617", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.04434", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010807", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002565", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005508", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.024343", "ticker_sentiment_score": "-0.086459", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNGX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.057761", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000199", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000419", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000374", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001824", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBLU", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015993", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXFY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000776", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.037797", "ticker_sentiment_label": "Neutral"}, {"ticker": "INGN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003479", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005634", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002598", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.02811", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.023724", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003729", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXTI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008298", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013152", "ticker_sentiment_label": "Neutral"}, {"ticker": "USNA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00143", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.389457", "ticker_sentiment_label": "Bearish"}, {"ticker": "ISRG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.053483", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012244", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTRS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001009", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.068341", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001545", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLIO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001458", "ticker_sentiment_label": "Neutral"}, {"ticker": "XELA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001002", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013186", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGHT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004241", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.204649", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.031021", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.272985", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCEL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003392", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNST", "relevance_score": "0.006956", "ticker_sentiment_score": "0.019695", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000126", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.039875", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008709", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.006956", "ticker_sentiment_score": "-4.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNDA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00522", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFBC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013615", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017205", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005309", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010078", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPAA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015124", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSV", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.59339", "ticker_sentiment_label": "Bearish"}, {"ticker": "AVRO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000253", "ticker_sentiment_label": "Neutral"}, {"ticker": "YTEN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.031949", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000982", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKOH", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004094", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010062", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRBO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005478", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYNT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012065", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGMS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017789", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.408704", "ticker_sentiment_label": "Bearish"}, {"ticker": "IBRX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003091", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.048664", "ticker_sentiment_score": "-0.003242", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001521", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014015", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009848", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000278", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.071126", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00431", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.032365", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFMS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009368", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01034", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOXF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.279613", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACMR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.0291", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015741", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001151", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.383431", "ticker_sentiment_label": "Bearish"}, {"ticker": "CEMI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007208", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001798", "ticker_sentiment_label": "Neutral"}, {"ticker": "KN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002199", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.038845", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002288", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012717", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPLD", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003671", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001943", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.358825", "ticker_sentiment_label": "Bearish"}, {"ticker": "ADPT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.022179", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000606", "ticker_sentiment_label": "Neutral"}, {"ticker": "TARA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.543695", "ticker_sentiment_label": "Bearish"}, {"ticker": "USX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007008", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.321695", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NRDY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008949", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTEX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009198", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000452", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000999", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014325", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPER", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010105", "ticker_sentiment_label": "Neutral"}, {"ticker": "KPLT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.023773", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIFY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.189098", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DTIL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003697", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.018232", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.003478", "ticker_sentiment_score": "0.000535", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.058218", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDLS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000815", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007873", "ticker_sentiment_label": "Neutral"}, {"ticker": "MG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007751", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.013785", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001193", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.038126", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005311", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011551", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002839", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAKE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.024648", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00022", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.025518", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005186", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCI", "relevance_score": "0.010434", "ticker_sentiment_score": "-0.00874", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCFC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010297", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003112", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001427", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006295", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002959", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFUS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00168", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNST", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013696", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009879", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQZ", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00349", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.021697", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMCX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003485", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.071927", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002823", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005056", "ticker_sentiment_label": "Neutral"}, {"ticker": "MESA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001901", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.0002", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000236", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.011154", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003052", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003067", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.015428", "ticker_sentiment_label": "Neutral"}, {"ticker": "HEAR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000837", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000661", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006936", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006674", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000871", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTBP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001863", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000446", "ticker_sentiment_label": "Neutral"}, {"ticker": "DELL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.053044", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYXH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004037", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003136", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.0007", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011451", "ticker_sentiment_label": "Neutral"}, {"ticker": "PMD", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005098", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLDR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005724", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMMX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013666", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014051", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002143", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009119", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCOV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009176", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.060278", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009026", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008106", "ticker_sentiment_label": "Neutral"}, {"ticker": "FXLV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000185", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010642", "ticker_sentiment_label": "Neutral"}, {"ticker": "APO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013092", "ticker_sentiment_label": "Neutral"}, {"ticker": "APP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000808", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLWS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.029896", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATUS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002683", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004771", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007665", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01639", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRIO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.023908", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005197", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001537", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01044", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.016234", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012615", "ticker_sentiment_label": "Neutral"}, {"ticker": "DENN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.028418", "ticker_sentiment_label": "Neutral"}, {"ticker": "NERV", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.18013", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MLAB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.033966", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.001837", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAND", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.067387", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010293", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSQR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015376", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.03741", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001805", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCMI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.389493", "ticker_sentiment_label": "Bearish"}, {"ticker": "CURI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003047", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAII", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.172552", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PACK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014442", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006059", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.024115", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001381", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000101", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPFI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011271", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000875", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017063", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009245", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00412", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010282", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003854", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002329", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSRR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.024285", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.037236", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.022452", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003245", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005093", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.446202", "ticker_sentiment_label": "Bearish"}, {"ticker": "PPBI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004512", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004505", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.02625", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002475", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010512", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTEC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005696", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003771", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYLN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006601", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTHM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001947", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017597", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008233", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKNA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.01199", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTES", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006794", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003267", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLFC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001133", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014593", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002758", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAAS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.525885", "ticker_sentiment_label": "Bearish"}, {"ticker": "SYNH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002169", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.020881", "ticker_sentiment_label": "Neutral"}, {"ticker": "TILE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.052336", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012392", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014251", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.182314", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HBI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005759", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.006956", "ticker_sentiment_score": "0.02293", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRON", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012079", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008347", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.014125", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006544", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003326", "ticker_sentiment_label": "Neutral"}, {"ticker": "UIHC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008093", "ticker_sentiment_label": "Neutral"}, {"ticker": "RWT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005272", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004262", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004065", "ticker_sentiment_label": "Neutral"}, {"ticker": "LASR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00727", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008439", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.061226", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011625", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010839", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004492", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001129", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBIO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003864", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009463", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017931", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.027563", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.282746", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GSHD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001756", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.013015", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHCO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.366969", "ticker_sentiment_label": "Bearish"}, {"ticker": "MRTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000817", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000642", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBUU", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00097", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.006956", "ticker_sentiment_score": "0.032139", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00404", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.001264", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOCS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008088", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01631", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004698", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001047", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00432", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00859", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006439", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.024224", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.060555", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.041404", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016703", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001744", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.027874", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIGL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003153", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUWE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00711", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004143", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001699", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONEW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.025066", "ticker_sentiment_label": "Neutral"}, {"ticker": "XL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.019773", "ticker_sentiment_label": "Neutral"}, {"ticker": "XM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009158", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSVB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000462", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.001264", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015613", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004247", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00132", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.030263", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFTR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.020452", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003641", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.015243", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDSA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016808", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.050771", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.031295", "ticker_sentiment_score": "0.002099", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.021551", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.035314", "ticker_sentiment_label": "Neutral"}, {"ticker": "FERG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00239", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPW", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001576", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.048426", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.020884", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005937", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000906", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBMT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001385", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.0384", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002331", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001587", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.070554", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASI", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006335", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014614", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTXR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009084", "ticker_sentiment_label": "Neutral"}, {"ticker": "MATW", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.00469", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.001566", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003614", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006117", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHPW", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008555", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOMD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.084826", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.010083", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCK", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.021997", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBF", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004728", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPL", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006191", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.002459", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDUC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.015428", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004112", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBNC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.035798", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001767", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOXX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.007798", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFCG", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009093", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003381", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.031259", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDNT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008022", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMMB", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004944", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.033572", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004164", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGCP", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000828", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOP", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001006", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000284", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.004438", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRLN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.007664", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAN", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005953", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.006956", "ticker_sentiment_score": "0.02371", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001331", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.008584", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000723", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLBY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.004238", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLCE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003271", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.00726", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNNE", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005717", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZBRA", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001386", "ticker_sentiment_label": "Neutral"}, {"ticker": "UCL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000159", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003243", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.011591", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEV", "relevance_score": "0.006956", "ticker_sentiment_score": "0.008696", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.006956", "ticker_sentiment_score": "0.028413", "ticker_sentiment_label": "Neutral"}, {"ticker": "UEIC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.006108", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.001284", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTZ", "relevance_score": "0.006956", "ticker_sentiment_score": "0.011944", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNGR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001894", "ticker_sentiment_label": "Neutral"}, {"ticker": "VFF", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002897", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.10209", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.013315", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.025077", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000432", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENIA", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.000742", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENIC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.017113", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003479", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.426632", "ticker_sentiment_label": "Bearish"}, {"ticker": "BEAM", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.04627", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.005071", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.006057", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLTR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001037", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHB", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014522", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001419", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLF", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012444", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01839", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.005276", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCS", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.014151", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.017232", "ticker_sentiment_label": "Neutral"}, {"ticker": "JPM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001563", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRT", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015017", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.020872", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.005609", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.003924", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.01495", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.016176", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002752", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGIO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.010525", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFST", "relevance_score": "0.006956", "ticker_sentiment_score": "0.001944", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.071345", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBH", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.02039", "ticker_sentiment_label": "Neutral"}, {"ticker": "XLO", "relevance_score": "0.006956", "ticker_sentiment_score": "0.012466", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002422", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.006956", "ticker_sentiment_score": "0.009716", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.006956", "ticker_sentiment_score": "0.002471", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003714", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDIMF", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.00185", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGTY", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.003869", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000901", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETWO", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.374436", "ticker_sentiment_label": "Bearish"}, {"ticker": "CMPR", "relevance_score": "0.006956", "ticker_sentiment_score": "0.034053", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.009777", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYLT", "relevance_score": "0.006956", "ticker_sentiment_score": "0.000769", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.015552", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAX", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.012043", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEL", "relevance_score": "0.006956", "ticker_sentiment_score": "-0.319319", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCZ", "relevance_score": "0.003478", "ticker_sentiment_score": "-0.020073", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Friday", "url": "https://www.benzinga.com/markets/options/22/04/26764450/52-weeks-high-and-low-article", "time_published": "20220422T162629", "authors": ["Benzinga Insights"], "summary": "On Friday, 431 companies hit new 52-week lows.\nNoteworthy Mentions In Today's 52-Week Lows:\nThe largest company by market cap to hit a new 52-week low was Meta Platforms  ( NASDAQ:FB ) .\nThe smallest company by market cap to set a new 52-week low was AnPac Bio-Medical Science  ( NASDAQ:ANPC ) .\nBaby", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7108.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.008194, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SSNT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.04002", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGLE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000288", "ticker_sentiment_label": "Neutral"}, {"ticker": "APP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.055017", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.006295", "ticker_sentiment_score": "0.003013", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSBF", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.027827", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCNC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005522", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.011696", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002197", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005764", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.054565", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007951", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000488", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMRD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001194", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008186", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000888", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008871", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003844", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003319", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008938", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.013615", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.013281", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROM", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002015", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005125", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.006295", "ticker_sentiment_score": "-0.00611", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001174", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003037", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003905", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.01154", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004559", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007537", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.017466", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.063278", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.207667", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PACK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.013536", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.0022", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003278", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009744", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00362", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGNC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00151", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLUE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.013598", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.04606", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006001", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.023699", "ticker_sentiment_label": "Neutral"}, {"ticker": "IESC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.181158", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PRGO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005214", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006933", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.057322", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001105", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.045251", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.017476", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007634", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.018882", "ticker_sentiment_score": "0.001113", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00271", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.004169", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006886", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001976", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.560818", "ticker_sentiment_label": "Bearish"}, {"ticker": "NVTS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.012871", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.019326", "ticker_sentiment_label": "Neutral"}, {"ticker": "INST", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003671", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEXAF", "relevance_score": "0.006295", "ticker_sentiment_score": "-0.000552", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002236", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.026752", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYLN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.018711", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.012589", "ticker_sentiment_score": "0.037272", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000217", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002872", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.023593", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002954", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005902", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00613", "ticker_sentiment_label": "Neutral"}, {"ticker": "TU", "relevance_score": "0.006295", "ticker_sentiment_score": "0.00025", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005374", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009782", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003932", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.018038", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.011243", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVZ", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003278", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005314", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001463", "ticker_sentiment_label": "Neutral"}, {"ticker": "FORA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006191", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.055877", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006364", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.248444", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EB", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008884", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005195", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000616", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.038037", "ticker_sentiment_label": "Neutral"}, {"ticker": "LABP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00382", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005224", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.024596", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000223", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002702", "ticker_sentiment_label": "Neutral"}, {"ticker": "YETI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.00638", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004135", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.009861", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.010216", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWIM", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003836", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005471", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005971", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYOV", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.015233", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005942", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003375", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002011", "ticker_sentiment_label": "Neutral"}, {"ticker": "FB", "relevance_score": "0.025174", "ticker_sentiment_score": "0.023313", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000444", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.029535", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.027942", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009669", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.012589", "ticker_sentiment_score": "0.054059", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006852", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSHD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.015145", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.024883", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001085", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000518", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.010341", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003332", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009446", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002622", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.033108", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002506", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.019667", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.031989", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBRV", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002136", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.010073", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.040503", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.033483", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPRO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.01059", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.004584", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002445", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUMU", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.028206", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007002", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003576", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.00577", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008531", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000172", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005556", "ticker_sentiment_label": "Neutral"}, {"ticker": "VQS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000542", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTH", "relevance_score": "0.012589", "ticker_sentiment_score": "0.033799", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000454", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.0038", "ticker_sentiment_label": "Neutral"}, {"ticker": "REKR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.025588", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANPC", "relevance_score": "0.025174", "ticker_sentiment_score": "0.035638", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.016927", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.012589", "ticker_sentiment_score": "0.011874", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHG", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.012297", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006878", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003093", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.011344", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDSA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003232", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANAB", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.005612", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00713", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.369351", "ticker_sentiment_label": "Bearish"}, {"ticker": "SBUX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.033597", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUZE", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.051845", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.033236", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001635", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.315281", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CYRX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00353", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.033412", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004799", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006859", "ticker_sentiment_label": "Neutral"}, {"ticker": "JSPR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001649", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.012589", "ticker_sentiment_score": "9.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000955", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.017962", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.369194", "ticker_sentiment_label": "Bearish"}, {"ticker": "CRDF", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000458", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006727", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006561", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000115", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002655", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.053433", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.012706", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.068075", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.031465", "ticker_sentiment_score": "-0.003981", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000144", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.025063", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00534", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNPR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001248", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000552", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003683", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008628", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000769", "ticker_sentiment_label": "Neutral"}, {"ticker": "AJX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.646094", "ticker_sentiment_label": "Bullish"}, {"ticker": "OCUL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.02295", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.031165", "ticker_sentiment_label": "Neutral"}, {"ticker": "OOMA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007986", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.03969", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.016877", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFCG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.0065", "ticker_sentiment_label": "Neutral"}, {"ticker": "COOK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008612", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002318", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003783", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008217", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.016722", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRGA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007052", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.017228", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00176", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.010775", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.042436", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.010251", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGCP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001663", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001529", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.004261", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBC", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002195", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.015191", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004674", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003547", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001112", "ticker_sentiment_label": "Neutral"}, {"ticker": "USAU", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000765", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLBY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001849", "ticker_sentiment_label": "Neutral"}, {"ticker": "IART", "relevance_score": "0.012589", "ticker_sentiment_score": "0.009061", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006914", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006347", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.012589", "ticker_sentiment_score": "0.019645", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.011275", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002501", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006808", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSTK", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006961", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORTX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.211815", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PEGY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004639", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.017445", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.016432", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009416", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHG", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.031937", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUCD", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006571", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000226", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.029997", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.012843", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001975", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.106522", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.006295", "ticker_sentiment_score": "-0.130957", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002716", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDLS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004082", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001979", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002127", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000724", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMK", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.039246", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.001283", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.00793", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.060536", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.025237", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.012589", "ticker_sentiment_score": "0.007236", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004036", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRKR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003901", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000523", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006817", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEAV", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008455", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.010403", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004871", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTL", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003643", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007628", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIND", "relevance_score": "0.012589", "ticker_sentiment_score": "0.50686", "ticker_sentiment_label": "Bullish"}, {"ticker": "GOEV", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000334", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGEN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.256995", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EEX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.00637", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008417", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.012589", "ticker_sentiment_score": "0.003479", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHTR", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.011615", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNPO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007526", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000678", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004845", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.268489", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VAPO", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.009243", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.0058", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.012589", "ticker_sentiment_score": "0.045139", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.007101", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRT", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.002131", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001979", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.021568", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000518", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.005179", "ticker_sentiment_label": "Neutral"}, {"ticker": "INPX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008001", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.000743", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGI", "relevance_score": "0.012589", "ticker_sentiment_score": "0.008306", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.004909", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.012589", "ticker_sentiment_score": "0.016677", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.009832", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYM", "relevance_score": "0.012589", "ticker_sentiment_score": "0.002674", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.0001", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAY", "relevance_score": "0.012589", "ticker_sentiment_score": "0.009599", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.04487", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTV", "relevance_score": "0.012589", "ticker_sentiment_score": "0.010249", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.024202", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.006879", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNHC", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.045502", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.041902", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.008505", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNUS", "relevance_score": "0.012589", "ticker_sentiment_score": "0.033762", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGTY", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.003595", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFSB", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001962", "ticker_sentiment_label": "Neutral"}, {"ticker": "OYST", "relevance_score": "0.012589", "ticker_sentiment_score": "0.000924", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.012589", "ticker_sentiment_score": "0.001609", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.012589", "ticker_sentiment_score": "0.006543", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.012589", "ticker_sentiment_score": "-0.35552", "ticker_sentiment_label": "Bearish"}, {"ticker": "LEV", "relevance_score": "0.012589", "ticker_sentiment_score": "0.004599", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPID", "relevance_score": "0.012589", "ticker_sentiment_score": "0.023936", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:BGN", "relevance_score": "0.006295", "ticker_sentiment_score": "0.004599", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Thursday", "url": "https://www.benzinga.com/markets/options/22/04/26742233/52-weeks-high-and-low-article", "time_published": "20220421T175401", "authors": ["Benzinga Insights"], "summary": "On Thursday, 236 companies hit new 52-week lows.\nIntriguing Points From Today's 52-Week Lows:\nSalesforce  ( NYSE:CRM )  was the largest firm by market cap to set a new 52-week low.\nVallon Pharmaceuticals  ( NASDAQ:VLON )  was the smallest firm by market cap to set a new 52-week low.\nAmpio Pharmaceut", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7009.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.021205, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CABA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002381", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.021637", "ticker_sentiment_score": "0.087135", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006649", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00113", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.01052", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.030051", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002758", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.022497", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001981", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.021637", "ticker_sentiment_score": "0.009944", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.008619", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00781", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYS", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00196", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.004795", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006897", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.300845", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HYRE", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.007066", "ticker_sentiment_label": "Neutral"}, {"ticker": "JSPR", "relevance_score": "0.021637", "ticker_sentiment_score": "0.014598", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00269", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOV", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00273", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.010819", "ticker_sentiment_score": "-0.009612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.009915", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002463", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDEX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.008528", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.009832", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.004491", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.029605", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.007497", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.006538", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.021637", "ticker_sentiment_score": "0.007612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTXR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.020915", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.021637", "ticker_sentiment_score": "0.019945", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.012905", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00033", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001906", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.106213", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001171", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.029072", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.01144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLK", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.275911", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PACK", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.02721", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.043258", "ticker_sentiment_score": "-0.188735", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZYME", "relevance_score": "0.021637", "ticker_sentiment_score": "0.127574", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.010819", "ticker_sentiment_score": "-0.006918", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.015053", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLUE", "relevance_score": "0.021637", "ticker_sentiment_score": "0.008871", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.003519", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.021637", "ticker_sentiment_score": "0.039881", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001819", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUL", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.000393", "ticker_sentiment_label": "Neutral"}, {"ticker": "OOMA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006997", "ticker_sentiment_label": "Neutral"}, {"ticker": "DJCO", "relevance_score": "0.021637", "ticker_sentiment_score": "0.004961", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003854", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.016297", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.021637", "ticker_sentiment_score": "0.036058", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.01678", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFCG", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.281532", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BCRX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.012726", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.006736", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.03245", "ticker_sentiment_score": "0.027112", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSC", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003807", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.305689", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SEEL", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00459", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006611", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.007523", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.010517", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUV", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.017051", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.009391", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000443", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003535", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRRX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.078383", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005134", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.008899", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00856", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.021637", "ticker_sentiment_score": "0.010485", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.226755", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GNRC", "relevance_score": "0.021637", "ticker_sentiment_score": "2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00264", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.004135", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002525", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.017299", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.004381", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.003188", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000793", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001875", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.006916", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.419221", "ticker_sentiment_label": "Bearish"}, {"ticker": "GHG", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.283903", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.28142", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BOLT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00614", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.010254", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002313", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.0031", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.050277", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001072", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.007017", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.010982", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCI", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.014516", "ticker_sentiment_label": "Neutral"}, {"ticker": "UK", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.010605", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.021637", "ticker_sentiment_score": "0.014995", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002158", "ticker_sentiment_label": "Neutral"}, {"ticker": "FORA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.009674", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000964", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005903", "ticker_sentiment_label": "Neutral"}, {"ticker": "EB", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.008842", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.000438", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002495", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.004457", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.076352", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.052763", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005382", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPAY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001576", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.021511", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005956", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002455", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.270087", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LCFY", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003964", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.004413", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.020588", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.021637", "ticker_sentiment_score": "0.309149", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DCT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.026108", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYOV", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.035215", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00075", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.021637", "ticker_sentiment_score": "0.021999", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005212", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006966", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHTR", "relevance_score": "0.021637", "ticker_sentiment_score": "0.004946", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003813", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.010819", "ticker_sentiment_score": "-0.008528", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQZ", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001288", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRM", "relevance_score": "0.043258", "ticker_sentiment_score": "0.037599", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.003287", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.431235", "ticker_sentiment_label": "Bearish"}, {"ticker": "VAXX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00036", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.021637", "ticker_sentiment_score": "0.009887", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.021637", "ticker_sentiment_score": "0.010195", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.01106", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSHD", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00259", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.413847", "ticker_sentiment_label": "Bearish"}, {"ticker": "MRTX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.018486", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.021637", "ticker_sentiment_score": "0.001187", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWTX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002142", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00011", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.012179", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005109", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.011783", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.021637", "ticker_sentiment_score": "0.023889", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.436295", "ticker_sentiment_label": "Bearish"}, {"ticker": "VRAY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.0315", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLB", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006139", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUNA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.007221", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005525", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.026772", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.021637", "ticker_sentiment_score": "0.001085", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPRO", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005236", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.043258", "ticker_sentiment_score": "0.22499", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FNHC", "relevance_score": "0.021637", "ticker_sentiment_score": "0.013294", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002184", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTAI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002113", "ticker_sentiment_label": "Neutral"}, {"ticker": "OYST", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000134", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002846", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00702", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.024102", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.306875", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FWBI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.009235", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00507", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.358426", "ticker_sentiment_label": "Bearish"}, {"ticker": "RUBY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.029741", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATBP", "relevance_score": "0.010819", "ticker_sentiment_score": "-0.00936", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.021637", "ticker_sentiment_score": "0.048038", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPID", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000519", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/news/22/04/26717868/stocks-that-hit-52-week-lows-on-wednesday", "time_published": "20220420T161438", "authors": [], "summary": "On Wednesday, 160 companies hit new 52-week lows.\nAreas of Significance In Today's 52-Week Lows:\nWalt Disney  ( NYSE:DIS )  was the largest firm by market cap to set a new 52-week low.\nVallon Pharmaceuticals  ( NASDAQ:VLON )  is the smallest company on a market cap basis to set a new 52-week low.\nNe", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_6909.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.03037, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CABA", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.004694", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADVM", "relevance_score": "0.015214", "ticker_sentiment_score": "0.00096", "ticker_sentiment_label": "Neutral"}, {"ticker": "SESN", "relevance_score": "0.015214", "ticker_sentiment_score": "0.001443", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.016189", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRKN", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.261041", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VRM", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.02712", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.027177", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.0135", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLQT", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.315611", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZYNE", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.013411", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.0001", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.004065", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.027366", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNX", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.001301", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.003753", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.02223", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTX", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.002833", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.006957", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.002545", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.015214", "ticker_sentiment_score": "0.000494", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.024302", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.007322", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDEX", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.001313", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.003991", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.015214", "ticker_sentiment_score": "0.001634", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.030908", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.00211", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.282844", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SOFI", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.003471", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.012207", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.011623", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWVL", "relevance_score": "0.015214", "ticker_sentiment_score": "0.006689", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.030423", "ticker_sentiment_score": "0.005802", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.045621", "ticker_sentiment_score": "-0.241231", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KOPN", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.003411", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.001054", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.002839", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.005357", "ticker_sentiment_label": "Neutral"}, {"ticker": "JP", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.006061", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.006022", "ticker_sentiment_label": "Neutral"}, {"ticker": "BQ", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.001506", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUL", "relevance_score": "0.015214", "ticker_sentiment_score": "0.001603", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRY", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.00436", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.005414", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.015214", "ticker_sentiment_score": "0.017321", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFCG", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.00446", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.018139", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.001263", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.001188", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.030423", "ticker_sentiment_score": "-0.064258", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.015214", "ticker_sentiment_score": "0.008014", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.003939", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.030423", "ticker_sentiment_score": "0.00485", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.015214", "ticker_sentiment_score": "0.000266", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRVS", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.266051", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ETSY", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.029213", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.00379", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.017856", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.015214", "ticker_sentiment_score": "0.001452", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.015214", "ticker_sentiment_score": "0.014488", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.006908", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.000815", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCN", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.229046", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KBNT", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.011749", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.000338", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.283486", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GRTS", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.00014", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.000395", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDN", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.005153", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCI", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.015102", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTYH", "relevance_score": "0.015214", "ticker_sentiment_score": "0.001432", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.003093", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.015214", "ticker_sentiment_score": "0.00378", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.012405", "ticker_sentiment_label": "Neutral"}, {"ticker": "EE", "relevance_score": "0.015214", "ticker_sentiment_score": "0.00088", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.015214", "ticker_sentiment_score": "0.005458", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.005558", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCLD", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.015996", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.00275", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.030423", "ticker_sentiment_score": "0.035042", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.015214", "ticker_sentiment_score": "0.007275", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANW", "relevance_score": "0.015214", "ticker_sentiment_score": "0.000803", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.011707", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.002303", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVO", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.006638", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGC", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.012953", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBCN", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.009575", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQZ", "relevance_score": "0.015214", "ticker_sentiment_score": "0.000883", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.003852", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.036665", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVR", "relevance_score": "0.015214", "ticker_sentiment_score": "0.001964", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.00787", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.015214", "ticker_sentiment_score": "0.001964", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.393189", "ticker_sentiment_label": "Bearish"}, {"ticker": "GAME", "relevance_score": "0.015214", "ticker_sentiment_score": "0.002209", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.015214", "ticker_sentiment_score": "0.001245", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRHC", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.007553", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNHC", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.024382", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.015214", "ticker_sentiment_score": "0.00638", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.000311", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.015214", "ticker_sentiment_score": "0.004132", "ticker_sentiment_label": "Neutral"}, {"ticker": "RUBY", "relevance_score": "0.015214", "ticker_sentiment_score": "-0.020703", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Tuesday", "url": "https://www.benzinga.com/news/22/04/26693085/stocks-that-hit-52-week-lows-on-tuesday", "time_published": "20220419T153817", "authors": [], "summary": "On Tuesday, 242 companies hit new 52-week lows.\nNoteworthy Mentions In Today's 52-Week Lows:\nThe largest company in terms of market cap to set a new 52-week low was Sony Group  ( NYSE:SONY ) .\nNova Lifestyle  ( NASDAQ:NVFY )  was the smallest firm by market cap to set a new 52-week low.\nCassava Scie", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_6805.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.018609, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VIAV", "relevance_score": "0.009731", "ticker_sentiment_score": "0.004657", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGLE", "relevance_score": "0.009731", "ticker_sentiment_score": "0.000825", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.009731", "ticker_sentiment_score": "0.008373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADVM", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.010138", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRKN", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.045182", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.059507", "ticker_sentiment_label": "Neutral"}, {"ticker": "ODC", "relevance_score": "0.009731", "ticker_sentiment_score": "0.023028", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFC", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.010172", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.00057", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.034271", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVCN", "relevance_score": "0.009731", "ticker_sentiment_score": "0.014762", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMP", "relevance_score": "0.009731", "ticker_sentiment_score": "0.00761", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCEL", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.01715", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.004092", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.009731", "ticker_sentiment_score": "-8.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.009731", "ticker_sentiment_score": "0.002697", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.009731", "ticker_sentiment_score": "0.001245", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.003787", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.019461", "ticker_sentiment_score": "-0.003593", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYS", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.001465", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.005924", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.009731", "ticker_sentiment_score": "0.003833", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.009731", "ticker_sentiment_score": "0.000678", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.279189", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PKOH", "relevance_score": "0.009731", "ticker_sentiment_score": "-8.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.006087", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAV", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.005031", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.004171", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWVL", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000876", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYME", "relevance_score": "0.009731", "ticker_sentiment_score": "0.001002", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.106726", "ticker_sentiment_score": "-0.023112", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.010389", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.011199", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGNC", "relevance_score": "0.009731", "ticker_sentiment_score": "0.000945", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.011134", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMX", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.003004", "ticker_sentiment_label": "Neutral"}, {"ticker": "AJX", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.618662", "ticker_sentiment_label": "Bearish"}, {"ticker": "STRY", "relevance_score": "0.019461", "ticker_sentiment_score": "0.057273", "ticker_sentiment_label": "Neutral"}, {"ticker": "OOMA", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.004008", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000401", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.009731", "ticker_sentiment_score": "0.0014", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.009731", "ticker_sentiment_score": "0.000599", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.009731", "ticker_sentiment_score": "0.00288", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLN", "relevance_score": "0.009731", "ticker_sentiment_score": "0.026093", "ticker_sentiment_label": "Neutral"}, {"ticker": "TURN", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.012014", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000365", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.019461", "ticker_sentiment_score": "0.039265", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.04114", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNAY", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.002005", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.009731", "ticker_sentiment_score": "0.000515", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.009731", "ticker_sentiment_score": "0.017942", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOL", "relevance_score": "0.009731", "ticker_sentiment_score": "0.008247", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.009731", "ticker_sentiment_score": "0.024856", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.33727", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GGR", "relevance_score": "0.009731", "ticker_sentiment_score": "0.002827", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.009731", "ticker_sentiment_score": "0.00121", "ticker_sentiment_label": "Neutral"}, {"ticker": "IART", "relevance_score": "0.009731", "ticker_sentiment_score": "0.00344", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRS", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.00628", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.009731", "ticker_sentiment_score": "0.011636", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.016246", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.009731", "ticker_sentiment_score": "0.000168", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.003032", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.009731", "ticker_sentiment_score": "0.000973", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.011114", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.040193", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.009731", "ticker_sentiment_score": "0.006848", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.00135", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.009731", "ticker_sentiment_score": "0.001294", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.009731", "ticker_sentiment_score": "0.044666", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVL", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000362", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.009731", "ticker_sentiment_score": "0.020672", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.009731", "ticker_sentiment_score": "0.004616", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.009977", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYT", "relevance_score": "0.009731", "ticker_sentiment_score": "0.000316", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.015136", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.01046", "ticker_sentiment_label": "Neutral"}, {"ticker": "EE", "relevance_score": "0.009731", "ticker_sentiment_score": "0.030052", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.009731", "ticker_sentiment_score": "0.015859", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRPO", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.011856", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.009731", "ticker_sentiment_score": "0.015427", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.009731", "ticker_sentiment_score": "0.001503", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.009731", "ticker_sentiment_score": "0.003258", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.007363", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.001866", "ticker_sentiment_label": "Neutral"}, {"ticker": "MX", "relevance_score": "0.009731", "ticker_sentiment_score": "0.00089", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.009731", "ticker_sentiment_score": "0.001798", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.009731", "ticker_sentiment_score": "0.000578", "ticker_sentiment_label": "Neutral"}, {"ticker": "RWT", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.005408", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVNT", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000742", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.019461", "ticker_sentiment_score": "0.028354", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBCP", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.014163", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.009731", "ticker_sentiment_score": "0.003093", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.009731", "ticker_sentiment_score": "0.006652", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAMI", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.003761", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPTN", "relevance_score": "0.009731", "ticker_sentiment_score": "0.002104", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOEV", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000289", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGEN", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000926", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000926", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVO", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000911", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.284155", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SMFG", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.125777", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVFY", "relevance_score": "0.019461", "ticker_sentiment_score": "0.022129", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.009731", "ticker_sentiment_score": "0.017592", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.00855", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.009731", "ticker_sentiment_score": "0.002419", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLF", "relevance_score": "0.009731", "ticker_sentiment_score": "0.009455", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000137", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.009731", "ticker_sentiment_score": "0.004785", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVR", "relevance_score": "0.009731", "ticker_sentiment_score": "0.003609", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.01612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.223704", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FHI", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.00966", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRR", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.020921", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.087408", "ticker_sentiment_score": "-0.02208", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENZ", "relevance_score": "0.009731", "ticker_sentiment_score": "0.004168", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.009731", "ticker_sentiment_score": "0.00022", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.001268", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.125777", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.009731", "ticker_sentiment_score": "0.015391", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.009731", "ticker_sentiment_score": "0.009777", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUB", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.001062", "ticker_sentiment_label": "Neutral"}, {"ticker": "XLO", "relevance_score": "0.009731", "ticker_sentiment_score": "0.011385", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.009731", "ticker_sentiment_score": "0.001724", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.009731", "ticker_sentiment_score": "0.004574", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNHC", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.079426", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVRX", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.000409", "ticker_sentiment_label": "Neutral"}, {"ticker": "PMD", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.015504", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.009731", "ticker_sentiment_score": "0.012686", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.013835", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.186681", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LYLT", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.004411", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.125777", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.001756", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.009731", "ticker_sentiment_score": "0.002785", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.007363", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.009731", "ticker_sentiment_score": "0.00267", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLRE", "relevance_score": "0.009731", "ticker_sentiment_score": "-0.002303", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/news/22/04/26669813/stocks-that-hit-52-week-lows-on-monday", "time_published": "20220418T154044", "authors": [], "summary": "On Monday, 466 companies hit new 52-week lows.\nNoteworthy Highlights From Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Walt Disney  ( NYSE:DIS ) .\nThe smallest company on a market cap basis to set a new 52-week low was InVivo Therapeutics Hldg  ( NASDAQ:NVIV )", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_6728.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.017864, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VIAV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002621", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003856", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.213067", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SESN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000595", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.293142", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACCO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007652", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012013", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.023223", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002695", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010655", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007513", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.022953", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNR", "relevance_score": "0.005428", "ticker_sentiment_score": "-4.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00106", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012709", "ticker_sentiment_label": "Neutral"}, {"ticker": "FARO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001331", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.272565", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BTCM", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002319", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.005428", "ticker_sentiment_score": "0.015021", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.021725", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011478", "ticker_sentiment_label": "Neutral"}, {"ticker": "NODK", "relevance_score": "0.005428", "ticker_sentiment_score": "1.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000121", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.011872", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006403", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAII", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013529", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAV", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002946", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDSX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002512", "ticker_sentiment_label": "Neutral"}, {"ticker": "METX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00156", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001026", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.008567", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006455", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWVL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000145", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNEY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.393211", "ticker_sentiment_label": "Bearish"}, {"ticker": "NDRA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001256", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.168617", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALGS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000859", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.072563", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002619", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001674", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003807", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAVM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000646", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTG-P-A", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000193", "ticker_sentiment_label": "Neutral"}, {"ticker": "BQ", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000507", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRY", "relevance_score": "0.005428", "ticker_sentiment_score": "0.024824", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKSI", "relevance_score": "0.005428", "ticker_sentiment_score": "-8.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005213", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000999", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001442", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRBK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000264", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.019851", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005448", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001483", "ticker_sentiment_label": "Neutral"}, {"ticker": "TURN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00029", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.148476", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.031319", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGRU", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001445", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.005428", "ticker_sentiment_score": "5.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.005428", "ticker_sentiment_score": "0.034663", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001707", "ticker_sentiment_label": "Neutral"}, {"ticker": "INST", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000759", "ticker_sentiment_label": "Neutral"}, {"ticker": "COHU", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000175", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000293", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003698", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.005428", "ticker_sentiment_score": "0.019272", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012305", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005128", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.010855", "ticker_sentiment_score": "0.013698", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.021159", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTHM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.029413", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001813", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014272", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011583", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.005428", "ticker_sentiment_score": "0.010204", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001225", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.014752", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014443", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001214", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.300391", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ETNB", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.218213", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZNTL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000217", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.035983", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002199", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002407", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.007737", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.031658", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.02329", "ticker_sentiment_label": "Neutral"}, {"ticker": "FORA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.052558", "ticker_sentiment_label": "Neutral"}, {"ticker": "RFL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012134", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011935", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005133", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.00035", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBCI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005416", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010832", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001718", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.009318", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013213", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002222", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002273", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00501", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012228", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014175", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005016", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00084", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00258", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00077", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.201905", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HTH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.018219", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.013285", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBIO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007266", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004162", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.022314", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVR", "relevance_score": "0.005428", "ticker_sentiment_score": "6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001694", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00084", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004346", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000535", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALKT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000246", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.0434", "ticker_sentiment_score": "-0.032182", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014396", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVIV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005773", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010281", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002196", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFFN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012272", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002797", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001501", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010843", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.010855", "ticker_sentiment_score": "-0.016624", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.005428", "ticker_sentiment_score": "0.004914", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005187", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004864", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.005428", "ticker_sentiment_score": "0.009875", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000128", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003774", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003205", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.218246", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OTRK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000812", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFTR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.009878", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001383", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTRS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.021764", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003243", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.024154", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.010855", "ticker_sentiment_score": "-0.003513", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000456", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002645", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00915", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001263", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001791", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.012632", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001613", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSKEF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006448", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013727", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTHR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004002", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.020798", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011236", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002607", "ticker_sentiment_label": "Neutral"}, {"ticker": "JSPR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001081", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003031", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002874", "ticker_sentiment_label": "Neutral"}, {"ticker": "MATW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014647", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.025859", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005691", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004298", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.031145", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005207", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.005428", "ticker_sentiment_score": "0.008014", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYME", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001234", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00633", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "XGN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.034691", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005096", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.075873", "ticker_sentiment_score": "-0.020157", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.422547", "ticker_sentiment_label": "Bearish"}, {"ticker": "IDYA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000207", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014477", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.012332", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000505", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000697", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004763", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.21154", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SKYT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002215", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003718", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.011845", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001918", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003493", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001372", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.216618", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INMD", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.028707", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002589", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000291", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.016146", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007096", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003183", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.008084", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001675", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGG", "relevance_score": "0.005428", "ticker_sentiment_score": "0.006956", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.00195", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMBIL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000167", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.026958", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000638", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001126", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.010855", "ticker_sentiment_score": "0.182297", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GGR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002554", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.029415", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000584", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003726", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLBY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000855", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003329", "ticker_sentiment_label": "Neutral"}, {"ticker": "CREX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003361", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.016527", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.009244", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000528", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011111", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001247", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUCD", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013516", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLCN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000703", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.24229", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APYX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003348", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.017793", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000686", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIKI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001314", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001623", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013866", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.026143", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.015312", "ticker_sentiment_label": "Neutral"}, {"ticker": "YELL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.019485", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00075", "ticker_sentiment_label": "Neutral"}, {"ticker": "MX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.025877", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.005428", "ticker_sentiment_score": "3.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.004797", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006973", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012472", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNSO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.272945", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FAMI", "relevance_score": "0.005428", "ticker_sentiment_score": "0.013901", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004544", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002467", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.008006", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFUS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000546", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00496", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLTR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000815", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.023", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.017485", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000564", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.022374", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00834", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.054091", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.006165", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.005428", "ticker_sentiment_score": "-6e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.017634", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001634", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000368", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006809", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVLO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003146", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.067704", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTK", "relevance_score": "0.005428", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "DELL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00953", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013699", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00091", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000528", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000163", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.009025", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003913", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002153", "ticker_sentiment_label": "Neutral"}, {"ticker": "YORW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.0031", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.004918", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYLT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000963", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007987", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLRE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00352", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.156421", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RUBY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000733", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012305", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of Directors", "url": "https://www.benzinga.com/pressreleases/22/04/g26646216/cytomx-therapeutics-announces-retirement-of-john-a-scarlett-m-d-from-board-of-directors", "time_published": "20220414T201500", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., April  14, 2022   ( GLOBE NEWSWIRE )  -- CytomX Therapeutics, Inc.  ( NASDAQ:CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that John A. Scarlett, M.D. is retiring from its board of directors, effective when his current t", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.209306, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.065595", "ticker_sentiment_score": "0.690191", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABBV", "relevance_score": "0.130748", "ticker_sentiment_score": "0.20252", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.319311", "ticker_sentiment_score": "0.145929", "ticker_sentiment_label": "Neutral"}, {"ticker": "GERN", "relevance_score": "0.065595", "ticker_sentiment_score": "0.003348", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.130748", "ticker_sentiment_score": "0.20252", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of Directors", "url": "https://www.globenewswire.com/news-release/2022/04/14/2423090/37704/en/CytomX-Therapeutics-Announces-Retirement-of-John-A-Scarlett-M-D-from-Board-of-Directors.html", "time_published": "20220414T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., April  14, 2022   ( GLOBE NEWSWIRE )  -- CytomX Therapeutics, Inc.  ( Nasdaq: CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that John A. Scarlett, M.D. is retiring from its board of directors, effective when his current ", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.256871, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.03564", "ticker_sentiment_score": "0.610195", "ticker_sentiment_label": "Bullish"}, {"ticker": "ABBV", "relevance_score": "0.071209", "ticker_sentiment_score": "0.273357", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.141851", "ticker_sentiment_score": "0.00377", "ticker_sentiment_label": "Neutral"}, {"ticker": "GERN", "relevance_score": "0.03564", "ticker_sentiment_score": "0.003348", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.071209", "ticker_sentiment_score": "0.273357", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/news/22/03/26326033/stocks-that-hit-52-week-lows-on-monday", "time_published": "20220328T154408", "authors": [], "summary": "On Monday, 147 stocks hit new 52-week lows.\nAreas of Significance In Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Stanley Black & Decker  ( NYSE:SWK ) .\nVallon Pharmaceuticals  ( NASDAQ:VLON )  was the smallest firm by market cap to set a new 52-week low.\nAmyl", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5274.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.013237, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALNA", "relevance_score": "0.016131", "ticker_sentiment_score": "0.007841", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTH", "relevance_score": "0.016131", "ticker_sentiment_score": "0.006178", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.016131", "ticker_sentiment_score": "0.00292", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.001019", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.016131", "ticker_sentiment_score": "0.002235", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00129", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000545", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00129", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001166", "ticker_sentiment_label": "Neutral"}, {"ticker": "MG", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00129", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEIP", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.01024", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.006207", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.005265", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERY", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001016", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHR", "relevance_score": "0.016131", "ticker_sentiment_score": "0.004099", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMLX", "relevance_score": "0.032255", "ticker_sentiment_score": "0.067314", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.050564", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.030956", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.01146", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.005223", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.009079", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001551", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMT", "relevance_score": "0.016131", "ticker_sentiment_score": "0.002616", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.016131", "ticker_sentiment_score": "0.035428", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.014571", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.016131", "ticker_sentiment_score": "0.023583", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDSX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.011561", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001323", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.201749", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BCAB", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00839", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.032255", "ticker_sentiment_score": "0.031252", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.007435", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.016131", "ticker_sentiment_score": "0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.23832", "ticker_sentiment_score": "-0.014788", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.017216", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.019198", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.19758", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GFF", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.294012", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BTTX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.395066", "ticker_sentiment_label": "Bearish"}, {"ticker": "CRMT", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.001846", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000394", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLXA", "relevance_score": "0.016131", "ticker_sentiment_score": "0.017783", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.096555", "ticker_sentiment_score": "0.055625", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.016131", "ticker_sentiment_score": "0.003778", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.016131", "ticker_sentiment_score": "0.014828", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001961", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBH", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.009", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTK", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001423", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.016131", "ticker_sentiment_score": "0.003775", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLYB", "relevance_score": "0.016131", "ticker_sentiment_score": "0.002161", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.015082", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVRX", "relevance_score": "0.016131", "ticker_sentiment_score": "7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.027164", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.016131", "ticker_sentiment_score": "0.046859", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.016131", "ticker_sentiment_score": "0.003925", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNGY", "relevance_score": "0.016131", "ticker_sentiment_score": "0.00026", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000832", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIGL", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.008789", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.016131", "ticker_sentiment_score": "0.000445", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000798", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.016131", "ticker_sentiment_score": "0.025218", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYLT", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00383", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICVX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.026081", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIR", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000993", "ticker_sentiment_label": "Neutral"}, {"ticker": "WGO", "relevance_score": "0.016131", "ticker_sentiment_score": "-6.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.004458", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Friday", "url": "https://www.benzinga.com/news/22/03/26299843/stocks-that-hit-52-week-lows-on-friday", "time_published": "20220325T160550", "authors": [], "summary": "On Friday, 166 companies set new 52-week lows.\nPoints of Interest From Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Stanley Black & Decker  ( NYSE:SWK ) .\nVallon Pharmaceuticals  ( NASDAQ:VLON )  was the smallest company by market cap to set a new 52-week low.", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5170.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.021025, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALNA", "relevance_score": "0.013769", "ticker_sentiment_score": "0.001401", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTH", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.000446", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMTD", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.011697", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.001204", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.012469", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.002131", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.013769", "ticker_sentiment_score": "0.001073", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.013769", "ticker_sentiment_score": "0.007372", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGI", "relevance_score": "0.013769", "ticker_sentiment_score": "0.002386", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZVO", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.026636", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.026874", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEIP", "relevance_score": "0.027533", "ticker_sentiment_score": "-0.004933", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.013769", "ticker_sentiment_score": "0.000404", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHR", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.001778", "ticker_sentiment_label": "Neutral"}, {"ticker": "WERN", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.386382", "ticker_sentiment_label": "Bearish"}, {"ticker": "WING", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.006185", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.014076", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTCC", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.015361", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.002906", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.005051", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCMI", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.003503", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.013769", "ticker_sentiment_score": "0.035827", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDSX", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.014418", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.013769", "ticker_sentiment_score": "0.002456", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.013769", "ticker_sentiment_score": "0.004787", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNRO", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.014517", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.001303", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLK", "relevance_score": "0.013769", "ticker_sentiment_score": "0.025028", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCAB", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.010926", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.027533", "ticker_sentiment_score": "0.015122", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.282949", "ticker_sentiment_score": "-0.025904", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.008441", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.268586", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LIQT", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.00547", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.013769", "ticker_sentiment_score": "0.005335", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.013769", "ticker_sentiment_score": "0.035991", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.00075", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMT", "relevance_score": "0.013769", "ticker_sentiment_score": "0.004898", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.01533", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.109805", "ticker_sentiment_score": "0.004088", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.001746", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNGX", "relevance_score": "0.013769", "ticker_sentiment_score": "0.002493", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.001358", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.008893", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLTH", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.020528", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.013769", "ticker_sentiment_score": "0.002618", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNAY", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.000407", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDFC", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.009875", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVRX", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.015703", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.041289", "ticker_sentiment_score": "0.020898", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.013769", "ticker_sentiment_score": "0.001427", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.007398", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.017372", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRN", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.008441", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.008405", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBC", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.010091", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGIH", "relevance_score": "0.013769", "ticker_sentiment_score": "-3.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICVX", "relevance_score": "0.013769", "ticker_sentiment_score": "-0.012898", "ticker_sentiment_label": "Neutral"}]}, {"title": "CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors", "url": "https://www.benzinga.com/pressreleases/22/03/g26266130/cytomx-therapeutics-announces-retirement-of-frederick-w-gluck-from-board-of-directors", "time_published": "20220323T201500", "authors": ["Globe Newswire"], "summary": "SOUTH SAN FRANCISCO, Calif., March  23, 2022   ( GLOBE NEWSWIRE )  -- CytomX Therapeutics, Inc.  ( NASDAQ:CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that Frederick W. Gluck is retiring from its board of directors, effective June 30th, 2022.\n\"It h", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.137036, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.123748", "ticker_sentiment_score": "0.20252", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.123748", "ticker_sentiment_score": "0.20252", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.302951", "ticker_sentiment_score": "0.154043", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors", "url": "https://www.globenewswire.com/news-release/2022/03/23/2408989/37704/en/CytomX-Therapeutics-Announces-Retirement-of-Frederick-W-Gluck-from-Board-of-Directors.html", "time_published": "20220323T201500", "authors": ["CytomX Therapeutics Inc."], "summary": "SOUTH SAN FRANCISCO, Calif., March  23, 2022   ( GLOBE NEWSWIRE )  -- CytomX Therapeutics, Inc.  ( Nasdaq: CTMX ) , a leader in the field of conditionally activated oncology therapeutics, today announced that Frederick W. Gluck is retiring from its board of directors, effective June 30th, 2022.", "banner_image": "https://ml.globenewswire.com/Resource/Download/c252869d-a4c1-4e56-88e8-d80b85d20c35?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.204942, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABBV", "relevance_score": "0.137318", "ticker_sentiment_score": "0.273357", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMY", "relevance_score": "0.137318", "ticker_sentiment_score": "0.273357", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTMX", "relevance_score": "0.270598", "ticker_sentiment_score": "0.003956", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/news/22/03/26261101/stocks-that-hit-52-week-lows-on-wednesday", "time_published": "20220323T154749", "authors": [], "summary": "On Wednesday, 63 companies set new 52-week lows.\nNoteworthy Mentions In Today's 52-Week Lows:\nThe largest company by market cap to hit a new 52-week low was Stanley Black & Decker  ( NYSE:SWK ) .\nVallon Pharmaceuticals  ( NASDAQ:VLON )  was the smallest company when considering market cap to set a n", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_4959.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.002898, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.10342", "ticker_sentiment_score": "-0.000605", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.041653", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.03456", "ticker_sentiment_score": "0.00171", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.003041", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.000307", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.069054", "ticker_sentiment_score": "-0.021784", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.03456", "ticker_sentiment_score": "0.004209", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.03456", "ticker_sentiment_score": "0.000611", "ticker_sentiment_label": "Neutral"}, {"ticker": "AJX", "relevance_score": "0.03456", "ticker_sentiment_score": "0.169636", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TBBK", "relevance_score": "0.03456", "ticker_sentiment_score": "0.018846", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLR", "relevance_score": "0.03456", "ticker_sentiment_score": "2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.038025", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIASP", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.002116", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.03456", "ticker_sentiment_score": "0.004306", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.024436", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLTH", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.010575", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUET", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.001794", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.01189", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.03456", "ticker_sentiment_score": "0.018846", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLYB", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.001363", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLKN", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.003568", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.03456", "ticker_sentiment_score": "0.045234", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.03456", "ticker_sentiment_score": "0.000298", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWAQR", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.17225", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ANNX", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.030484", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIL", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.030295", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.009163", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.03456", "ticker_sentiment_score": "0.006613", "ticker_sentiment_label": "Neutral"}, {"ticker": "POWL", "relevance_score": "0.03456", "ticker_sentiment_score": "0.000623", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.001947", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.000403", "ticker_sentiment_label": "Neutral"}, {"ticker": "USNA", "relevance_score": "0.03456", "ticker_sentiment_score": "0.006613", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.021062", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGIH", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.238618", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VLON", "relevance_score": "0.069054", "ticker_sentiment_score": "0.040022", "ticker_sentiment_label": "Neutral"}, {"ticker": "WGO", "relevance_score": "0.03456", "ticker_sentiment_score": "0.000919", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/news/22/03/26125409/stocks-that-hit-52-week-lows-on-monday", "time_published": "20220314T161153", "authors": [], "summary": "On Monday, 671 companies achieved new lows for the year.\nPoints of Interest From Today's 52-Week Lows:\nAlibaba Group Holding  ( NYSE:BABA )  was the largest firm by market cap to set a new 52-week low.\nThe company with the smallest market cap to set a new 52-week low was Reshape Lifesciences  ( NASD", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_4242.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.011152, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003884", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGLE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001398", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLWS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.2171", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FEIM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005288", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004681", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000696", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIGR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005376", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001195", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002642", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCNC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002637", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016064", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACTG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000542", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000421", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000629", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNET", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00337", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTGN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.013657", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015648", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002718", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007926", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001817", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000373", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIASP", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00185", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMSI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008021", "ticker_sentiment_label": "Neutral"}, {"ticker": "COUP", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002201", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLQT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003108", "ticker_sentiment_label": "Neutral"}, {"ticker": "XMTR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012959", "ticker_sentiment_label": "Neutral"}, {"ticker": "BILI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016807", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004046", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTWO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005292", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.086934", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003916", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.036134", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.007545", "ticker_sentiment_score": "-0.00664", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000895", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007487", "ticker_sentiment_label": "Neutral"}, {"ticker": "AI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.013531", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOXC", "relevance_score": "0.003772", "ticker_sentiment_score": "-1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.007468", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001396", "ticker_sentiment_label": "Neutral"}, {"ticker": "NODK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002816", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003546", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009121", "ticker_sentiment_label": "Neutral"}, {"ticker": "MILE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000833", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002657", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOVO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015766", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004298", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.023894", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.014346", "ticker_sentiment_label": "Neutral"}, {"ticker": "RH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002168", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAII", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008781", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.030443", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00462", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000338", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001946", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002155", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTFT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003706", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLLI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005305", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006016", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012121", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.26753", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AIRG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003296", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005562", "ticker_sentiment_label": "Neutral"}, {"ticker": "VITL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010979", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016062", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAY", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002103", "ticker_sentiment_label": "Neutral"}, {"ticker": "COGT", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000549", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIAN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026157", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOMR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001124", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.031246", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAVM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001456", "ticker_sentiment_label": "Neutral"}, {"ticker": "BQ", "relevance_score": "0.003772", "ticker_sentiment_score": "0.011731", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.018211", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOHU", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000634", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004268", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006066", "ticker_sentiment_label": "Neutral"}, {"ticker": "S", "relevance_score": "0.003772", "ticker_sentiment_score": "0.017354", "ticker_sentiment_label": "Neutral"}, {"ticker": "YALA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001731", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001488", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000985", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001058", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYXI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000317", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000912", "ticker_sentiment_label": "Neutral"}, {"ticker": "THS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004609", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000744", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.031218", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003476", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLXS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000416", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003032", "ticker_sentiment_label": "Neutral"}, {"ticker": "WNW", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007135", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDOC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000708", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00181", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHM", "relevance_score": "0.003772", "ticker_sentiment_score": "4.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001944", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011047", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAA", "relevance_score": "0.003772", "ticker_sentiment_score": "0.019391", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003501", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001442", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKSY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00577", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNVY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.055909", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005562", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.20535", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AIRT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010498", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012368", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000437", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.014428", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001765", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOUR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00485", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017855", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALZN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004668", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.0021", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001462", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003591", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATY", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002065", "ticker_sentiment_label": "Neutral"}, {"ticker": "CANG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000198", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009292", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.014548", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003887", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010771", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005998", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002295", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.018453", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007713", "ticker_sentiment_label": "Neutral"}, {"ticker": "DV", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006021", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005693", "ticker_sentiment_label": "Neutral"}, {"ticker": "JWEL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.010903", "ticker_sentiment_label": "Neutral"}, {"ticker": "UK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012282", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSFTF", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011045", "ticker_sentiment_label": "Neutral"}, {"ticker": "FENG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004916", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.003772", "ticker_sentiment_score": "0.014836", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017551", "ticker_sentiment_label": "Neutral"}, {"ticker": "RFL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002186", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMDI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00428", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIVN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000776", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.019955", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012193", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00234", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007568", "ticker_sentiment_label": "Neutral"}, {"ticker": "BABA", "relevance_score": "0.007545", "ticker_sentiment_score": "-0.082091", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001945", "ticker_sentiment_label": "Neutral"}, {"ticker": "EH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002015", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCOM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.035733", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.012546", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.033258", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVLU", "relevance_score": "0.003772", "ticker_sentiment_score": "0.011865", "ticker_sentiment_label": "Neutral"}, {"ticker": "POSH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007586", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMTX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.157538", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HCM", "relevance_score": "0.007545", "ticker_sentiment_score": "0.00015", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.024422", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRCL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015492", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.01034", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000791", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.01273", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008573", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002822", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.185347", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IMVT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011815", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLOW", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006276", "ticker_sentiment_label": "Neutral"}, {"ticker": "TZOO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00175", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEKE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00369", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006156", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOSL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015294", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000436", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017092", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000792", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOYU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.17358", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OSPN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003938", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001017", "ticker_sentiment_label": "Neutral"}, {"ticker": "WB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001531", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.01886", "ticker_sentiment_score": "-0.000329", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006788", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003752", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVOX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004313", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTES", "relevance_score": "0.003772", "ticker_sentiment_score": "0.01205", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.019435", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNSA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004339", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001895", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026404", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUIZ", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002233", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.007545", "ticker_sentiment_score": "-0.005092", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010687", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000171", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONEM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004359", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXFY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003989", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.19891", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FWRG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000847", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUMU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016747", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016108", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZUN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.014003", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNLX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.014796", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.032201", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002703", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000238", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESMT", "relevance_score": "0.007545", "ticker_sentiment_score": "0.019141", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNA", "relevance_score": "0.003772", "ticker_sentiment_score": "0.006782", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026571", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001942", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006324", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.027162", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000699", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIDU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005157", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001117", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNDI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00019", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016003", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCTZF", "relevance_score": "0.003772", "ticker_sentiment_score": "0.0249", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003942", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.021849", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000841", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002247", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004604", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000154", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.032621", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCWX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000263", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002183", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCEL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003941", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000506", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLMD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001887", "ticker_sentiment_label": "Neutral"}, {"ticker": "IH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000983", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005539", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMB", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003137", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000896", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002896", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.036623", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000463", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004726", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007501", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010448", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007923", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000373", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.005304", "ticker_sentiment_label": "Neutral"}, {"ticker": "UXIN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005353", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00436", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009461", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCOR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004134", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001695", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004278", "ticker_sentiment_label": "Neutral"}, {"ticker": "PUBM", "relevance_score": "0.003772", "ticker_sentiment_score": "0.0049", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBTX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.037601", "ticker_sentiment_label": "Neutral"}, {"ticker": "APVO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.006064", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTHT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003211", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.24313", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000986", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHPW", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015471", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGMS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000371", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026293", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.022996", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.101578", "ticker_sentiment_score": "-0.031418", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000849", "ticker_sentiment_label": "Neutral"}, {"ticker": "WKME", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00343", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002691", "ticker_sentiment_label": "Neutral"}, {"ticker": "JP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000603", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000409", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.021216", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001758", "ticker_sentiment_label": "Neutral"}, {"ticker": "NATI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000291", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017566", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.0052", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNET", "relevance_score": "0.003772", "ticker_sentiment_score": "0.005232", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002206", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.021636", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMB", "relevance_score": "0.003772", "ticker_sentiment_score": "6.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "KC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011045", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACMR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001943", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001019", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002686", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000397", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009274", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004006", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009405", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEMI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000695", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIZZ", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004299", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPTX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002684", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLKN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000103", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.015132", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.183661", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLSE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002302", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003124", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUYA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.200057", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DAO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZME", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00376", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.024477", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003664", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005525", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.003772", "ticker_sentiment_score": "0.007321", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.010813", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLCE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017888", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00375", "ticker_sentiment_label": "Neutral"}, {"ticker": "RERE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004203", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002099", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000192", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEEV", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001905", "ticker_sentiment_label": "Neutral"}, {"ticker": "LU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012338", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.031217", "ticker_sentiment_label": "Neutral"}, {"ticker": "LW", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002687", "ticker_sentiment_label": "Neutral"}, {"ticker": "LX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00118", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOAH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.024247", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00092", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002876", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVDX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008111", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.331932", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RBLX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.226863", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "YUMC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011795", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBTX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010036", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMK", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001564", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.003772", "ticker_sentiment_score": "0.013143", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00082", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGC-U", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002724", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001394", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.028282", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADSK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006709", "ticker_sentiment_label": "Neutral"}, {"ticker": "DADA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001804", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002978", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNSS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.041602", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026571", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.013487", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00355", "ticker_sentiment_label": "Neutral"}, {"ticker": "MX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001261", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAKE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005316", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008951", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSLS", "relevance_score": "0.007545", "ticker_sentiment_score": "0.016914", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000325", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUTU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001885", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005903", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.003772", "ticker_sentiment_score": "0.03092", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLYS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001614", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003553", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARNC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005316", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPTN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002669", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELEV", "relevance_score": "0.003772", "ticker_sentiment_score": "0.011302", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011591", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000744", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001489", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDRX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.024689", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.033841", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.018437", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.025468", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00941", "ticker_sentiment_label": "Neutral"}, {"ticker": "STNEV", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001007", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIMI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.160316", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "COCO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000798", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002419", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012574", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003266", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.03283", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003613", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNDY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000582", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005335", "ticker_sentiment_label": "Neutral"}, {"ticker": "UFI", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00244", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003877", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIPS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003349", "ticker_sentiment_label": "Neutral"}, {"ticker": "QFIN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010737", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007097", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00594", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002952", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010934", "ticker_sentiment_label": "Neutral"}, {"ticker": "FINV", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001903", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIOT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000215", "ticker_sentiment_label": "Neutral"}, {"ticker": "PD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000522", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001095", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.031327", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPA", "relevance_score": "0.003772", "ticker_sentiment_score": "0.005079", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001893", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003442", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLNO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.01092", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAIN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000917", "ticker_sentiment_label": "Neutral"}]}]}